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Abstract
Influenza vaccine is a safe and effective vaccine in preventing influenza infection in the
general population. The Centers for Disease Control (CDC) recommend that pregnant women
receive the influenza inactivated vaccine (IIV) due to the high morbidity and mortality associated
with influenza infection in pregnant women. Despite the recommendation, the U.S. national
influenza vaccine uptake rates among pregnant women continue to remain low. Studies have
shown barriers to influenza vaccine uptake in pregnant women to include issues with access,
unavailability of vaccine, and lack of time during prenatal visits. These barriers can be overcome
using pharmacists because among healthcare providers, pharmacists are the most accessible;
approximately 250 million individuals make a trip to the pharmacy every week, however, there
are few qualitative studies on pharmacists perspectives on the role they can play to increase
influenza vaccine uptake in pregnant women. This study aims to qualitatively study explore: (a)
The course content related to influenza immunization and how pharmacy students perceive it, and
(b) Influenza vaccine administering practices among licensed pharmacists. The objectives will be
achieved qualitatively through the use of in-depth interviews and focus groups. Exploration of
pharmacy school curriculum revealed a need for pregnancy-specific immunization content.
Qualitative interviews with licensed pharmacists revealed that most pharmacists believe they have
a role to play in providing influenza immunization to pregnant women. This study suggests that
systematically implementing more pregnancy-specific content into pharmacy school curricular
would be effective in intervening with pharmacy students. Findings also indicate the need for
continued education intervention with practicing pharmacists, as access to immunization services
should not be mitigated by a lack of knowledge and personal beliefs.

vi

Introduction
Purpose of the Study
Pregnancy is a unique immunological state, in which the immune system is modulated as
a result of placental response and its tropism for specific pathogens and viruses. These affect the
pregnant woman's susceptibility to certain infections (Mor & Cardenas, 2010). Research has
shown an increase of about a four-fold in influenza antibody titers during pregnancy. (Mak,
Mangtani, Leese, Watson, & Pfeifer, 2008). In between influenza epidemics, and during
influenza pandemics, pregnant women are usually more susceptible to contracting influenza and
its subsequent complications such as pneumonia, spontaneous abortions, preterm births, birth
defects and fetal loss (Mak et al., 2008; Rasmussen, Jamieson, & Bresee, 2008). Usually the
morbidity from influenza in this population is low, however during the influenza pandemics such
as 1918, 1957, 2009 and other influenza outbreaks, there were high death rates in pregnant
women (Callaghan, Chu, & Jamieson, 2010; Mak et al., 2008; Thompson et al., 2011).
During the 1918 influenza pandemic in the U.S., 27% of pregnant women died, also in
the 1957 pandemic influenza, 20% of influenza-associated deaths occurred in pregnant women
(Rasmussen et al., 2008). There is four times risk of hospitalization in pregnant women
compared to the non-pregnant individual (Hamborsky, Kroger, & Wolfe, 2015). This increase in
mortality during influenza pandemics is a significant cause for concern, thereby placing pregnant
women as a priority group for recommending the inactivated influenza vaccine (IIV) (Callaghan
et al., 2010; Thompson et al., 2011). Also, uptake of IIV during pregnancy has a two-fold
1

benefit, as it protects the mother and the baby for its first few months of life (Simondsen &
Hayney, 2011). This protection for the baby is essential, as there is no licensed influenza vaccine
for infants under six months of age, and also because, during influenza outbreaks, children
experience the highest infection rates (Simondsen & Hayney, 2011).
The purpose of this study was to explore the role pharmacists can play to increase IIV
uptake among pregnant women in Florida. Using the Theory of Planned Behavior (TPB), this
study sought to explore and understand what pharmacy students are being taught regarding
immunization with respect to pregnant women, and the day to day experiences of licensed
pharmacists as they provide immunization services generally and with respect to pregnant
women. In addition, the study examined pharmacy schools curricular to understand how the
course content on immunization is being taught and what it entails. A qualitative analysis design,
involving in-depth interviews with academic deans and licensed pharmacists, and focus groups
with pharmacy students was employed to meet these objectives. The goal of this study was to
create a set of recommendations to pharmacy schools and the department of health regarding
pregnancy immunization content in pharmacy curriculum and advocate for additional avenues
through which pregnant women can obtain IIV.
Background and Significance
Influenza in its epidemic form can cause mortality and morbidity in as much as twenty
percent of the population in the United States. During the 2009/2010 flu pandemic, pregnancy
was identified to be a risk factor for extreme cases influenza; among women aged 18-29,
influenza-pregnancy related deaths occurred in about 16% and hospitalizations in 29%
(Biggerstaff, Cauchemez, Reed, Gambhir, & Finelli, 2014; Memoli, Harvey, Morens, &
Taubenberger, 2013). Influenza viruses are RNA viruses; there are three types namely, A, B, and
2

C, of which A and B are known to cause major seasonal outbreaks with associated illnesses and
deaths (Cox & Subbarao, 2000). The Influenza viruses change regularly either through
"antigenic drifts," which are minor points of mutation or through major "antigenic shifts," which
are major points of mutation (Biggerstaff et al., 2014; Cox & Subbarao, 2000). These antigenic
drifts and shifts can cause a new version or strain of the influenza virus to be introduced into the
human population of which individuals are yet to receive the vaccine, causing epidemics and
pandemics (Biggerstaff et al., 2014; Cox & Subbarao, 2000; Treanor, 2004). As a result of these
changes, the pattern of new pandemics will be hard to predict (Biggerstaff et al., 2014). Influenza
virus disease is the 8th leading cause of death in the U.S. and is responsible for influenza-related
deaths in about 12,000-56,000 people (Arnold, Luong, Rebmann, & Chang, 2019).
Several groups of individuals are considered as high risk for major influenza illness and
mortality, and they include pregnant women, children, adults aged 65 years or older, and
individuals who have chronic conditions such as diabetes, immunodeficiencies, heart disease,
obesity, and asthma. (Nowak, Sheedy, Bursey, Smith, & Basket, 2015). About 31 million
individuals contacted the influenza virus disease in during the 2016/2017 influenza season, and
about 50% visited a healthcare provider (Arnold et al., 2019). The economic cost of seasonal
influenza in the United States is estimated to be about $11 billion including direct medical costs
of about 10 billion and missed workdays, and loss in productivity account for the bulk of the
burden; these consequences emphasize how much influenza illness is a drain on the U.S.
economy (Arnold, et al., 2019; Molinari et al., 2007; Nowak et al., 2015).
Influenza virus overview. The influenza virus is an RNA virus which depending on the
annual genetic change and severity of the illness can be grouped as seasonal or pandemic. The
influenza virus is transmitted through inhaling aerosols contaminated with the virus (Iwasaki &
3

Pillai, 2014). Influenza epidemics occur yearly all over the world. In the U.S. they cause
significant comorbidities and deaths in about 20% of the U.S. population annually (Biggerstaff et
al, 2014). The Influenza viruses change regularly either through "antigenic drifts," which are
minor points mutations of through major "antigenic shifts" which are mayor points mutations
(Biggerstaff et al., 2014; Cox & Subbarao, 2000). The pandemic strains of the virus, which occur
every ten to twenty years, are as a result of the “antigenic shift”, while the “antigenic drift is
responsible for the seasonal strain of the influenza virus (Iwasaki & Pillai, 2014). These
antigenic drifts and shifts can cause a new version or strain of the influenza virus to be
introduced into the human population of which individuals are not yet immune against hence,
causing epidemics and pandemics (Biggerstaff et al., 2014; Cox & Subbarao, 2000; Treanor,
2004). As a result of these changes, the pattern of new pandemics will be hard to predict
(Biggerstaff et al., 2014). Vaccines remain the best tool to prevent illness from the influenza
virus (WHO, 2012).
Influenza vaccines. Inactivated influenza vaccines (IIV) have been licensed for use since
1945 in the United States (Fiore, Bridges, Katz, & Cox, 2012), while the live attenuated type was
first made available in 2003 (Plotkin & Plotkin, 2013). The effectiveness of the seasonal
influenza vaccine is reviewed periodically so the current circulating strain of the virus can be
included when developing the vaccine (Weir & Gruber, 2016). The review process is
coordinated worldwide by the World Health Organization (WHO) and it is based on updated
surveillance data obtained every February for countries in the Northern Hemisphere. The report
is sent to the respective countries where composition and formulation of the vaccines is
undertaken pending approval of the regulating agencies, which is the FDA in the United States
(U.S.) (Weir & Gruber, 2016).
4

In the U.S., the two types of influenza vaccines available are the live attenuated influenza
vaccine (LAIV), and the inactivated influenza vaccine (IIV). The formulations include the
quadrivalent influenza vaccines which contain A(H1N1), type A(H3N2), and two type B strains,
while the trivalent contains type A(H1N1), type A(H3N2), and one type B strain (Hamborsky,
Kroger, & Wolfe, 2015). The IIV is the only recommended for uptake in pregnant women
(Hamborsky, Kroger, & Wolfe, 2015).
Influenza vaccination guidelines. The Advisory Committee on Immunization Practices
(ACIP) recommends that all individuals 6 months or older receive the influenza vaccine, as it
remains the most effective way to prevent influenza illness and its comorbidities (Lu et al.,
2018). The CDC prioritizes influenza vaccination in several groups of individuals considered
high risk or priority, and especially if vaccine shortage occurs. These individuals include
children aged six months to fifty-nine months, people 50 years and older, pregnant women or
women who plan get pregnant during the influenza season, health care personnel, residents of
chronic care centers and nursing homes, people aged six months to 18 years on long term aspirin
treatment who with the influenza illness can develop Reye syndrome, individuals who are
Alaskan natives or American Indians, and contacts and caregivers of adults 50 and older and
children younger than 5 years, with an important focus on children aged younger than 6 months
(CDC, 2016a, 2016b). Other groups of individuals who are also considered as priority or high
risk for major influenza illness and mortality, such as individuals who have chronic conditions
such as diabetes, immunosuppression, obesity and, asthma (Nowak et al., 2015).
History of influenza vaccine recommendation in pregnant women. The Advisory
Committee on Immunization Practices (ACIP) of the Centers for Disease Control (CDC) in 1997
added recommending the influenza vaccine for pregnant and breastfeeding women (Arden,
5

Izurieta, Fukuda, Cox, & Schonberger, 1998; CDC, 2003; Fiore et al., 2010). This was added to
the influenza vaccine recommendation guideline following a study of the effect of influenza
virus infection in pregnant women during seventeen interpandemic influenza infection seasons
(Arden et al., 1998). It was documented that there is an associated increase in morbidity in
pregnant women in their second and third trimesters; it was also concluded that one out of two
hospitalizations or admissions in pregnant women could be avoided per 1000 women who get the
influenza vaccine (Arden et al., 1998). The influenza vaccine remains the best way to prevent
influenza illness among this population (Naleway, Smith, & Mullooly, 2006).
The American College of Obstetricians and Gynecologists (ACOG) in 2004 sent out a
directive to all its members to use the ACIP recommendation that all pregnant women should
receive the influenza vaccine (ACOG, 2004; Fiore et al., 2010; Thompson et al., 2011). The
ACOG has the following recommendations regarding the annual inactivated influenza vaccine
(IIV) uptake for pregnant women: (i) all pregnant women or women planning to be pregnant
should receive the vaccine; (ii) healthcare providers should recommend, advocate and counsel
pregnant women about the twofold benefits of the vaccine for them and their baby, and the safety
of the vaccine; (iii) OB/GYNs should administer the vaccine to the women and also stock the
vaccine; (iv) If OB/GYNs do not stock the vaccines, they should refer patients to other providers
such as pharmacies or other healthcare providers; (v) OB/GYNs should ensure their staff
receives the vaccine every year; (vi) Women with a history of allergy to eggs with reactions such
as hives can receive the vaccine; (vii) Women with allergic reactions that are worse than hives
should receive the vaccine on an inpatient or outpatient basis; (viii) Pregnant women with
influenza-like illnesses should receive antiviral medication regardless of their vaccine status; and
(ix) Pregnant women should receive post-exposure antiviral chemoprophylaxis once daily for ten
6

days, to avoid the morbidity associated with the infection (ACOG, 2018).
Table 1. Trends of Influenza vaccine uptake rates among pregnant women

Flu Season

Influenza Vaccine Uptake in Pregnant Women

2011-2012

44.0%

2012-2013

46.4%

2013-2014
2014-2015
2015-2016
2016-2017
2017-2018

52.2%
50.3%
49.9%
53.6%
35.6%

*CDC 2011-2018 data source

Despite the ACIP recommendations, IIV uptake remains suboptimal in pregnant women.
As of November 2017, IIV uptake among pregnant women was 35.6% (CDC, 2017). Also,
previous CDC influenza surveys show that the overall vaccine coverage in this population has
been low (see Table 1). All these vaccination rates are much lower than the targeted 90%
coverage proposed by the healthy people 2020 goals (Lu, Bridges, Euler, & Singleton, 2008;
Plans-Rubió, 2012; Whitley & Monto, 2006; Xakellis, 2005).
According to ACOG, during pregnancy, a woman can receive basic level prenatal care
from healthcare providers such as OBs, family physicians, advance-practice nurses, and certified
nurse-midwives (American Academy of Pediatrics, & American College of Obstetricians and
Gynecologists, 2002). While these women do not obtain prenatal care from pharmacists, they can
when referred by prenatal health care providers, obtain the IIV at pharmacies. Pharmacists have
been shown to be the first healthcare provider that is questioned on medication advice.
Literature, however, has shown that they usually do not feel equipped about providing
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information to pregnant women and would instead refer them to their respective physicians
(Samuel & Einarson, 2011).
Justification for the Study
Studies have shown barriers to IIV uptake in pregnant women to include concerns with
safety for their unborn child and themselves; lack of awareness of the “two-fold” benefit of the
vaccine; and women in their first or second trimester (Chamberlain et al., 2015; Meharry,
Colson, Grizas, Stiller, & Vázquez, 2013; Wheelock et al., 2013). Other barriers to influenza
vaccine uptake in this population include access, lack of time, distance to care centers, lack of
transportation to a health care center, and lack of availability of influenza vaccine at providers’
office (Arao, Rosenberg, McWeeney, & Hedberg, 2015; Healy, Rench, Montesinos, Ng, &
Swaim, 2015; Meharry et al., 2013).
Among providers, reasons for low IIV uptake in pregnant women included insufficient
time during prenatal visits, allergic reaction to the vaccine, and their lack of knowledge about the
vaccines (Healy et al., 2015). Providers also reported that the prior beliefs held by the women,
their lack of enthusiasm when recommending the vaccine and insufficient time to explain the
benefits of the vaccine during visits are some reasons for low influenza vaccine uptake in
pregnant women (Arao et al., 2015). A study by Wallis et al. reported that obstetric practices had
lower influenza vaccination rates versus family physicians, and larger health (group practices vs.
private/solo practices) care centers had lower vaccine recommendation rates (Wallis, Chin, Sur,
& Lee, 2006). Some healthcare workers also reported a non-belief in the safety and effectiveness
of the IIV in pregnant (Broughton, Beigi, Switzer, Raker, & Anderson, 2009).
Additionally, several interventions have been developed to improve influenza vaccine
uptake (Odone et al., 2015). Most influenza vaccine intervention studies have focused on vaccine
8

campaigns, computerized reminders, the use of text message reminders, social networks, and
web-based portals, and a few of these interventions have focused on pregnant women (Odone et
al., 2015). This serves as a potential limitation, as pregnant women encounter other barriers that
are not the same as the general population such as concerns with the baby and issues with access,
such as unavailability of the vaccine at the healthcare providers clinic during an initial visit, and
a failure of a provider to recommend or prescribe the vaccine in subsequent visits (Arao et al.,
2015; Healy et al., 2015; Meharry et al., 2013).
Community-level determinants of vaccine uptake in pregnant women, which include
transportation issues (Beel et al., 2013; Healy et al., 2015), distance from the clinic (Ballas et al.,
2015; Beel et al., 2013) will be classified as problems with access to the vaccine. Problems with
access, lack of availability of the vaccine at care providers clinic, and lack of time during visits
from providers’ perspective are barriers that can be overcome using community pharmacies.
Individuals have access to community pharmacies over more extended hours and days
(Grabenstein, 1998; Steyer, Ragucci, Pearson, & Mainous III, 2004). The study by Steyer et al.
showed that in states that allowed pharmacists to administer immunization, the vaccine rate
increased significantly in adults between the ages of 18-64 years. Among health care providers,
pharmacists are the most accessible, as approximately 250 million individuals make a trip to the
pharmacy every week (Steyer et al., 2004). In the year 2000, the ACIP recommended standing
order programs, which authorize pharmacists and nurses to administer vaccines to adults
((McKibben, Stange, Sneller, Strikas, & Rodewald, 2000). This recommendation followed
studies that demonstrated that having nurses and pharmacists administer vaccines improved
vaccination rates in adult populations. Implementation of programs such as this helps to take the
pressure off physicians and increase adult vaccine coverage (McKibben et al., 2000).
9

Some studies have identified gaps and barriers in the role of pharmacists in administering
and offering vaccines, and gaps have also been identified among pharmacy students. A study by
Bain and Cullison (2009) reported that only about 38% of U.S pharmacy schools have
immunization lectures and training as part of their core curricula (Bain & Cullison, 2009).
Recent studies, however, report that almost all pharmacy schools in the U.S. provide a form of
instruction on immunization (Prescott & Bernhardi, 2019). It is unclear, however, if it provides
information specific to pregnant women. Several studies have identified various barriers to
pharmacists administering vaccines in general, and they include; not being immunization
certified, legal liability, inadequate training, lack of time, and lack of support from staff and
management, (Burson et al., 2016; Neuhauser et al., 2004; Pace et al., 2010). Other barriers
identified include lack of acceptance by the public, lack of a compensation structure from
insurance companies, and lack of clarity of roles with other health professionals (Goad &
Durham, 2013).
With regards to administering the influenza vaccines to pregnant women, a study showed
that majority of pharmacists were less likely to believe they had an important role in
administering inactivated influenza vaccines to pregnant women, compared to the general public
(Dolan et al., 2012). There are few studies that try to qualitatively explore the role pharmacists
play in administering vaccines, especially from the perspective of the pharmacists themselves.
Some studies have qualitatively explored the perceptions of the community and other health care
personnel on the role pharmacists have played, but no studies available exploring the
pharmacist’s perspective (Blake, Blair, & Couchenour, 2003). A quantitative study by Dolan et
al (2012), assessed pharmacists’ knowledge attitudes and practice as it relates to treatment and
vaccination of pregnant women during the 2009 influenza virus pandemic. They reported that
10

pharmacists did not believe they had an important role in administering inactivated influenza
vaccines to pregnant women (Dolan et al., 2012). The study, however, aims to explore the role
pharmacists play in inactivated influenza vaccine administration in pregnant women practice,
and this will be carried out qualitatively. This study attempts to fill these gaps by investigating
and exploring the course content in pharmacy schools in Florida and also explore the perceptions
of licensed Florida pharmacists about their role in offering and administering inactivated
influenza vaccines to pregnant women. According to a study by Kennedy et al., the state of
Florida had a 21.6% IIV coverage among pregnant women during the 2009-2010 influenza
season, and it also ranked the lowest among the states studied (Kennedy et al., 2012). For this
reason, the study will be carried out in Florida.
Public Health Significance
The next step in the research course for improving IIV uptake among pregnant women is
innovative and important, as it seeks to understand the role pharmacists can play in increasing
accessibility of the influenza vaccines in pregnant women. This formative research will
contribute to future research and the development of interventions aimed to increase IIV uptake
rates among pregnant women. Additionally, this research responds to several national research
priorities. The American College of Obstetricians and Gynecologists calls for more efforts to
improve the rate of IIV uptake among pregnant women (ACOG, 2018). The Centers for Disease
Control and Prevention (CDC) also calls for implementation of “standing orders” for vaccination
to increase IIV uptake in pregnant women (Ding et al., 2017). This research also addresses the
Healthy People 2020 goal of increasing the coverage of IIV among pregnant women to 90%
coverage annually (Lu, Bridges, Euler, & Singleton, 2008).
Finally, this research is relevant to the call for how pharmacists can improve preventive
11

healthcare services and help address the shortage of primary care providers in the United States
(Manolakis & Skelton, 2010). Therefore, it is important to understand the perceptions of
pharmacists when it comes to administering IIV in pregnant women. The influenza vaccine
uptake rate in this population remains suboptimal, exploring the role of pharmacists is important
as this problem still persists.
Research Design
The long-term goal is to increase IIV uptake rates in pregnant women, ultimately
increasing protection for pregnant women and their fetuses during influenza outbreaks. The
design of this study focused primarily on the role of pharmacists in increasing IIV among
pregnant women through a qualitative process. However, to understand the bigger picture
regarding influenza vaccine administration practices among pharmacists in the state of Florida,
an additional qualitative assessment of pharmacy school curricular and pharmacy students
learning content regarding such practices were carried out. The study was conducted
qualitatively using both in-depth interviews and focus groups. Thus, the scope of the study was
expanded beyond understanding the perceptions of licensed pharmacists, in order to assess
pharmacy education and how it may enhance or limit the role of pharmacists. For the study, both
aspects of the qualitative analysis will be conducted concurrently, the pharmacy school’s
curricular analysis provides a supportive role for the overall aim of the study.
Specific aims and research questions. This study has two purposes: Firstly, the course
content related to influenza immunization and how pharmacy students perceive it will be
assessed. Secondly, the influenza vaccine administering practices among licensed pharmacists
will be explored. The objectives will be achieved through the following specific aims, using indepth interviews and focus groups. This study used the Theory of Planned Behavior (TPB)
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approach for study design by informing the interview guide development for both pharmacists
and pharmacy students.
1. Aim 1a: To understand how the course content of the six accredited schools of
pharmacy in Florida is taught regarding vaccine administration in pregnant women, with
a focus on inactivated influenza vaccine (IIV).
Research Questions
a.) What courses and lectures regarding influenza vaccine administration, in
general, are provided in the required courses of the accredited schools of
pharmacy in Florida?
b.) What courses and lectures regarding IIV administration in pregnant women are
provided in the required courses of the accredited schools of pharmacy in Florida?
2. Aim 1b: To understand how 3rd and 4th-year pharmacy students perceive vaccine
administration course content regarding vaccine administration in pregnant women,
with a focus on IIV.
Research Questions
a.) What did pharmacy students learn about the inactivated influenza vaccine
(IIV) administration in pregnant women in their pharmacy school classes?
b.) What are the projected practices of IIV administration in pregnant women
practices among pharmacy students after graduation?
3. Aim 2: To explore the knowledge, attitudes, social factors, affect, and facilitating
conditions that influence IIV in pregnant women administration practices among licensed
pharmacists.
Research Questions
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a.) How does knowledge affect the inactivated influenza vaccine (IIV)
administration in pregnant women practices among licensed pharmacists in
Florida?
b.) How do attitudes affect the inactivated influenza vaccine (IIV) administration
in pregnant women practices among licensed pharmacists in Florida?
c.) How social factors affect inactivated influenza (IIV) vaccine administration in
pregnant women practices among licensed pharmacists in Florida?
d.) How does perceived control affect the inactivated influenza vaccine (IIV)
administration in pregnant women practices among licensed pharmacists in
Florida?
Overview of Methods. To achieve these specific aims, a qualitative study design will be
conducted. For the first aim which has two components: (a) in-depth key informant interviews
were conducted with the six academic deans in the accredited pharmacy schools in the state of
Florida, and (b) three focus group sessions with about 2-8 participants was conducted with 3rd
and 4th year pharmacy students in three Florida schools. For the second aim, in-depth interviews
were conducted with licensed pharmacists in Florida with a sample size of 18 stratified by the
type of pharmacist’s workplace, such as community vs clinical. The research questions as
informed by the TPB were designed to be open-ended, to allow the participants to describe their
personal opinions, experiences, and perceptions regarding inactivated influenza vaccine
administration in pregnant women practices. Interview participants were recruited through
emails (academic deans), and flyers for licensed pharmacists and pharmacy students. All 6
academic deans of the accredited pharmacy schools in Florida, and 18 licensed pharmacists out
of the 28 that were recruited, participated in in-depth interviews, and 3 focus groups with
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pharmacy students (n=18) were conducted. Interviews were digitally recorded and transcribed
verbatim, and a second coder independently coded the majority of interviews.
Implications
Findings from this formative research will inform a quantitative survey utilizing the TPB
theory to expand this research to a larger sample of pharmacists and increase the generalizability.
Moreover, it will inform campaign messages for pregnant women to obtain the IIV from the
pharmacy, giving the pharmacists more credibility to perform this function and ultimately
improving IIV uptake among pregnant women. Future theory-based interventions developed
from these findings will utilize the TPB theory approach for designing strategies to increase the
implementation of guidelines (Francis et al., 2004). Moreover, future research should triangulate
the findings from this study among pharmacists with pregnant women, and also with physicians
and other health care providers that attend to pregnant women. While previous research indicates
patients and sometimes providers do not view pharmacists as qualified providers of
immunization services (Blake, Blair, & Couchenour, 2003), an understanding of how this bias
occurs, and the barriers that may be needed to overcome them is required.
This study has the potential to advance public health practice and theoretical
methodology. Azjen in 1985 proposed the use of TPB to understand determinants for intention to
engage in a behavior, based on its constructs; attitudes, subjective norms, and perceived
behavioral control (Glanz et al., 2008). Previous research has been conducted using the TPB to
predict pharmacist’s intention to provide medication disposal education (Tai, Hata, Wu, Frausto,
& Law, 2016), and this study uses it to predict pharmacists behavior in administering IIV in
pregnant women, and also providing education to pregnant women regarding the vaccine.
Therefore, there is the potential to expand the utility and application of TPB theory to other
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health care professionals and new procedures.
Definition of Key Terms
Vaccine uptake. Is a situation where vaccines are made accessible to individuals, and the
individuals accept the vaccines (Thomson, Robinson, & Vallée-Tourangeau, 2016). Vaccine
uptake continues to be suboptimal and the reasons for this are context-dependent and complex
and are much broader than just accessibility and acceptance (Gargano et al., 2011; Thomson et
al., 2016). There are several determinants of vaccine uptake and they include, access,
affordability, acceptance, activation, and awareness (Thomson et al., 2016). Acceptance is the
degree to which persons refuse, accept or question the vaccine, and it is influenced by factors
such as, perceived efficacy, perceived severity, health beliefs, past behavior, social norms, and
health care provider influence (Halliday, Thomson, Roberts, Bowen, & Mead, 2003; Thomson et
al., 2016). Activation is the degree to which persons are coerced to take a vaccine. It is
influenced by factors such as workplace policies and reminders and prompts (Halliday et al.,
2003; Thomson et al., 2016). Awareness is the degree to which persons know the
recommendation for, availability of and the need for vaccines alongside their perception of the
risks and benefits (Thomson et al., 2016). This is influenced by factors such as lack of
knowledge about the vaccine, and vaccine schedule, also, poor education (Thomson et al., 2016;
Zhang, While, & Norman, 2011).
Several studies have shown a positive influence of health care provider recommendation
and sometimes administration on vaccine uptake (Ding et al., 2017; Rosenthal et al., 2011; Wiley
et al., 2013; Ylitalo, Lee, & Mehta, 2013). The study by Ding et al (2017), also reported that
among the 1893 pregnant women surveyed, 67.3% of women received both the inactivated
influenza vaccine IIV recommendation and offer by their physicians, the uptake or coverage rate
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among them was 70.5%. About 12% of the women received influenza vaccine recommendation
but no offer, and the vaccine uptake or coverage rate among them was 43.7% (Ding et al., 2017).
Based on these, for this study, healthcare provider recommendation will not be treated as a factor
influencing acceptance. Instead, it will be treated as a factor directly affecting vaccine uptake.
Hence, for this study, vaccine uptake will be defined as a situation where vaccines are available,
healthcare providers recommend the vaccine and individuals accept the vaccine (figure 1).

Figure 1. Diagram of modified definition of vaccine uptake as applied to the study.
Vaccine hesitancy. This can broadly be defined as arousal or delay in receipt of vaccines
despite the availability of immunization services. It is multifaceted and context-specific, varying
across time, place and vaccines, and is influenced by factors such as (i) confidence, which is
when individuals do not trust the provider or the vaccine, (ii) convenience, which has to do with
access, and (iii) complacency, which has to do with individuals not perceiving the need for the
vaccine (Larson, Jarrett, Eckersberger, Smith, & Paterson, 2014; MacDonald, 2015). There are
three determinants of vaccine hesitancy namely, contextual factors, individual and group
influences, and vaccine and vaccination specific issues (Larson et al., 2014).
Herd Immunity. The term herd immunity has been defined in various ways by different
authors and researchers. It was defined in the Dorland’s illustrated medical dictionary as “the
resistance of a group to attack by a disease because of the immunity of a large proportion of the
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members and the consequent lessening of the likelihood of an affected individual coming into
contact with a susceptible individual" (John & Samuel, 2000; Saunders, 1994). It can also be
defined as “Immunity to the unimmunized individuals by the secondary spread of the attenuated
viruses or bacteria in the vaccine” (Paul, 2010). Other benefits vaccines have on the community
that is similar to herd immunity include herd protection and herd effect, and they have been used
interchangeably in various studies (John & Samuel, 2000; Paul, 2010).
One of the limitations of the herd immunity is that it is not a naturally acquired type of
immunity, which makes individuals protected by the indirect herd effect to be completely
susceptible to the infection when exposure occurs (Fine, Eames, & Heymann, 2011). An
example was the 1993 congenital rubella epidemic that occurred in Greece and affected pregnant
women and their fetuses (Panagiotopoulos, Berger, & Valassi-Adam, 1999). It was caused by
delays in unvaccinated individuals coming down with the infection as a consequence of herd
immunity from MMR which is a live vaccine. Pregnant women are at risk for coming down with
these vaccine-preventable illnesses when they do not receive the vaccine or have been exposed to
the wild virus. Hence, there is a need to increase vaccine coverage in such populations (Fine et
al., 2011).
Conceptual Framework
There usually exists a gap between research evidence and day to day practice among
healthcare providers. Several factors can affect clinical behavior adoption among healthcare
providers such as individual level, organizational level, political level and economic factors
(Grol & Wensing, 2004). Usually, individual decision making is key to adopting a behavior
(Knabe, 2012). To achieve the best possible outcomes for individuals to adopt a behavior
(pharmacists for this study), it is essential to design interventions that target or improve behavior
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change. For this study it is hypothesized that if pharmacists intend to administer inactivated
influenza vaccines to pregnant women, then they will have positive attitudes towards
administering the influenza vaccine to pregnant women, they will perceive important individuals
think they should administer the vaccine, and their perceived control over this action will
increase. Based on this rationale the theory of planned behavior is going to be used as the
conceptual framework for the study.
Theory of planned behavior overview. The Theory of Planned Behavior (TPB) is an
intrapersonal level theory that has been extensively used in various types of health research that
show reasons that can envisage why an individual would or would not engage in a behavior
(Glanz et al., 2008). Central to this theory is an individual’s intention regarding a specific
planned behavior and the theory posits that behavioral intention is the best predictor of behavior.
Furthermore, it is believed that determinants of this intention are behavioral attitudes, social
norms surrounding the behavior, and the perceived behavioral control regarding the behavior
(Glanz et al., 2008, pp 68).
Theoretical underpinnings. Icek Ajzen first described TPB in 1985; it is an expansion
of the Theory of Reasoned Action (TRA), which was developed earlier by Ajzen and Fishbein
(Ajzen & Fishbein, 1980). TRA assumes that individuals are rational and make informed choices
based on the information they have available. The TRA assumes that individuals contemplate the
repercussions of their actions before they make decisions regarding performing a behavior or not
(Ajzen & Fishbein, 1980). The TRA has two constructs; subjective norms and attitudes,
however, the effect of these factors in influencing an individual’s intention differs from person to
person (Ajzen & Fishbein, 1980). TRA was developed to explain volitional behaviors, while
TPB was developed to include actions that are not entirely volitional. The TPB has an added
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construct, perceived behavioral control (Ajzen & Fishbein, 1980; Glanz et al., 2008), and was
developed to resolve the shortcomings involving the fact that behaviors are not entirely volitional
that were identified by the originators through their research (Glanz et al., 2008; Montano &
Kasprzyk, 2015). The TPB includes three determinants for intention to engage in a behavior:
attitudes, subjective norms, and perceived behavioral control (see Table 2 for the description of
each construct and sub-construct and an example application to inactivated influenza vaccine
administration by pharmacists to pregnant women).
TPB application to pharmacists providing medication disposal education. As
previously stated, the TPB was initially developed as a behavioral framework to predict if an
individual intends to participate in an activity. To predict their intention, it is essential to know if
they are in favor of engaging in the activity (attitude), the effect of the social pressure they feel
(subjective norm), and if the person feels they are in control of the activity in question (perceived
behavioral control) (Francis et al., 2004). Previous research has been conducted using the TPB to
predict pharmacist’s intention to provide medication disposal education (Tai, Hata, Wu, Frausto,
& Law, 2016). Using this theory, Tai et al. (2016), posited that pharmacists would have a
favorable attitude, social norm, and perceived behavioral control, which would increase their
intention to provide medication disposal information.
Regarding attitude, most pharmacists were comfortable in providing medication disposal
education to patients. However, 40% of them felt providing the education would lead to an
increase in their workload. For subjective norm, most pharmacists believed that other health
professionals and patients would be okay with them providing medication disposal education.
Lastly, for perceived behavioral control, most pharmacists indicated that they would be able to
keep themselves updated with required rules and regulations and would have sufficient time to
20

provide medication disposal education (Tai et al., 2016). The authors of this study highlighted
the unique structure of the TPB theory constructs for pharmacists providing medication disposal
education to patients, and they were able to identify shortcomings in pharmacists providing the
education. These shortcomings, such as the increase in workload should be targeted when
developing interventions (Tai et al., 2016). Moreover, the findings from this study have
implications for this study. All three constructs report heuristic beliefs, individual influences, and
influences from other healthcare providers and patients that translate for the pharmacist’s role in
administering inactivated influenza vaccines to pregnant women. The results of this study were
applied in using the TPB constructs to develop the in-depth interview and focus group guide
instrument for the study. For healthcare professionals, the TPB is a useful tool when designing
strategies to assist in increasing the implementation of guidelines (Francis et al., 2004).
TPB theory application to the study. The TPB theory applies to this study because it
provides a potential framework for the study as it can be used to study or understand the role
pharmacists can play in inactivated influenza vaccine administration in pregnant women
practices. TPB addresses the problem with partial volitional control (Ajzen, 2002). The three
constructs of the TPB have a direct positive relationship. The more the attitude and subjective
norms to engage in a specific practice become favorable, the more the perceived behavioral
control, and the intention to participate in the behavior increases (Ajzen, 1991, 2002).
There are motivational implications for intentions with perceived control, in which
individuals who do not have the opportunity and means to engage in a behavior will not likely
have a strong intention regardless of their attitudes or norms (Ajzen, 1991). Perceived control
also can directly predict behavior or as an alternative measure of control (figure 2). Perceived
control as a determinant of intention is especially relevant to the study because a pharmacists'
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ability for inactivated influenza vaccine administration to pregnant women may vary based on
the perceived difficulty or ease of offering and administering the vaccine. That is, vaccine
administering practices of pharmacists may not be under their volitional control. For example, if
a pharmacist is not comfortable administering the inactivated influenza vaccine to a pregnant
woman and does not want to give the vaccine but perceives that if she or he refuses that they
may be fired or reprimanded, the pharmacists may decide to administer the vaccine anyway. For
the purposed study, however, the theory will be modified to include “knowledge” as one of the
constructs to be tested (Table 2). This is to account for the fact that subjective norm has been
considered to be a weak predictor of intention (Knabe, 2012). Though the theory does not
include knowledge as a predictor of behavior, in his work, Ajzen noted that "at the most basic
level of explanation, behavior is assumed to be a function of salient information, or beliefs,
relevant to the behavior” (Dwivedi, Wade, & Schneberger, 2011). Several studies that have
applied the use of TPB has found it to be useful in predicting intention (Knabe, 2012).

Table 2. Modified TPB Model Constructs Application to Study
Construct and
Subconstructs
Attitude
i. behavioral
belief
ii. evaluation

Definition

Application

A Person's belief Information on what pharmacist feel about how beneficial
regarding
administering influenza vaccines to pregnant women is, and how
performing a
comfortable they feel regarding administering the influenza vaccines to
behavior
pregnant women (their favorable/unfavorable disposition towards
The notion that doing the behavior)
doing a particular
thing has specific
outcomes
The value associated
with behavioral
outcome
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Table 2 Continued
Subjective
Notions of how certain individuals
norms
view and approve or disapprove of
i. normative
performing a behavior
beliefs
A Person's engagement in a particular
action if they feel people close to
them think they should
Motivation to engage in practice
ii. motivation based on what the individual thinks
to comply
Perceived
control

Knowledge

How much a person feels that
engaging or not engaging in a
behavior is under their volitional
control

Information on how other healthcare providers, and
pregnant women attitudes towards pharmacists can
influence administering influenza vaccines to pregnant
women

Information on how much control pharmacists think
they have as regards to administering influenza
vaccines in pregnant women

Theoretical or practical understanding Information on pharmacist's general knowledge of
of a subject
influenza vaccines, especially as it relates to pregnant
women

Figure 2. Diagram of the modified Theory of Planned Behavior applied to the study.
Criteria for the theory. According to Glanz et al., for a theory to be regarded as suitable
for use in a research study, it should have (i) internal consistency, which refers to the idea
23

assumptions that a theory must be logically consistent and not be contradictory; (ii) parsimony,
which refers to the simplicity of the concept the theory aims to measure, it should be generally
relevant as it is using a controllable sum of concepts; and (iii) plausibility, which refers to the
theory fitting in a reasonable way with other current theories (Cramer, 2013; Glanz et al., 2008).
Other criteria to judge the utility and validity of a theory include (iv) comprehensiveness, which
refers to a theory encompassing a broader scope to explain a phenomenon (Cramer, 2013), (v)
precision and testability, which refers to a theory having constructs that are well defined, closely
interrelated, and are readily open to valid measurements, and (vii) applied value, which is the
extent to which a theory can offer practical solutions to life's problems (Cramer, 2013). The TPB
meets all the criteria and is appropriate to guide the research.
In summary, the TPB is the most appropriate theoretical framework for guiding the
research to understand the reasons why pharmacists may or may not want to administer
inactivated influenza vaccine to pregnant women, and the reasons for why this behavior may or
may not be favorable to them. This modified theory comprises of knowledge, attitudes, social
norms and perceived behavioral control factors that can be applied to this research. In order to
keep pregnant women and her baby healthy during the influenza season, and to promote vaccine
uptake behaviors in these women, uptake of the influenza vaccine reduces the risk of developing
the influenza illness and its subsequent complication (Simondsen & Hayney, 2011). Thus, it is
necessary to understand ways we can close the gaps of vaccine accessibility using pharmacists.
In addition, it is important to understand how pharmacists perceive themselves to act in this role.
Manuscripts
This study was designed to explore the role of pharmacists in increasing influenza
vaccine uptake in pregnant women. The results of this study are presented in two separate
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manuscripts. As described above, to get a better understanding of what is going on with
influenza vaccine teaching and practice in pharmacy schools and among licensed pharmacists
respectively in the state of Florida, two manuscripts were developed as follows:
1) “An Assessment of Pharmacy School Curricula in Florida on Influenza Vaccine
Administration to Pregnant Women”. This manuscript addresses Research Aim 1a and b,
and their associated research questions.
2) “The Role of Pharmacists in Administering Inactivated Influenza Vaccines to Pregnant
Women. This manuscript addressed Research Aim 2, and its associated research
questions.
3) Community-pharmacist-led inactivated influenza vaccine administration in pregnant
women in the United States. This manuscript provides a theoretical concept of physicianpharmacists partnership as emerged from the results of Aims 1 and 2.
Conclusion
In order to keep pregnant women and her baby healthy during the influenza season, and
to promote vaccine uptake behaviors in these women, uptake of the influenza vaccine reduces
the risk of developing the influenza illness and its subsequent complication (Simondsen &
Hayney, 2011). Thus, it is necessary to understand ways we can close the gaps of vaccine
accessibility using pharmacists. In addition, it is important to understand how pharmacist
perceive themselves to act in this role.
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Manuscript 1: An Assessment of Pharmacy School Curricula in Florida regarding
Inactivated Influenza Vaccine Administration to Pregnant Women
Abstract
Background: There is a high risk for morbidity and even mortality in pregnant women as a result
of the influenza virus illness. Vaccine uptake rates remain lower than the targeted Healthy
People 2020 goals despite recommendations from the CDC. Few studies have examined the role
of the pharmacist in providing immunization services to pregnant women, fewer studies have
directly examined the PharmD curricula and the perspectives of pharmacy students on how they
perceive their role in providing influenza vaccines to pregnant women. Purpose: This study
examined the PharmD curricula instruction with regards to immunizing pregnant women and
how pharmacy students perceive it. The study also explored the projected inactivated influenza
vaccine administration in pregnant women practices among 3rd and 4th year pharmacy students in
Florida. Methods: Semi-structured, in-depth, in-person qualitative interviews were conducted
with the 6 Academic Deans of the accredited schools of pharmacy in Florida. The study also
conducted 3 focus group sessions among 3rd and 4th year pharmacy students (n=18) in Florida. A
thematic comparative analysis was conducted to examine outcomes. Results: The majority of the
Academic Deans reported providing instruction on immunization in schools with respect to
vaccine administration in pregnant women and called for a need for all schools to make it
compulsory to include pregnant women-specific content. Pharmacy students reported a gap in
knowledge of content related to administering the influenza vaccine in pregnant women. Despite
that pharmacy students believe that when presented with the opportunity, they will be willing to
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provide influenza vaccines to pregnant women. Conclusions: Pharmacists are in a good position
and play an important role in increasing inactivated influenza vaccination rates among pregnant
women. Implications for practice include the need for incorporation of pregnancy-specific
content to immunization curricula.
Introduction
A key epidemiologic finding during influenza epidemics and pandemics is the increased
risk for severe morbidity and mortality in various at-risk populations, such as the elderly, young
children and pregnant women and their fetuses (Memoli, Harvey, Morens, & Taubenberger,
2013). During the 2009/2010 flu pandemic, pregnancy was a major risk factor for serious cases
influenza; among women aged 18-29, influenza-pregnancy related deaths occurred in about 16%
and hospitalizations in 29% (Biggerstaff, Cauchemez, Reed, Gambhir, & Finelli, 2014; Memoli
et al., 2013). Pregnant women continue to be at risk for influenza-associated diseases that are
usually fatal (Memoli et al., 2013; Callaghan, Chu, & Jamieson, 2010; Mak et al., 2008;
Thompson et al., 2011). Influenza infection in these women lead to complications such as
pneumonia, spontaneous abortions, preterm births, birth defects and fetal loss (Arnold et al.,
2019; Mak et al., 2008; Rasmussen, Jamieson, & Bresee, 2008). Also, uptake of inactivated
influenza vaccine during pregnancy has a two-fold benefit, as it protects the mother and the baby
for its first few months of life (Simondsen & Hayney, 2011). This protection for the baby is
essential, as there is no licensed influenza vaccine for infants under six months of age, and also
because, during influenza outbreaks, children experience the highest infection rates (Simondsen
& Hayney, 2011).
The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease
Control (CDC) in 1997 added recommending the inactivated influenza vaccine for pregnant and
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breastfeeding women (Arden, Izurieta, Fukuda, Cox, & Schonberger, 1998; CDC, 2003; Fiore et
al., 2010). It is said that one out of two hospitalizations or admissions in pregnant women could
be avoided per 1000 women who get the influenza vaccine (Arden et al., 1998). Despite the
recommendations, inactivated influenza vaccine uptake remains suboptimal in pregnant women.
As of November 2017, inactivated influenza vaccine uptake among pregnant women was 35.6%
(CDC, 2017). Also, previous CDC influenza surveys show that the overall vaccine coverage in
this population has been lower than the targeted 90% coverage proposed by the Healthy People
2020 goals (Lu, Bridges, Euler, & Singleton, 2008; Plans-Rubió, 2012; Whitley & Monto, 2006;
Xakellis, 2005).
Several interventions have been developed to improve influenza vaccine uptake (Odone
et al., 2015). Most influenza vaccine intervention studies have focused on vaccine campaigns,
computerized reminders, the use of text message reminders, social networks, and web-based
portals (Odone et al., 2015). This serves as a potential limitation, as there are other barriers such
as problems with access among pregnant women such as distance to care centers, lack of
transportation and availability of the vaccine at care providers clinic (Arao et al., 2015; Healy et
al., 2015; Meharry et al., 2013; Ballas et al., 2015). The importance of maintaining high
immunization rates to curb the spread of infectious diseases cannot be over emphasized, as there
is a need to prevent high mortality and morbidity rates (Prescott & Bernhardi, 2019). The
standing order which authorizes other health care providers including pharmacists to administer
vaccines was instituted in the year 2000, by the ACIP (McKibben, Stange, Sneller, Strikas, &
Rodewald, 2000).
Current Perspectives. In 2016, the Accreditation Council for Pharmacy Education
(ACPE), which is the National agency for the accreditation of professional degree programs in
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pharmacy and providers of continuing pharmacy education published the accreditation standards
and key elements for the professional program in pharmacy leading to the Doctor of Pharmacy
degree. For a pharmacy school to become accredited by the ACPE, they must meet minimum
requirements as stipulated by the ACPE (Accreditation Council for Pharmacy Education, 2015;
Prescott & Bernhardi, 2019). Among the required elements of the Doctor of Pharmacy
curriculum, some topics have to be covered in the required content areas and should be taught
within integrated or individual courses and may be covered under multiple disciplines
(Accreditation Council for Pharmacy Education, 2015; Prescott & Bernhardi, 2019). It is
required that under the topic “public health” which deals with advancing public health and
wellness, students should be provided an avenue through which certification in administering
vaccines can be earned (Accreditation Council for Pharmacy Education, 2015).
Since pharmacists got involved in providing immunization to the general population,
legislation has been pushed by all states in the U.S. as of July 2016 to allow pharmacists to
provide such services (Kamal, Madhavan, & Maine, 2003; Prescott & Bernhardi, 2019). With the
expansion of the roles of pharmacists in administering vaccines, pharmacy schools have started
to place emphasis on immunization training at their schools (Kamal, Madhavan, & Maine, 2003),
and instruction is usually delivered through the American Pharmacists Association (APhA), and
others such as the Minnesota College of Pharmacy Immunization Delivery Program, and the
Collaborative Education Institute Immunization Training (Kamal, Madhavan, & Maine, 2003;
Prescott & Bernhardi, 2019). According to the study by Prescott & Bernhardi (2019), almost all
pharmacy schools in the U.S. provide a form of instruction on immunization (Prescott &
Bernhardi, 2019), another study by Turner et al (2007), showed that pharmacy students can
successfully administer vaccines to adults when trained to (Turner et., al 2007). However, when
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it comes to pregnant women, studies have demonstrated reluctance by pharmacists to immunize
this population (Dolan et al., 2012).
This study aims to explore the course content and perception of pharmacy students
regarding pharmacy school curricular training on vaccine administration to pregnant women with
a focus on the inactivated influenza vaccine. The study attempts to fill these gaps by
investigating the pharmacy school curricular and exploring the knowledge and perceptions of
pharmacy students about their role in offering and administering inactivated influenza vaccines
to pregnant women using the Theory of Planned Behavior (TPB) as a guiding framework.
Methods
Overview. This qualitative research study employed a use of interviews and focus
groups. The study involved two major research aims and their additional research questions. The
main aims utilized separated qualitative methods to address each related research question. The
first aim was addressed through a brief interview with the 6 Academic Deans of the 6 accredited
schools of pharmacy in Florida. The second aim was addressed through focus groups with thirdand fourth-year pharmacy students at four of the six accredited schools of pharmacy in Florida.
Put together, the findings show what is taught to pharmacy students, what the pharmacy students
learned, and how the pharmacy students perceived their future influenza vaccine administration
in pregnant women practices. This study explored both education and perception of pharmacy
students regarding influenza vaccine administration in pregnant women.
The study was approved by the University of South Florida Institutional Review Board
(IRB). All records were stored on the USF Box folder and in locked filing cabinets in a locked
room at USF. This project was non-invasive and presented a minimal risk to human subjects.
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Aim 1: Review of Pharmacy School Curricula.
Target population & sampling frame. The first research aim, to understand how the
course content of the six accredited schools of pharmacy in Florida is taught regarding vaccine
administration in pregnant women, with a focus on influenza vaccine, was addressed through a
short interview with the Academic Deans of the 6 accredited schools of pharmacy in the state of
Florida. The and seventh school of pharmacy in Florida, currently has a candidate status by the
Accreditation Council for Pharmacy Education (ACPE) and was therefore excluded. The
Academic Deans of the 6 accredited schools were chosen as the target population for this study
aim as they are usually responsible for the school curricula and are the most knowledgeable
about it. Also, the accredited schools were chosen as pharmacy students must graduate from such
schools to become licensed to practice in the U.S.
The following four letters were constructed and emailed to all 6 Academic Deans: (a) a
pre- notice mail, (b) an informed consent form, (c) sample interview questions, and (d) a thank
you/reminder letter. Their email addresses and phone numbers were retrieved from the various
schools’ websites, and the pre-notice emails were followed up with a phone call if no response
two to three days after. The interview asked the Academic Dean’s questions pertaining to the
curricula offered in their Pharm. D. programs regarding vaccine administration in general and
then in pregnant women, with a focus on influenza vaccine, they also identified appropriate
course titles and numbers. Electronic copies of the syllabus were identified, retrieved, reviewed
and summarized by the investigator.
The study participants were usually the Academic Deans, and, in some cases, it was the
individuals overseeing the school curriculum. Names of the particular schools and Academic
Deans were kept confidential and were not linked to the data. The participants were asked to
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provide a verbal informed consent prior to participating in the interview. Interviews were
conducted for approximately ten minutes and were audio-recorded. All 6 Academic Deans of the
accredited schools of pharmacy in Florida or their equivalent participated in in-depth or
telephone interviews. All notes, audio recordings and other pertinent materials collected during
the interviews were kept confidential. The documents were stored in a locked cabinet and no
personal identifiers were utilized. Additionally, considerations were made to utilize curricula
found on school websites to find information on immunization content had all the deans not been
reached. Data was collected, transcribed and analyzed.
The Academic Deans interview was piloted with the Director of the Doctor of Public
Health Program at the USF College of Public Health. The primary purpose of this pilot test was
to assess the feasibility, validity, and acceptability of the interview guide. Qualitative interviews
are usually pilot tested with a few interviews among people that have similar characteristics to
the population of interest (Hennink, Hutter, & Bailey, 2011).
Aim 2: Pharmacy Student Focus Groups.
Target population & sampling frame. The second research aim, to understand how 3rd
and 4th-year pharmacy students perceive vaccine administration course content regarding vaccine
administration in pregnant women, with a focus on influenza vaccine, was addressed through
focus groups at three of the six accredited schools of pharmacy in Florida. All three schools were
contacted regarding their participation in the focus groups and gave their approval. The focus
groups offered insight into how the curricula regarding vaccine administration in pharmacy
schools are perceived and operationalized by pharmacy students. The sampling frame was both
third- and fourth-year pharmacy students at the three accredited schools of pharmacy in Florida
and the samples for the focus groups were created through purposive sampling. The Pharm. D.
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degree it a four-year program, with the first two years dedicated to course work, and by the end
of 3rd year, they are done with course work and the last year is used for advanced practicum,
where pharmacy students participate in clinical rotations to apply what they have been taught in
class. Hence, third- and fourth-year pharmacy students were recruited as they will have already
completed the majority of their coursework.
Focus group discussion guide. The focus group guide was developed topically by the
researcher to (a) understand what pharmacy students learned about influenza vaccine
administration in pregnant women in their pharmacy school classes, (b) understand the projected
practices of influenza vaccine administration in pregnant women among pharmacy students after
graduation. The focus group guide was also developed guided by the Theory of Planned
Behavior (TPB) to understand pharmacy students’ attitudes, subjective norms, and perceived
control regarding administering influenza vaccines to pregnant women. The focus group guide
was piloted with the graduate students (n=8) at the USF College of Public Health to assess the
feasibility, validity, and acceptability of the focus guide.
Sampling plan. Each of the three accredited pharmacy schools was contacted and asked
if focus groups could be conducted with students at their institutions. A total of three focus
groups were conducted; one at each school. Emails and flyers which briefly introduced the study
and announced the time and date for the focus groups, and how to contact the researcher were
sent to pharmacy students to recruit study participants. The schools all supported and participated
in the dissemination of the flyers and helped in the recruitment of students. One focus group each
was held at each of the four schools and aimed to recruit 10 students and only 3rd and or 4th year
students.
Each focus group consisted of a moderator (researcher) who facilitated the focus group
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discussion and an assistant who took notes and distributed gift cards, refreshments, and
participants’ identification numbers. Study participants were asked to give verbal informed
consent at the beginning of the focus group discussion. Students were presented with a $10 gift
certificate to Starbucks for their participation at the beginning of the discussion, should they
decide to leave during the discussion. Focus groups lasted for approximately one hour and were
audio-recorded. A moderator and an assistant to take notes were present during the focus group
sessions. A total, 18 third- and fourth-year pharmacy students participated in the focus group
discussions (8, 2, and 8). After informed consent was obtained, the demographic survey was
administered, and the focus group conducted. All notes, audio recordings and other pertinent
materials collected during the focus groups were kept confidential. The documents were stored in
a locked cabinet and no personal identifiers were utilized. Data were collected, transcribed and
analyzed.
Recruitment challenges. The recruitment process for the pharmacy students’ focus
groups was achieved over a seven-month period between February and August 2019, as 3rd and
4th year pharmacy students are usually undergoing clinical rotations and are scattered around the
State. Although about 8-10 students were recruited for each focus group, on one occasion only
one student during one of the school focus groups showed up for the focus group session and it
was canceled. On another occasion at another school, only two students showed up for the focus
group session, but the focus group was still conducted. Morgan, 2016, argues that two-three
person focus groups provide value as they sill create interactive discussions, provide depth and
detail from each participant, and help with the difficulty of recruitment (Morgan, 2016).
However, to help assist the recruitment process for the pharmacy students focus groups, a more
rigorous recruitment strategy was employed where deans of student affairs were approached to
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assist in the recruitment, and flexibility for the student to be able to call in via zoom. Through the
second round of recruitment, an additional eight students were recruited and 8 participated in the
focus group.
Data Analysis.
Data management. To ensure reflexivity through the research process, comprehensive
field notes were taken that documented the focus groups and interviews, thoughts on them, and
potential causes of bias that may interfere with interpreting results (Miles, Huberman, & Saldana,
2013). The recorded interviews and focus groups were transcribed word for word and were
crosschecked for accuracy. All demographic information and transcripts were uploaded on
MAXQDA analysis software which was used to analyze and manage data.
Data condensation. An a priori codebook was developed that had themes based on the
interviews and focus group guides and the guiding modified TPB theory (i.e. knowledge,
attitudes, perceived control and subjective norms). The analysis was carried out concurrently as
interviews were being conducted and transcribed, and emergent codes were added to the
codebook with revised definitions as needed. The codebook contained the names of the codes,
what the code signified (inclusion criteria for applying the code), what it does not signify
(exclusion criteria for when no to apply the code), as well as a sample of the type of quote that
should be used with the code (Bernard et al., 2016). The codebook development was an iterative
and continuous process, as new themes emerged during analysis. The codebook was imported
into the MAXQDA software and was applied to relevant parts of the transcripts. The inductive
thematic process involved the development of themes from the transcripts was then employed in
the study to analyze interview and focus group data to examine conditions and interactions, and
determine categories that clustered together (Guest et al., 2011). To identify themes and
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subthemes, the transcripts were read two times, as well as looking out for repetition, metaphors,
and content that was related to the TBP theory that guided the study in the text (Bernard et al.,
2016). After themes were selected, the portions of texts that represented the themes were then
identified (Bernard et al., 2016).
Data display and analysis. This employed the use of a matrix table in which codes and
coded texts were displayed for the purpose of analysis (Miles et al., 2013). Analytic memos were
used to note considerations and anything else that came up during the analytic process (Miles et
al., 2013). The analysis was carried out by two independent coders. The primary investigator
coded all the interviews (9) and the second researcher (LB) coded 10% (1) of the transcripts
independently to produce an inter-rater reliability measure. Ongoing discussions of codes and
themes continued through the analyses process, and discrepancies in the codes were discussed
and a decision on the appropriate approach to go forward was determined. A Cohen’s kappa
provides a statistical measure for the coders to use as a standard and limiting subjective
assessment, a kappa of 80% is used to denote agreement (Miles et al., 2013). The Cohen’s kappa
inter-rater reliability for this study was 84% denoting an agreement.
Results
The results from both the pharmacy schools’ academic deans and the pharmacy students
indicated that there were several areas discussed by participants, including their knowledge of
influenza vaccines in pregnant women, and the role they had to play. Both of these areas were
substantially impacted by what they know and their projected practices of interactions with
pregnant women.
Review of pharmacy school curricula. This section answered the research questions on
what courses and lectures regarding influenza vaccine administration in general and in pregnant
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women are provided in the required courses of the accredited schools of pharmacy in Florida.
Several themes emerged during the analysis and they include a) course content on immunization,
b) course content on immunization in pregnancy, c) compulsory immunization teaching d)
compulsory pregnant women immunization teaching e) sufficiency of immunization training,
and f) role of a pharmacist.
Demographics. A total of 6 participants from the 6 accredited schools of pharmacy in
Florida were interviewed (Table 3), 83% (n=5) of them were female, and 17% (n=1) was male;
also 83% (n=5) of them were academic or associate deans, and 17% (n=1), i.e. one person was
an associate professor. Fifty percent (n=3) of them had less than or equal to 5 years of associate
dean experience, while the other 50% (n=3) had greater than 5 years’ experience as an associate
dean. The mean age was 45 years (range: 36–55 years). All six academic deans are from
accredited schools of pharmacy in Florida. Fifty percent (n=3) of the participants reported they
had administered the influenza vaccines in the past, while the other half reported they had never
administered vaccines before.
Table 3. Academic Deans Demographics
Characteristics

Number
(n=6)

Percentage
%

2
3
1

33
50
17

1
5

17
83

5
1

83
17

3
3

50
50

3
3

50
50

Age
31-40
41-50
51-59
Gender
Male
Female
Position
Academic Dean
Other
Time in Position
1-5 years
>5 years
Administered Vaccine
Yes
No
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Course content on immunization. When asked if their pharmacy schools offered courses
that provide content on immunization practices, all the participants (n=6, 100%) reported they
offered required courses that covered immunization content and a few (n=2, 33%) reported
offering elective courses that contained extra information on immunization.
“That’s a required course, it’s actually part of their first-year milestones, so if they don’t
complete that they haven’t necessarily completed their first year of pharmacy school, so
we require everyone to do that” AD6

The names of courses that contained immunization content were also provided (Table 2). The
course content was explained to include online and in-class modules, course readings, training,
and videos on immunization. A common theme among all the respondents (n=6, 100%) was the
mention of the use of APhA modules to complement the required teachings and training on
immunization, and the role of APhA in the certification of pharmacy students to immunize.

“We also have the students do a certification course through the “American Pharmacists
Association” and through that course the students are certified to give immunization.
That course is a twenty-hour seminar, also with self-study. So, they will do 12 hours of
self-study, and then we have faculty members who are trained and licensed to deliver the
course, the seminar portion in xxx University. So, that’s an eight-hour live course, and
after finishing the self-course, they would demonstrate their technique, they would get
assessed on it, a faculty member will do the assessment and the evaluation and all of that
is sent to APhA, and APhA will give the certification to the student”. AD2
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“American Pharmaceutical Association has a sort of vocation program for pharmacists
to take, and what we did was to embed it in our curriculum and so it is offered to our
students in their first year of the program through our public health course.” AD1
“APhA has 12 hours of online content that they have to review, and then they have an 8hour live session, and at the end of the session they have to administer three vaccines”.
AD6

Majority of the participants (n=5, 83%) reported that the course required for immunization
certification was offered in the first year of the pharmacy school curricular, while 17% (n=1)
reported it was offered in the second year.
“they get their certificate…, and as part of the skills lab grade they have to submit the
requirements to the board of pharmacy to become certified immunizing interns. The
reason that we do it in their first year is because they go into the community in their first
summer spending four weeks in the community pharmacy during the summer, it is our
hope that they will practice immunizing while they are there” AD 6

“The students have to be certified in immunization through the school and through
APHA. It is a required course in 1st year. There is an in-class portion of it, and also the
online part” AD 4
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Table 4. A Typology of Courses that Contain Content on Immunization
Participant
AD1
AD2
AD3
AD4
AD5
AD6

Participants
AD3
AD6

Required Courses
Foundations of Public Health
Immunology and Infectious Disease
Population Health
Applied Patient Care
Pharmacotherapeutics III
Integrated Pharmacy Application I
Integrated Disease Management
Public health medication safety and disease
prevention
Professional Practice Skills lab
Endocrine women and men’s health

Year Offered
PG Y1
PG Y2
PG Y1
PG Y1
PG Y3
PG Y1
PGY2
PG Y1

Pregnancy Content
NA

PG Y1
PG Y2

NA
NA

Elective Courses
Vaccine and Immunizations
Women’s Health

Year Offered
PG Y2
PG Y2

Pregnancy Content
Covered
Covered

Covered
Covered
Covered
Covered

Course content on immunization in pregnant women. When asked if their schools of
pharmacy offered immunization classes that with respect to vaccine (influenza) administration in
pregnant women (Table 4), 83% (n=5) indicated that information on vaccine administration was
covered in either required (n=4, 67%), or in elective courses (n=2, 33%).
“…and I also teach an elective in women’s health and we spend a lot of time talking
about pregnancy and disorders in pregnancy. It also covers vaccines, and obviously there
are certain vaccines you cannot get in pregnancy. But also, we also re-emphasize the
importance of the flu vaccine in pregnancy no matter what trimester the person is at”
AD 6
“they have another required course where they have a couple of hours of lectures that
cover it. And all those three different places they learn about pregnancy and vaccines”
AD 3
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“Yeah, and in that, all three, the seminar and the two courses. But definitely population
health I, that’s a higher-level course, and in the APhA immunization certification course
they would go through pregnancy”
AD2

Four of the respondents (67%) mentioned that immunization content specific to pregnant women
are covered under “special populations” which include pregnant women, however, two of them
mentioned that immunization content is not necessarily focused on pregnant women.
“Not necessarily a focus on pregnant women, the gist of it is about the administration
technique, and the different types of vaccines that pharmacists can actually administer,
and then there is a special populations discussion, but it is not, you know, like a situation
where there is any push to increase administration in pregnant women or anything of that
nature” AD1
“It’s broad and covers all the vaccine preventable diseases like influenza, pneumonia,
shingles and those sorts of things. There is not necessary a focus just on pregnant
women, and it covers other special populations that are immunocompromised, elderly
patients, as well as pregnant patients.” AD 6

“For population health, that would teach about pregnancy, different populations,
minorities, and so how to immunize, but not just immunization by themselves, they just go
through different populations and how to properly treat them for preventive measures.”
AD2

51

“We teach when vaccines are indicated or contra indicated, what populations should get
it and who should not. Just like how we teach about the drugs.” AD4

Compulsory immunization teaching. Regarding making it compulsory for the School of
Pharmacy curricula in the U.S. to include content material on immunization, all respondents
(n=6, 100%) agree it should be made compulsory.
“I think, at this point because we have the opportunity to make it required, we can
definitely do that and not have to justify it…, and we actually got a request from our
preceptors to actually make sure the students came either already trained or aware
of what that would mean or what their role will be. So, I think all programs should
probably do that and make it a requirement. The other thing is I think it is an advantage
to students, it gets them very close to feeling like they are pharmacists, and when they get
out it is not something that they would have to learn, because they didn’t get to do it
when they were students and so it’s kind of almost like a credential so to speak, so for the
schools that aren’t doing it, they have that advantage over those students.” AD1

“It’s very important, especially with the health risk it prevents and with the requirements
that student pharmacists have to have prior to coming to their rotations. Most of the
pharmacy schools now, try to ensure that they are certified before they go on rotations.”
AD2

“Most schools already do, a lot has changed in the past few years and Florida is usually
one of the last states to do anything, so if we are, I believe almost everyone is.” AD4
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Two of the respondents (n=2, 33%) reported that all schools should now be teaching
immunization as part of their curriculum in accordance with the ACPE accreditation standards.
“It is part of our standards now. In the required elements of the Doctor in pharmacy
curriculum, under the public health curriculum, it says, ‘implementation of activities that
advance public health and wellness, as well as provided avenue through which students
earn certificates in immunization delivery’ It started in 2016, so everybody should have
something in their program that teaches that.” AD6

“I think it should be required; I think it is required. I think it is part of the accreditation
documents from ACPE as a topic that has to be covered.” AD 5

Compulsory pregnant women immunization teaching. When asked about making it
compulsory for the School of Pharmacy curricula in the U.S. to include content material on
immunization specific to pregnant women, all respondents (n=6, 100%) reported pregnancy
specific information should be made compulsory. One respondent reported it would be a way for
pharmacy students to become advocates for vaccine uptake in this population.
“Very important. Because in one of the suggestions for pregnant women is always to get
flu shots, so in our population with our students, with them doing rotations, a lot of them
do rotations in women’s health, also they do rotations in the hospital, even in the
community just as an advocate for preventive health and we stress that people get their
flu shots, so, it is very important they become advocates and do that.” AD2
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“Well, yes, I think that, but I think the angles need to change, I think we have some
opportunity for some reinforcement where we teach what immunization is and how to do
it. And then I think as we talk about how you treat or deal with or provide care to
pregnant women, immunization should be a part of that.” AD1

“I feel pretty strongly that content material on immunization regarding pregnant women
should be part of it.” AD4

“I think it should also be covered along with the women’s health content, because it is a
really important piece, and if we can prevent illness during pregnancy, we have more
successful outcomes.” AD6
Sufficiency of immunization training. Regarding the classes/courses and training on
immunization being enough to equip students to get certified, all the participants (n=6, 100%)
agreed the coursework together with the APhA modules are sufficient to equip and prepare the
students to be certified for immunization. Students are required to go through the course and
practice a demonstration of vaccine administration technique to earn their certification.
“So, with the course, with the 12 hour of self-study they really go through the
background information and kind of reiterate the things that they go through at XXXs
curriculum and then being able to demonstrate your technique and get practice before
you are certified, then yes, they are equipped to go out and deliver immunizations.” AD2
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“Yes, the course for certification follows a very very specific format, which includes the
patient assessment process, they are taught to evaluate the patient and they go through
these guidelines and steps on what to do.” AD4

One respondent mentioned that students get the certification in school, but to maintain the
certification after graduation they need to get more continuing education credit.

“ to get the certificate they have to do a demonstration of actually administering the
vaccine, and then that allows them to go to their training sites to participate, but once
they get licensed, then they just become responsible for maintaining the certification, and
they have to just get more CEs.” AD1

Another participant mentioned that after students get the certification, it will depend on their
experience after that to get them more comfortable with administering vaccines, and their
subsequent employers to get them more training.
“So, the courses are one thing, they have to practice 3 vaccines that is required for the
certificate. The real practice occurs in real life, that is why we want them to be certified
before they go into their first year of practice, so that if the they would have experienced
that. And then, hopefully many of them will work in community pharmacies additionally,
so if they are certified they can practice. And then again, they get practice during their
fourth year because they do 6 weeks of community pharmacy where they will get
additional practice. And then, for most employers, once they get a job, the company
requires them to do the training again for them. I mean hopefully with that, just like with
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anything, it takes a while to build your comfort. I mean, it is kind of scary the first time
with a real person. It is one thing doing it to your classmate who is like ‘okay go ahead’
but the first time you are doing it with your patient, and nobody is looking over your
shoulder, that is a scary thing. We have encouraged them to practice a lot when they are
out during the summer.” AD6
Role of pharmacists. When asked about participants’ perceptions regarding pharmacists
administering influenza vaccines to pregnant women, all academic deans felt that it was
something pharmacists could do.
“I honestly think it is a good thing, anything we can do to bring care to pregnant women.
But also hope though that pregnant women are getting the health care that they need,
if their providers recommend the vaccine, then great get it. But I will want the vaccine to
be given with the caveat where following up and making sure she is getting the care for
her pregnancy. I know there are controversies giving any kind of medication or drugs to
pregnant women.” AD6

Three respondents (50%) mentioned pharmacists being accessible and therefore it would be
easier for pregnant women.
“Oh, I think it’s a no brainer, you know, the access that we have to the community
through community pharmacies is second to none. Right now, they don’t have to make an
appointment to see us, so we are so accessible, actually the most accessible health care
professionals, so I think it’s a no brainer that we would join the list of professionals that
could give the immunization ...” AD1
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“I feel confident, that it is one of the things that pharmacists are certified to do, with
pharmacists being so accessible, one of the professions that are on the frontline as far as
accessibility, you know someone has to go get an appointment and go to the doctor’s
office, it may be an additional cost associated, whereas you can pretty much walk into
any retailer or grocery store that has a pharmacy, and the pharmacy would be able to
deliver it at that time. So, I think accessibility puts us at an advantage of making sure that
a pregnant woman or public is getting the vaccine.” AD2
“I think the number one most important thing to me when it comes to immunization is
accessibility, it is always the excuse that I hear from people it was too difficult or they
didn’t have the time to receive their vaccine, and I think that is a major barrier. So, with
the pharmacists being so easily accessible. I think it is important to make it as easy as
possible for a pregnant patient to receive the vaccines that they need.” AD3

One respondent mentioned pharmacists as being qualified to administer vaccines, while another
believed there are no controversies or concerns with regards to pharmacists administering the
influenza vaccine to pregnant women.

“I believe they are very much qualified regardless of whether the patient is pregnant or
not. And it is something they can do and should do.” AD4

“I don’t think there are any controversies with pharmacists, I think when you have
pregnant patients, they are more obviously concerned about different procedures that
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they are undergoing. I think in general pregnant women getting immunized, I don’t see
that as a concern with pharmacists doing it.” AD5

Generally speaking, all the accredited schools of pharmacy in Florida have content on
immunization being taught at their schools, while not all schools may teach immunization in
pregnancy-specific content, it may have been covered in other topics. There was agreement
across board that pharmacy students get the education and training required to get certified and
that pharmacists are equipped and knowledgeable to provide immunization services to the
general public and to pregnant women. There were sentiments that pharmacy students must keep
practicing immunization and a call for the need for pregnancy-specific immunization content to
be incorporated into curriculum.
Pharmacy student focus groups. This section answered the research questions on what
pharmacy students learned about influenza vaccine administration in pregnant women in their
pharmacy school classes, and their projected practices of influenza vaccine administration to
pregnant women after graduation guided by the Theory of Planned Behavior. Each theoretical
component was explored during the focus group discussion. In general pharmacy students
discussed their knowledge about the influenza vaccine, including where and how the instruction
was received. The students also described the individuals, groups or agencies who influence their
present and projected future practices. In order to understand their vaccine administration in
pregnant women practices, students were asked about situational and internal factors that affect
their practices. Finally, pharmacy students discussed any personal experiences with influenza
vaccine administration in general and or in pregnant women. The findings are presented below.
Demographics. A total of 18 participants from three of the six accredited schools of
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pharmacy in Florida participated in the focus groups (Table 5), 83.3% (n=15) of them were
female and 16.7% (n=3) were males. All participants had received instruction on immunization,
83.3% (n=15) mentioned they had received instruction regarding immunization in pregnant
women, while 16.7% (n=3) were not sure if they had. All, but one participant was certified to
immunize, and none of the participants have provided vaccination to a pregnant woman.

Table 5. Pharmacy Student Focus Group Survey Data
Variable
What is your age range?
18-30
31-40
What gender do you identify as?
Male
Female
Did you take any classes in your Pharm D program which taught you about
immunization?
Yes
No
Have your pharmacy school classes discussed immunization in pregnant
women?
Yes
No
Not sure
Are you certified to administer vaccines?
Yes
No
Have you ever administered a vaccine before?
Yes
No
Have you ever administered a vaccine to a pregnant woman before?
Yes
No

N

Percent

15
3

83.3%
16.7%

3
15

16.7%
83.3%

18
0

100%
0%

15
0
3

83.3%
0%
16.7%

17
1

94.4%
5.6%

9
9

50%
50%

0
18

0%
100%

TPB constructs influencing influenza vaccine administration in pregnant women
practices. Knowledge. The primary purpose of the focus group was to determine how what
pharmacy students know and were taught regarding influenza vaccines and its administration
especially with respect to pregnant women. Students were generally agreeable about their
knowledge of the influenza vaccines, and that resonated across all three schools. Pharmacy
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students described four major areas of knowledge: a) knowledge about the mechanism of action,
b) knowledge about the types of the vaccine, and c) knowledge about who should get it.
Knowledge about the mechanism of action refers to how the influenza vaccine works in the
body.
“As far as the mechanism of action once you administer the vaccine, it is usually
administered into the deltoid of muscle intramuscularly, and once that is done the body is
able to mount an immune response to the inactivated or the live attenuated vaccine and
by mounting that response you then gain immunity to the strains within that vaccine
through the formation of antibodies, so that if you are exposed to it again the body is able
to defend against it…”

“We all know that there is the live vaccine and there is the inactivated vaccine.
Depending on what the patient’s position is, you may not want to give one over the other
and there are like different formulations that are better for the younger population and
some that are better for the older. There is the trivalent, quadrivalent and all that, they
come in different strengths and different amounts.”

Two students mentioned the importance of all individuals getting the vaccines and linked it to
the concept of herd immunity.

“Everybody should get it. When they are of age… Well I mean you are not going to give
it to like a newborn or something and… I think everybody should get it to protect those
who haven’t gotten it, like herd immunity. To stop it from spreading”
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“I think of herd immunity and how everyone should be vaccinated on an annual basis”

Students were also knowledgeable about the about the influenza vaccine not causing the
influenza illness and were able to discuss correct information about the misconception.

“It takes a couple of weeks to actually have a full effect of the immunization, so if you
get sick during those two weeks after having the flu shot, it is not because of the vaccine,
but because of the flu virus itself, and you just happen to get it during that time. It is a
common misconception. I know that there are different variants of the flu vaccines and
every year they come out with a new formulation for it to cover the most common strains
after doing research. The trivalent and the quadrivalent are the ones we commonly use.”

“… obviously and there is always a lot of people that are afraid that it is going to give
them the flu virus. So, there is still a lot of stigma about that, and I try to tell them it is not
true.”

“… it is an opportunity to educate people as well, you are not going to catch the flu from
getting the vaccine, you might experience some symptoms, which people are mistaking
for the flu, so, I think education and counseling is a good thing for us to do, when we are
doing immunizations like that.”
When asked where students learned about influenza vaccines, all students indicated that
they had received instruction and information regarding influenza vaccines within the first two
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years of their training, in required classes. In addition, others expressed taking some required
courses that also contained teaching on immunization. When asked if they remembered receiving
instruction with influenza vaccination or immunization in pregnancy-specific content there was a
disconnect between what they answered on the demographic survey and during the focus groups.
Initially, during the survey, only three participants had previously indicated they were not sure if
they had received instruction specific to pregnant women regarding influenza vaccines.
However, during the discussion in one school 5 participants either did not remember or were not
sure pregnancy-specific content was taught, and one other student from a different school also
did not remember. See the excerpt below:

Participant 1: “I personally don’t.”

Participant 2: “Me neither.”

Participant 3: “I remember just a “horror story” being told of like giving the shots to a
pregnant woman and then her bleeding - because they have more blood vessels and stuff.
So, that’s all I remember was like ‘Oh, I gave the vaccine and she started bleeding
profusely’.”

Participant 4: “I remember thinking that pregnant women should get the vaccine, I just
don’t remember when and where.”
Participant 5: “I think it was mentioned but I don’t remember details.”
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“For me, since we had the immunization training quite a while ago, I don’t recall that we
discussed pregnant patients too much as far as vaccine administration.”

One student mentioned that during the instruction received regarding influenza vaccination or in
pregnancy specific content, it was covered under “special populations”.

“They told us how to go to the CDC and look up and see based on their like… special
populations.”

Regarding what the pharmacy students knew about the influenza vaccines and pregnant women,
they all agreed the vaccine was safe in pregnant women, so far it is the inactivated vaccine.

“We have the data and the science that it is safe and effective, and it is not going to be
harmful as long as it is an inactivated vaccine…”

“One of the biggest things I learned is not to give a pregnant woman a live vaccine
because that may transfer to the baby and may cause complications regarding that.”

“In the vaccine elective, where we talked about certain vaccines, you know they will say
which ones they do recommend to pregnant women, and which ones you cannot give to
pregnant women like live vaccines they can’t get.”

Two students, however, expressed the need for more pregnancy specific training in their
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curricular.
“…but I feel like they should be touched on a little bit more in school. Because I feel like
we didn’t really get enough information for me to be comfortable.”

“…maybe if they included more patient specific populations in the immunization
training, the pharmacists may feel more comfortable, especially when they go ahead to
get their re-certification hours to learn more about that and why it is okay to do it in
certain populations.”
Attitudes. The theme of attitudes reflects the pharmacy student’s beliefs regarding
providing influenza immunization to pregnant women and the notion that doing so has specific
outcomes. Participants were asked about the advantages and disadvantages of providing the
influenza vaccine to both the general public and pregnant women, which was expressed as
advantages and disadvantages. Across the focus groups, participants believed it was
advantageous to the community and pregnant women that pharmacist provides immunization
services. Pharmacy students described positive attitudes expressed in the following sub-themes:
a) accessibility and b) expertise. Pharmacists are known to be the most accessible healthcare
providers, and the participants believed this placed them in a position to provide such services
effectively, not just in terms of availability of pharmacies/pharmacists, but also in terms of
availability of the influenza vaccine. This sentiment was shared across all focus groups.
“Pharmacists are some of the most accessible health care providers, so even in areas
where going to the doctor’s office might sound like a trip, there’s a possibility that there
is a pharmacy that is accessible even closer. So, we are within reach of a lot of people.”
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“I agree with XXX I think we are more accessible and given the protocols and the
availability of vaccines that pharmacists are now allowed to give. I mean it started out
with just influenza and now it is expanding even more and more now. Sometimes
doctors’ offices aren’t even carrying certain vaccines anymore, and they say you have to
get it at the pharmacy…”

“… pharmacists are easily accessible in the community settings it is a huge advantage
for patients to be able to gain access to receiving immunizations. It really opens up as far
as the number of immunizations we are able to provide…”

Pharmacist are trained healthcare professionals, and the participants believed they are equipped
to provide immunization services and can provide professional assistance to patients.

“Bouncing off of that they have multiple vaccines that they are able to give, so if the
patients have questions about the vaccines they can ask the pharmacists and see what
they are able to take and what they need to take and maybe discuss their vaccines that
they have received…”

“I think we are qualified just in the knowledge that we are providers... Also, we can touch
up on things that fall under our scope such as vaccines.”

“I feel like we are qualified, and just like I know what resources I need to go to if I don’t
know the information…”
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Other subthemes that came up had to do with benefits or ease for the patients.

“It’s less cost if you think about it because they have to make an appointment with their
doctor which they have to do a co-pay and then, like, get the vaccine and… it just, it
creates less cost for the patient.”

“I work for xxx, and by no way endorsing this, but… we gave a $10 gift card during the
Flu season for people to come in and actually get vaccinated.”

Participants also expressed concerns as to why they may not be in the best position to provide
immunization to pregnant women, under the following subthemes: a) Not enough information
(as they do not usually have background information on the pregnant women), b) limited
knowledge and c) fear of liability. Others expressed concerns about having limited knowledge
when it comes to pregnant women and the influenza vaccines, but not everyone shared these
sentiments.
“…one disadvantage I think of is, since we are so accessible, we don’t make
appointments, we don’t know the patients background health history, generally if the
person is not a long time patient or customer of the pharmacy, we are not going to know
their story.”

“I agree with…, at xxx we have 6 different questions we use for all vaccines, …we don’t
know the background of the patient as maybe we should”
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“We might not have answers to all their questions that they may ask to the doctor, as far
as things that might affect the pregnancy. We can talk about like Flu shot, as far as our
knowledge at least now as students we are kind of like limited.”

“I think there could possibly be more liability associated with administering vaccines to
pregnant women because of adverse effects whether it is related to the vaccine or
otherwise could be definitely a liability issue and it could come back to the pharmacist
regardless of if they administered it appropriately for that patient. It is just higher risk for
the pharmacist’s license”

“I don’t really think there is a disadvantage of providing an inactivated vaccine to a
pregnant woman, as long as CDC deems it safe and the patients doctor is aware that they
are going to get the vaccine… We have the data and the science that it is safe and
effective and it is not going to be harmful as long as it is an inactivated vaccine, so, I
don’t see an issue with giving it as long as the physician is aware that the patient is
requesting it”

Perceived Control. The theme of perceived control reflects how much the pharmacy
students feel that providing immunization or not providing immunization to pregnant women is
under their volitional control. Participants were asked about their thoughts and feelings about the
facilitators or barriers to providing the influenza vaccine to pregnant women, alongside
education and counseling. Participants described healthcare provider recommendation as a
facilitator to providing influenza vaccine immunization to pregnant women across all focus
groups.
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“If they received a note from the doctor, and they speak to their doctor about why it is
okay to receive the vaccines from pharmacists and why they should do it, that may make
them more likely to”

“I think it would help if they have a recommendation from the physician. For XXX
specifically, I know that you can send the vaccine information to the doctor and request
it...”

“Would be helpful if the provider can recommend it…, just patient education like in the
Doctor’s offices…”
Other facilitators that were mentioned include the use of marketing in the form of posters to
inform pregnant women about going to the pharmacists to obtain their influenza vaccines, and
also a provision of incentives to pregnant women.
Participant 1“Like posters or something like that”

Participant 2 “Yeah! A poster like ‘hey, you can get it here, but you can also go to your
Pharmacist and get it there”

Participant 3 “Incentives too. Like last year was the first time xxx did the whole gift card
thing and we had a huge turnout”

When asked about the barriers, pharmacy students expressed various sentiments including lack
of a relationship or trust between pregnant women and the pharmacist, lack of awareness by
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pregnant women of the safety of the vaccine during pregnancy, lack of time, and lack of
education of themselves as pharmacist regarding providing vaccines to pregnant women.

“I think it would depend on your relationship with the patient you know. Like say in the
community settings which is where a lot of pharmacists are going to be administering
vaccines. If it is just a patient that frequents the store not the pharmacy, it might be hard
to kind of convince them of your trust. It is a trusting relationship, like they have that
relationship with the doctor. So, they will probably feel safer getting it there.”
“One of the barriers is patients lack of information, they may say I am pregnant why
would I get a vaccine that’s going to hurt the baby and they may like keep this
information and spread it to others saying, you know, don’t vaccinate when you are
pregnant, it is not good for you, that kind of thing.”

“They don’t always think it is safe and sometimes no matter what we tell them, they
don’t always believe us.”

“Just based on previous retail experience, I think there is a huge disadvantage in the time
constraint that pharmacists have, they have a limited amount of time and usually
corporate pharmacy tends to push numbers in terms of goal number of vaccines given per
season, usually the flu vaccines specifically. So, the pharmacists feel pressured to meet
that number and if they don’t have a pharmacy intern or anybody else to give those
vaccines, they have to constantly be leaving the workflow in order to administer
vaccine…, it is a pretty time-consuming process.”
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“I guess where I am at right now, probably lack of education, we never really focused
much on the pregnant women, at least in our education so far. I guess if I was more
comfortable and more familiar with administering the flu vaccine or other vaccines to
pregnant women and felt really solid in that knowledge.”

“In addition the pharmacists may not feel comfortable administering the vaccine to a
pregnant patient even if they are educated about you know, it is okay to, they may still be
concerned and maybe not necessarily turn the patient away, but may not inform the
patients about getting vaccinated when they are at the pharmacy, they may just not say
anything.”

Other themes regarding factors that may affect pharmacy students’ volitional control in
administering the influenza vaccine to pregnant women include the type of insurance or the
community settings (rural, urban) of the pregnant woman. When asked about insurance type,
pharmacy students expressed sentiments that insurance type may be a barrier.

“Insurance doesn’t always cover it. We have to put in particular codes on the computer
and sometimes, depending on the vaccine, and depending on the insurer/insurance
coverage, Insurance won’t always cover it. They won’t cover like a Pharmacist giving
it.”
“Yeah, I agree. I got my flu shot and I asked them if they’d take my insurance. I called
my Insurance and they told me it has to be administered in a medical office - not the
Pharmacy.”
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“Some of them will only pay for it at the doctor’s office to be billed like as a service,
whereas pharmacists don’t have provider status yet. it really depends on what plan the
patient is enrolled in as well. Unfortunately, xxx health insurance doesn’t cover vaccines
at the pharmacy, so for us to go get the mandatory flu shot that I have to get, we have to
pay out of pocket, so I think that hinders a lot of it. If your insurance only covers it
through your doctor, then a lot of patients are not going to get it at the pharmacy.”

When asked about the patient’s location or community settings (rural vs. urban), pharmacy
students across all three focus groups believed that in rural areas patients may not be well
informed, have transportation, or be able to afford the vaccines.

“You know a lot of people in more rural areas don’t have the knowledge and aren’t
educated enough about general health, wellbeing, so they don’t go to the doctor, so I
think it kind of stems from that.”

“I think one of the problems with being in a rural setting is that they may be much farther
away from their pharmacy or from the doctor and that may lead to some issues in
general, like they are not…, they are like ‘oh it is so far away, I am not going to do that’,
it is like not worth the trip or anything like that. So, that could be a barrier and they may
be scare and nervous or just disregard vaccinations altogether, that may be an issue.”

“I agree, they might also, maybe not have enough access to information regarding
vaccination, either through their provider of through basically any other resources they
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could obtain in a more urban setting.”
“I think the knowledge definitely is a barrier”
“And access… like having transportation or insurance, being able to afford it”

In summary, the facilitators mentioned include healthcare provider recommendation,
posters or advertisements letting pregnant women know they can get the vaccine at the
pharmacy, and incentives for the women. Barriers mentioned include pregnant women’s lack of
awareness of the pharmacy as a place to obtain vaccines, lack of time, women’s insurance type,
women living in rural areas, women’s lack of trust in the pharmacist, and the pharmacists
themselves not receiving enough education regarding immunizing pregnant women.

Subjective Norms. The theme of subjective norms refers to the notions of how certain
individuals view and approve or disapprove of pharmacists providing immunization services to
pregnant women. It also refers to pharmacy students’ engagement in providing influenza
vaccines to pregnant women if they feel people close to them think they should. These then
motivates the pharmacy students to administer influenza vaccines based on what these
individuals think. For the study, the students were asked about the influences of the following
individuals on them providing influenza vaccines to pregnant women: a) the CDC, b) the APhA,
c) the Florida state statutes, d) physicians, e) pregnant women, and f) their peers.

CDC. When asked about the influence of the CDC, pharmacy students believe it plays a
role as a resource for information to keep up with the latest guidelines and changes regarding the
influenza vaccine administration.
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“I think their role would be to keep the information updated because we are constantly
learning so we go to the CDC for updated guidelines for what has changed regarding the
vaccine or regarding a special population. I feel like they are the most updated
information that we should be able to go to help answer questions that patients may have
regarding the vaccine.”
“I actually have the CDC vaccine schedule app on my phone, so even as a student, if I
were to be at work and someone should ask for the vaccine, I even looked it up… So, I
am expecting that this app is up to date and current with child schedules, adult schedules
and special population schedules you know. I am expecting that resource to be on top of
the game.”

APhA. When asked about the influence of the APhA, pharmacy students believed it is a
key resource through which they obtained their training on immunization and for continuing
education, and also expressed the need for the APhA training to focus more on special
populations.
“I am not sure as far as re-certification goes, but as far as our previous certification and
initial training in APhA…, they could focus more on special populations and it’s
probably a time constraint and they can’t address everything which is why they just have
us refer to the CDC vaccination schedule. But I think that it certainly could be useful to
us to educate us more on those populations, or populations that we will encounter
frequently in practice as well as continuing the education like throughout the
curriculum.”
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“We had a… during our first year of Pharmacy school, we had an Immunization course
given by APHA (which is the American Pharmaceutical Association) and… that’s where
we were trained to give vaccinations.”

“I believe that as some of these conferences like APhA conferences, they provide
continuing education for pharmacists that provides…, they have like an immunization
parcel for that that would kind of give you the updated information that you need, some
kind of mini version of what we took our first year at school.”

Florida State Statutes. When asked about the influence of the Florida state law regarding
pharmacists providing immunization services under the supervision of a Physician within a
framework of an established protocol (Florida, 2018), pharmacy students expressed mixed
feelings on how it affects their vaccine administration practices, as they feel it takes away from
their autonomy and may not be necessary, as seen in the excerpt below.
Participant 1: “We are a long way from Pharmacists being considered practitioners. We
are not even considered practitioners. So, for us to be able to vaccinate, we had to put
something in place.”

Participant 2: “It’s a start.”

Participant 3: “It’s a start, yes!”

Participant 4: “I don’t know… I feel like it’s not necessarily like a “bad thing” like in
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case of I guess in case of “special cases” or whatever. Then again, it also kind of
hinders. To be honest with you, I couldn’t even tell you who xxx, that is my particular
store, is contracted with as far as the Physician goes and things like that. I couldn’t even
tell you if it’s the same Physician for all xxx stores – you know what I mean? So, it’s just
that we have to have it to say there’s a Doctor’s name on it but… why? You know…”
Participant 5: “We’ll get there… eventually.”

Pharmacy students from the other focus groups shared the same sentiment as above, one
participant expressed that the arrangement is useful for the pharmacist, and one further expressed
how the physician plays a role in determining the type of vaccine manufacturer the pharmacy
dispenses.
“The standing order they have one provider that they can use that the prescription is
automatically signed by. I have never really had an opinion about, I guess it does kind of
put the provider at some risk for liability, but in my experience I have always thought it
was very convenient that we have that, and it is very helpful to the pharmacist so, I am
sure there are definitely cons to it, but I think it is a useful thing to have for the
pharmacist.”
“I think one of the things they do is dictate what manufacturer the vaccines are gotten
from or something like that. I just learned that last week, depending on like the doctor
that you are practicing under, they actually pick what vaccine or what manufacturer the
NDC that you use in your own store. They actually dictate that. But I don’t know if that is
a benefit to us, or a disadvantage, because we are sent the vaccine to our store and then
we administer it. We know that that is the NDC we have available, so that is the NDC we
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are going to use, we don’t really know what other ones are available or what other states
may use either. So, I think that could be a disadvantage, but nobody, I feel like nobody
really talks about it, so we are just kind of like in limbo, we are very unaware about it.”

Physicians. When asked about the influence of the physician on pharmacists
administering the influenza vaccines to pregnant women, pharmacy students believed if
physicians refer pregnant women, they will feel safer coming to the pharmacy for their shots,
some believe doctors are already referring patients to go to the pharmacy to receive the influenza
vaccine and others expressed the need for communication between pharmacists and doctors.

“Yeah, coming from them (the physician), they (pregnant women) feel more safe doing it
at the pharmacy.”

“Yeah, I think there is a lot of doctors that are always telling patients like go to your
retail pharmacy, go get your vaccines. Honestly, I feel like a lot of Doctors are
overwhelmed these days with high patient numbers, so, essentially it is like less work for
them, they know that we do it.”

“I think as far as we are in communication with each other, it will take some load of the
OBGYNs and if they pharmacists have questions to be able to contact whenever, and say
‘hey, we are giving this patient this vaccine is that okay with you, and then they proceed
in that way. And keeping contact with the patient all in the same loop.”
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Pregnant Women. When asked about the influence of pregnant women on pharmacists
administering the influenza vaccines to them, pharmacy students had all not had prior experience
to providing immunization to a pregnant woman. But they expressed that pregnant women may
not be comfortable getting their immunizations from the pharmacist, others felt that with proper
counseling pregnant women will be comfortable getting their shots from a pharmacist.

“I actually do not have any experience with giving or witnessing the vaccination in
pregnant women… But I think they will probably feel a little scared or worried or they
may feel like it is in the community, so it is unclean maybe the pharmacist should not do
it. If I did it in the doctor’s office, it will be cleaner and be better for me…, you know
they may have their different opinions about getting vaccinations in the community.”
“I don’t think I have ever given a pregnant woman a flu shot. The chances are they are
probably getting it from their doctor, because I feel like the woman is going to be more in
touch with their OBGYN.”
“I would hope they want to come to the pharmacy… I personally wouldn’t know how to
approach a pregnant woman who had concerns I would definitely grab my boss who is a
Pharmacist and kind of “tag-team” - as I call it – and counsel her and hopefully, with
what we explain to her she’d be comfortable getting immunized.”
“I did witness a patient that came up to my counter once, and she asked if she was able to
get the flu vaccine, and she seemed like scared and nervous… After speaking with her,
the pharmacist gave her the vaccine.”

Peers. When asked about the influence of their peers or other pharmacists on them
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administering the influenza vaccines to pregnant women, pharmacy students believed that their
colleagues choosing not to provide immunization services to these women, may not affect them
personally, but they expressed that when pharmacists do not immunize, it pushes the practice of
pharmacy back and pharmacists who do not immunize pregnant women tend to be older, set in
their ways and are not interested in broadening their scope of practice.

“I think that pushes us back, because I actually had a pharmacist who told me that she
refused to give vaccines when it was first started for like a solid two years. Like patients
would come in to ask for the vaccine and she would turn them away. I feel like it makes
the patient, probably feel some type of way that a pharmacist with a doctorate is refusing
to give the vaccine, so, are all pharmacists capable of giving this vaccine? or what is the
reason behind it, I do think that does push us back. And I feel like those pharmacists are
set in their ways and they really don’t want to expand our scope of practice”

“I kind of understand where those pharmacists will be coming from, they will probably
think it is better for the pregnant women to go to their primary care providers or their
gynecologist specifically in order to receive that kind of vaccination or treatment. They
feel like that is kind of outside their scope”

“I know that the older generation of Pharmacists weren’t really too keen – at least some
of the pharmacists that I’ve worked with who’ve been on the field for twenty plus
years… “so, I have to give vaccines now?” It’s not something that I think they care to
do… But the newer generation of Pharmacists are definitely more on-board for doing
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something like that.”

They also expressed that when pharmacists immunize it would increase the number of women
receiving the vaccine and will reduce missed opportunities.
“I think it would solidify… because that’s one less person that could give the vaccine so
that many more patients are not missed”

Projected future practices. When asked about if they would be willing to administer
influenza vaccines to pregnant women, should the opportunity arise, pharmacy students all
expressed the same sentiment about their willingness to administer influenza vaccines to
pregnant women and most believed it would not feel different from giving a non-pregnant person
the vaccine, but may administer I with more caution.
Participant 1: “I would be fine with it.”

Participant 2: “Yeah.”

Participant3: “I would be fine with it too… I personally would probably want to do a
little bit more research to make sure that the vaccine that I am giving is safe.”

Participant 4: “But I think we have access to the appropriate resources so that wouldn’t
be a problem.”
Participant 5: “Yeah, I would definitely have to consult that resource before I do
anything but then as long as it says it is fine, I would have no problem doing it.”
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Participant 6: “I would be comfortable. I personally would probably double and triple
check myself as far as the vaccine is safe to give.”

Participant 7: “Yeah, as long as there is not any other co-morbidity or anything wrong
with that woman’s pregnancy… and same with another patient that might have another
co-morbidity – I would want to make sure that everything checks out before giving the
vaccine.”

Participant 8: “…but giving it to a pregnant woman, I would just treat them like any
other patient.”

Participant 9: “Yeah, pregnant or non-pregnant person, it is the same thing”

Participant 10: “I will feel fine as long as I double check and the pharmacist manager
says it is alright, so it will be like just administering the vaccine to any other patient.”

Summary of focus group discussion, main themes and subthemes and a representative quote are
seen are seen in table 6 below.
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Table 6. Main Themes of Students focus Group Findings and Representative Quotes
Themes
Knowledge
Mechanism of action

Representative Quote
“…the body is able to mount an immune response to the inactivated or the live attenuated
vaccine and by mounting that response you then gain immunity to the strains within that
vaccine through the formation of antibodies, so that if you are exposed to it again the body
is able to defend against it…”

Types of vaccine

“…there is the live vaccine and there is the inactivated vaccine. Depending on what the
patient’s position is, you may not want to give one over the other and there are like
different formulations that are better for the younger population and some that are better
for the older. There is the trivalent, quadrivalent and all that, they come in different
strengths and different amounts.”

Recommended groups

“Everybody should get it. When they are of age… Well I mean you are not going to give it
to like a newborn…”

Misconceptions

“It takes a couple of weeks to actually have a full effect of the immunization, so if you get
sick during those two weeks after having the flu shot, it is not because of the vaccine, but
because of the flu virus itself, and you just happen to get it during that time. It is a common
misconception…”

Instruction on
pregnancy vaccine

“I remember thinking that pregnant women should get the vaccine, I just don’t remember
when and where.”

Attitudes
Access

Experts
Ease for patients

Limited information
Limited knowledge
Liability

Perceived Control
Facilitators
Provider
recommendation
Marketing

“…pharmacists are easily accessible in the community settings it is a huge advantage for
patients to be able to gain access to receiving immunizations. It really opens up as far as
the number of immunizations we are able to provide…”
“I think we are qualified just in the knowledge that we are providers... Also, we can touch
up on things that fall under our scope such as vaccines”
“It’s less cost if you think about it because they have to make an appointment with their
doctor which they have to do a co-pay and then, like, get the vaccine and… it just, it
creates less cost for the patient.”
“…we don’t know the background of the patient as maybe we should”
“… We can talk about like Flu shot, as far as our knowledge at least now as students we
are kind of like limited.”
“I think there could possibly be more liability associated with administering vaccines to
pregnant women because of adverse effects whether it is related to the vaccine or otherwise
could be definitely a liability issue and it could come back to the pharmacist regardless of
if they administered it appropriately for that patient. It is just higher risk for the
pharmacist’s license”
““If they received a note from the doctor, and they speak to their doctor about why it is
okay to receive the vaccines from pharmacists and why they should do it, that may make
them more likely to”
“…A poster like ‘hey, you can get it here, but you can also go to your Pharmacist and get it
there’.”

Barriers
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Table 6. Continued
No trust

No awareness
of vaccine
safety
No time

No education
Community
settings

Insurance

Subjective Norms
CDC

APhA
Florida State
Physicians
Pregnant Women
Peers

Projected Practice

“…If it is just a patient that frequents the store not the pharmacy, it might be hard to kind
of convince them of your trust. It is a trusting relationship, like they have that relationship
with the doctor. So, they will probably feel safer getting it there.”
“They don’t always think it is safe and sometimes no matter what we tell them, they don’t
always believe us.”
“the pharmacists feel pressured to meet that number and if they don’t have a pharmacy
intern or anybody else to give those vaccines, they have to constantly be leaving the
workflow in order to administer vaccine…, it is a pretty time-consuming process.”
“I guess where I am at right now, probably lack of education, we never really focused
much on the pregnant women, at least in our education so far…”
“I think one of the problems with being in a rural setting is that they may be much farther
away from their pharmacy or from the doctor and that may lead to some issues in general,
like they are not…, they are like ‘oh it is so far away, I am not going to do that’, it is like
not worth the trip or anything like that. So, that could be a barrier and they may be scare
and nervous or just disregard vaccinations altogether, that may be an issue.”
“Insurance doesn’t always cover it. We have to put in particular codes on the computer
and sometimes, depending on the vaccine, and depending on the insurer/insurance
coverage, Insurance won’t always cover it. They won’t cover like a Pharmacist giving it.”

“I think their role would be to keep the information updated because we are constantly
learning so we go to the CDC for updated guidelines for what has changed regarding the
vaccine or regarding a special population. I feel like they are the most updated
information…”
“I am not sure as far as re-certification goes, but as far as our previous certification and
initial training in APhA…, they could focus more on special populations…”
“I don’t know… I feel like it’s not necessarily like a “bad thing” like in case of I guess in
case of “special cases” or whatever. Then again, it also kind of hinders…”
“Yeah, coming from them, they (pregnant women) feel more safe doing it at the
pharmacy.”
“…The chances are they are probably getting it from their doctor, because I feel like the
woman is going to be more in touch with their OBGYN.”
“I know that the older generation of Pharmacists weren’t really too keen – at least some of
the pharmacists that I’ve worked with who’ve been on the field for twenty plus years… “so,
I have to give vaccines now?” It’s not something that I think they care to do… But the
newer generation of Pharmacists are definitely more on-board for doing something like
that.”

“I will feel fine as long as I double check and the pharmacist manager says it is alright, so
it will be like just administering the vaccine to any other patient.”

Overall, all students responded they were taught about influenza vaccine administration
in a required course and called for a need for pregnancy-specific instruction which substantiated
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the findings from the Academic Deans curriculum review. The participants across all the focus
groups generally expressed positive attitudes about providing immunization services to pregnant
women coupled with the belief of being experts in their field and being accessible to increase
influenza vaccine uptake in pregnant women, which also substantiated findings from the
Academic Dean interviews. Pharmacy students identified attitudes, perceived control factors and
subjective norms in their role in administering the influenza vaccine to pregnant women.
Discussion
Connecting the Academic Dean’s interview findings with the pharmacy students’ focus
groups allowed for a better understanding of pharmacy school curricula in Florida. Not only did
this study review the immunization with respect to influenza vaccines in pregnant women
curricula, but the focus groups provided an insight on how the curriculum is translated to the
pharmacy students who received the instruction. The qualitative methods employed in this study
best address the issue of cognitive understanding or perceptions of course instruction on
immunization in their pharmacy school courses because qualitative research is useful to provide
an understanding of human behaviors involving cognition.
The pharmacy school’s curriculum review findings showed that among the six accredited
schools of pharmacy in Florida, 50% percent of them provided immunization content with
respect to pregnant women in their required courses. However, all (100%) six accredited schools
provide instruction on immunization as part of the ACPE requirements. All six (100%)
Academic Deans reported that pharmacy schools should include compulsory immunization
content with a focus on vaccines in pregnant women. Academic Deans reported that the majority
of the courses that provide content on immunization are covered under “special populations”
which include pregnant women. This finding was substantiated by the information gathered from
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the focus groups discussion. Understanding the types of courses that provide instruction
regarding immunization on pregnancy to pharmacy students is important to guide educational
intervention efforts. In summary the findings from the review of the family school curriculum
included the following: a) the accredited schools of pharmacy in Florida, all provide instruction
on immunization including influenza vaccine administration in their pharmacy school classes, b)
majority of the schools provide immunization instruction with respect to pregnant women, c)
pharmacy students are equipped and certified to provide immunization services after receiving
instruction and training, and d) there was a call for the need for the integration of pregnancyspecific immunization content to be incorporated into curriculum.
The pharmacy students focus groups provided information on the knowledge of
pharmacy students learned about immunization with a focus on influenza vaccine in pregnant
women, the types of vaccines, mechanism of action, the recommendations, and misconceptions.
The focus group discussions showed an important discrepancy between what the students
reported in their surveys and what they reported during the discussion regarding if they received
instruction on the administration of influenza vaccines in pregnant women. Initially, only a few
students reported not being sure about being taught about it, but during the focus group,
additional students shared this sentiment. In addition, students reported they wished they had
received more information about influenza vaccine administration to pregnant women. This
finding demonstrates that what is taught in pharmacy schools is perceived to be insufficient in
equipping pharmacists with the confidence to provide vaccines to pregnant women.
In discussing pharmacy students’ attitudes about administering inactivated influenza
vaccines to pregnant women, the overall positive attitude assessment is that they believe they are
in a good position to provide influenza vaccines to pregnant women as pharmacists are
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accessible, are qualified to provide such services, and it may be more cost-effective for pregnant
women. Consistent with previous research by Steyer et al (2004), which shows pharmacists are
the most accessible health care provider (Steyer et al., 2004). Some have reported that it is costeffective for pharmacists to administer the influenza vaccine to adults (Grabenstein et al., 1998;
Prosser et al., 2008). Pharmacy students also expressed some negative feelings that may interfere
with them providing such services such as not having enough background information about the
women, fear of liability and as students they feel they might be limited in their knowledge to
provide influenza vaccine to pregnant women. Dolan et al (2012), also reported that pharmacists
that are certified to immunize had concerns or fear of liability when it came to providing
immunization to pregnant women (Dolan et al., 2012).
For the perceived control, pharmacy students reported facilitating factors to provide
influenza immunization to pregnant women to include provider recommendation or referral and
marketing campaigns. A study by Ding et al (2017), reported that higher rates of influenza
vaccine uptake were seen among pregnant women who received a recommendation from their
provider compared to those who did not (Ding et al., 2017). Research shows that pharmacists
advocating or providing marketing campaigns on vaccines save costs and prevent hospitalization
(Grabenstein et al., 1998). In discussing barriers to provide influenza immunization to pregnant
women, pharmacy students mentioned pregnant women may not trust the pharmacist and do not
believe the vaccine is safe during pregnancy. This is in contrast to a study by Wang et al (2014),
which showed that pharmacists are one of the most trustworthy health care providers (Wang et
al., 2014). Other barriers include lack of time during work hours, and feelings of not being
educated about immunizing pregnant women, type of insurance and the community settings of
the women. The study by Dolan et al (2012), also reported that pharmacists believe pregnant
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women may not be interested in the vaccine and the patient’s insurance may not cover it (Dolan
et al., 2012). A study by Murphy et al (2012), reported accessibility of pharmacists administered
influenza vaccines to individuals residing in medically underserved areas (Murphy et al., 2012),
which was not a sentiment brought up during the focus group discussions.
In discussing the subjective norms, pharmacy students reported that CDC serves as a
resource to go to for vaccine information and update and the APhA was viewed as a training
resource. The students view these agencies to provide guidelines to make them want to provide
influenza vaccines to pregnant women. This is in line with the study by Dolan et al (2012),
which reported that one of the reasons pharmacists provide immunization to pregnant women is
because it complies with the CDC guidelines (Dolan et al., 2012). However, students expressed
the need for training to focus more on special populations such as pregnant women. Students
expressed that pregnant women may prefer to get vaccines from their doctors and emphasized
the importance of provider referral of pregnant women to the pharmacy. Pharmacy students
reported that they felt older pharmacists may not want to immunize pregnant women.
When discussing the Florida state statutes as it relates to the standing order for vaccines,
pharmacy students had mixed feelings on how it affects their vaccine administration in pregnant
women practices, but still see the relevance of it. This is partly in line with studies that reported
that pharmacists providing immunization is facilitated by the standing order (Goode et al., 2007;
Steyer et al., 2004; Weitzel, 2000).
Overall, Academic Deans and pharmacy students shared the sentiments that they are
equipped to provide immunization services. Despite the call for the need for inclusion of
pregnancy focused immunization training, pharmacy students believe that when presented with
the opportunity, they will be willing to provide influenza vaccines to pregnant women. This
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resonates with studies that assessed pharmacy students and showed they gained self-confidence
in administering vaccines, and can boost vaccine uptake rates (Globe, Johnson, Conant, &
Frausto, 2004; Turner et al., 2007).
This study had several limitations. Firstly, it composed of qualitative studies with small
sample sizes and hence not generalizable. Another limitation of focus groups with respect to the
study is that no two students remember or learn the same way, and both the Academic Deans and
the student’s reports are based on self-report, therefore, perception on instruction may be
subjective. However, the focus groups provided a recollection of what students were taught, and
correct representation of the instruction they received on influenza vaccine administration in
pregnant women.
This study also has several important benefits. Many of the studies regarding pharmacy
students and immunization look at students providing immunization in adults, not in special
populations including pregnant women. The qualitative nature of this study is important in
examining how students perceive what they learn and how they may relate it to their ability as
licensed pharmacists in the future. In addition, this study provided an opportunity not to only
examine students’ perceptions, but also the perceptions of the Academic Deans of pharmacy
schools in Florida. Furthermore, this study included the perception of individuals i.e.
pharmacists, that are often overlooked when it comes to providing care for pregnant women.
Conclusion
Pharmacists are in a good position and play an important role in tackling the issue of low
influenza vaccine uptake among pregnant women rates. Since pharmacists already provide
immunization to adults, drawing attention to vaccine administration to pregnant women should

87

not be an issue. Pharmacy schools and the APhA should include opportunities and strategies in
into their PharmD curricula and continuing education and certification training.
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Manuscript 2: The Role of Pharmacists in Administering Inactivated Influenza Vaccines
(IIV) to Pregnant Women
Abstract

Background: Influenza vaccine rates in pregnant women continue to remain suboptimal despite
the recommendations from healthcare organizations. Although pharmacists can provide
immunization services as a result of the standing order by the CDC, relatively few studies have
examined the role of the pharmacist in providing immunization services to pregnant women.
Despite the feasibility of pharmacists providing these services, few studies have directly
considered pharmacists’ perspective on how they perceive their role in increasing influenza
vaccines among pregnant women. Purpose: This study utilized the Theory of Planned Behavior
to explore the inactivated influenza vaccine administration in pregnant women practices among
licensed Florida pharmacists. Methods: Semi-structured, in-depth, in-person qualitative
interviews were conducted with 18 licensed Florida pharmacists including clinical and retail
pharmacists. A thematic comparative analysis was conducted to determine differences in
practice. Results: Majority of pharmacists (94%) knew pharmacists could administer influenza
vaccines in pregnant women. Participants expressed positive and negative attitudes and identified
barriers, facilitators, and subjective norms that influenced their vaccine administration practices
among pregnant women. Overall, they believed they were equipped and able to provide
influenza immunization to pregnant women. Conclusion: There is a need to strengthen
immunization services provided by pharmacists by tailoring them to include pregnant women
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specifically.
Introduction
During pregnancy, the immunity of a mother is lowered making her more susceptible to
various infections including the influenza virus illness (Mor & Cardenas, 2010). Research has
shown an increase of about a four-fold in influenza antibody titers during pregnancy. (Mak,
Mangtani, Leese, Watson, & Pfeifer, 2008). In between influenza epidemics, and during
influenza pandemics, pregnant women are usually more susceptible to contracting influenza and
its subsequent complications such as pneumonia, spontaneous abortions, preterm births, birth
defects and fetal loss (Mak et al., 2008; Rasmussen, Jamieson, & Bresee, 2008). Usually, the
morbidity from influenza in this population is low, however during the influenza pandemics such
as 1918, 1957, 2009 and other influenza outbreaks, there were high death rates in pregnant
women (Callaghan, Chu, & Jamieson, 2010; Mak et al., 2008; Thompson et al., 2011).
During the 1918 influenza pandemic in the U.S., 27% of pregnant women died, also in
the 1957 pandemic influenza, 20% of influenza-associated deaths occurred in pregnant women
(Rasmussen et al., 2008). This increase in mortality during influenza pandemics is a significant
cause for concern, thereby placing pregnant women as a priority group for recommending the
influenza vaccine (Callaghan et al., 2010; Thompson et al., 2011). The American College of
Obstetricians and Gynecologists and Advisory Committee on Immunization Practices (ACIP)
from the centers for disease control, recommend that all pregnant women should obtain the
influenza vaccine (ACOG, 2004; Fiore et al., 2010; Thompson et al., 2011). Despite the
recommendations, inactivated influenza vaccine uptake rate in this population remain suboptimal
with about 33% -35% of pregnant women receiving the flu vaccine during the 2016/2017
influenza season (Arnold et al., 2019; CDC, 2017).
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In pregnant women reasons for influenza non-vaccination are as a result of determinants
such as concerns with safety for their unborn child and themselves; lack of awareness of the
“two-fold” benefit of the vaccine; and women in their first or second trimester (Chamberlain et
al., 2015; Meharry, Colson, Grizas, Stiller, & Vázquez, 2013; Wheelock et al., 2013). Other
barriers to influenza vaccine uptake in this population include access, lack of time, lack of
transportation to health care center, and lack of availability of influenza vaccine at providers’
office (Arao, Rosenberg, McWeeney, & Hedberg, 2015; Healy, Rench, Montesinos, Ng, &
Swaim, 2015; Meharry et al., 2013). Some of these reasons corroborated among providers
include insufficient time during prenatal visits, shortage of vaccines, allergic reaction of women
to the vaccine, and their lack of knowledge about the vaccines (Healy et al., 2015; Frew et al.,
2018). Providers also reported their personal lack of enthusiasm when recommending the
vaccine and insufficient time to explain the benefits of the vaccine during visits, reimbursement
challenges (Arao et al., 2015; Clark et al., 2013; Frew et al., 2018).
In the year 2000, the ACIP recommended standing order programs that authorized
pharmacists and nurses to administer vaccines to adults (McKibben, Stange, Sneller, Strikas, &
Rodewald, 2000). This recommendation followed studies that demonstrated that having nurses
and pharmacists administer vaccines improved vaccination rates in adult populations.
Implementation of programs such as this helps to take the pressure off physicians and increase
adult vaccine coverage (McKibben et al., 2000). Among health care providers, pharmacists are
the most accessible, as approximately 250 million individuals make a trip to the pharmacy every
week (Steyer et al., 2004). Some of the barriers in inactivated influenza vaccine uptake in
pregnant women can be overcome using community pharmacists due to them being accessible
and they have more extended hours and days of work (Grabenstein, 1998; Steyer, Ragucci,
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Pearson, & Mainous III, 2004). The study by Steyer et al. showed that in states that allowed
pharmacists to administer immunization, the vaccine rate increased significantly in adults
between the ages of 18-64 years (Steyer et al, 2004).
Studies have demonstrated and assessed the scope or feasibility of pharmacists practice in
administering vaccines to adults, it was noted to be facilitated by policies such as the standing
order which increased influenza vaccine administration and hence uptake in various states in the
U.S. (Goode et al., 2007; Steyer et al., 2004; Weitzel, 2000). Other studies have demonstrated
pharmacists’ administrating influenza vaccines to adults was cost-effective (Grabenstein et al.,
1992; Prosser et al., 2008). The study by Grabenstein et al., (1992) reported that pharmacists
playing the role of advocates and facilitators through campaigns inadvertently prevent
hospitalizations and save costs (Grabenstein et al., 1992). The study by Prosser et al., (2008),
reported the cost of vaccination was lower with pharmacists administered vaccines compared to
clinics (Prosser et al., 2008). The study by Murphy et al., 2012, noted the accessibility of
pharmacists administered influenza vaccines to individuals residing in medically underserved
areas emphasizing the unique positions pharmacies might play reducing geographic barriers.
Other studies noted that several factors were associated with individuals accepting pharmacies
and pharmacists as vaccine administrators, and they include long hours of operation,
convenience and easy accessibility (Ernst et al., 1997; Goode et al., 2007; Murphy et al., 2012).
A study by Wang et al. (2014), noted that individuals placed pharmacists as the second most
trustworthy vaccine administrators among health professionals following doctors. The study also
noted that individuals reported that they would be comfortable receiving their influenza shot
from pharmacists (Wang et al., 2014).
There are few studies that have qualitatively explored the role pharmacists play in
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administering vaccines, especially from the perspective of the pharmacists themselves. Some
studies have qualitatively explored the perceptions of the community and other health care
personnel on the role pharmacists have played (Blake, Blair, & Couchenour, 2003), but no
studies available exploring the pharmacist’s perspective. A quantitative study by Dolan et al
(2012), assessed pharmacists’ knowledge attitudes and practice as it relates to treatment and
vaccination of pregnant women during the 2009 influenza virus pandemic. They reported that
pharmacists did not believe they had an important role in administering inactivated influenza
vaccines to pregnant women (Dolan et al., 2012). The study, however, aims to explore the role
pharmacists play in inactivated influenza vaccine administration in pregnant women practice,
and this will be carried out qualitatively. This study attempts to fill these gaps by exploring the
perceptions of licensed Florida pharmacists about their role in offering and administering
inactivated influenza vaccines to pregnant women using the Theory of Planned Behavior (TPB)
as a guiding framework.
Methods
Overview. This qualitative research study employed in-depth interviews. The main
research question aimed to explore the knowledge, attitudes, social factors, barriers and
facilitating conditions that influence IIV in pregnant women administration practices among
licensed pharmacists in Florida. The study was approved by the University of South Florida
Institutional Review Board (IRB). All records were stored on the USF Box folder and in locked
filing cabinets in a locked room at USF. This study was non-invasive and presented minimal risk
to human subjects.
Target population & sampling frame. The research aim, to explore the knowledge,
attitudes, social factors, barriers and facilitating conditions that influence the influenza vaccine in
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pregnant women administration practices among licensed pharmacists, was addressed through
in-depth interviews with the licensed pharmacists in the state of Florida. Twenty licensed
pharmacists in the state of Florida were chosen as the target population, as most pharmacists
work under state and local state board regulations, regardless of the impact of national
organizations such as the American Pharmaceutical Association (APhA). The sample size of 20
was used because generally, the sample size for qualitative studies ranges from between 12-60
(Edwards & Holland, 2013). The target the population is pharmacists in Florida who are
registered with the Florida Board of Pharmacy.
In-depth interview guide. The interview guide was developed guided by the Theory of
Planned Behavior (TPB) to understand the influenza vaccine administration in pregnant women
practices among pharmacy students after graduation. Using the TPB, the interview guide asked
questions about their knowledge, attitudes, subjective norms, and perceived control regarding
administering the influenza vaccines to pregnant women. The interview guide was piloted with a
licensed pharmacist who is also an Associate Professor at the USF College of Pharmacy to assess
the feasibility, validity, and acceptability of the focus guide. The primary purpose of this pilot
test was to assess the feasibility, validity, and acceptability of the interview guide. Qualitative
interviews are usually pilot tested with a few interviews among people that have similar
characteristics to the population of interest (Hennink, Hutter, & Bailey, 2011).
Sampling plan. Licensed pharmacists were recruited via non-probabilistic stratified
purposive sampling for the in-depth interviews. The use of a stratified purposive sampling is to
give room for comparison among study participants (Guetterman, 2015; Patton, 1990). In-depth
interviews, as opposed to a focus group, were used as they provide an opportunity to explore
individual perceptions of decisions regarding influenza administration in pregnant women.
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Licensed pharmacists were stratified based on the type of center where they provide services into
clinical and community (retail, independent, and others such as floaters who worked both at
retail and home infusion and industry). A list of sites where pharmacists work was generated
using a convenience sampling method, and the ‘gatekeeper’ or whoever was in charge at the
various sites was contacted to help gain access and recruit participants. Emails and flyers which
briefly introduced the study and described how to contact the researcher were sent to licensed
pharmacists to recruit study participants.
Pharmacists were eligible for the study if they met the criteria of being a licensed Florida
pharmacist. The study used a quota sampling strategy (Bernard & Ryan, 2010). There were two
stratified sub-groups for which the adequate sample sizes were aimed to obtain, the participants
were stratified by type of pharmacy where they work (clinical/hospital setting or community
setting). This stratification provided some variability to the data to assess the impact of the type
of pharmacy were pharmacists work on their knowledge, attitudes, subjective norms, and
perceived control related to administering the influenza vaccine to pregnant women. The
minimum number of pharmacists recruited for the pharmacists who work in a clinical setting was
5, while the minimum recruited for those who worked in community pharmacists was 13. More
community pharmacists were recruited as they are known to provide immunization to the
community, while fewer clinical pharmacist were recruited as it was unclear if they provided
immunization in hospitals, however, their perceptions may provide a different view. This
resulted in a total of 18 participants, saturation and redundancy was reached after 16 interviews
and two more pharmacists were interviewed to reach a sample size of 18 (Table 7). The
interview was piloted with a pharmacist who is also an Assistant Professor at the USF College of
Pharmacy.
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Table 7. Pharmacy Interview Sampling Strategy
Certified to
Immunize

Not certified
to Immunize

Total

Clinical Pharmacist
N=3

N=2

N=5

Community
Pharmacist

N=10

N=3

N=13

Total

N=13

N=5

N= 18

Data Analysis.
Data management. To ensure reflexivity through the research process, comprehensive
field notes were taken that documented the focus groups and interviews, thoughts on them, and
potential causes of bias that may interfere with interpreting results (Miles, Huberman, & Saldana,
2013). The recorded interviews and focus groups were transcribed word for word and were
crosschecked for accuracy. Transcriptions did not include participants’ names or any other type
of identifying information. Once transcriptions were completed, the audio files were deleted to
protect participants’ confidentiality. A distinctive participant identifying number was used to
differentiate each participant. All demographic information and transcripts were uploaded on
MAXQDA analysis software, which would be used to analyze and manage data.
Data condensation. An a priori codebook was developed that had themes based on the
interviews and focus group guides and the guiding TPB theory. The analysis was carried out
concurrently as interviews were being conducted and transcribed, and emergent codes were
added to the codebook with revised definitions as needed. The codebook contained the names of
the codes, what the code signified (inclusion criteria for applying the code), what it does not
signify (exclusion criteria for when no to apply the code), as well as a sample of the type of
quote that should be used with the code (Bernard et al., 2016). The codebook development was
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an iterative and continuous process, as new themes emerged during analysis. The codebook was
imported into the MAXQDA software and was applied to relevant parts of the transcripts. The
inductive thematic process, which involves the development of themes from the transcripts, was
then employed in the study to analyze interview data to examine conditions and interactions, and
determine categories that clustered together (Guest et al., 2011). To identify themes and
subthemes, the transcripts was read two times, as well as looking out for repetition, metaphors,
and content that was related to the TBP theory that guided the study in the text (Bernard et al.,
2016). After themes were selected, the portions of texts that represented the themes were then
identified (Bernard et al., 2016).
Data display and analysis. This employed the use of a matrix table in which codes and
coded texts were displayed for the purpose of analysis (Miles et al., 2013). Analytic memos were
used to note down considerations and anything else that came up during the analytic process
(Miles et al., 2013). The analysis was carried out by two independent coders. The primary
investigator coded all the transcripts (18) and the second researcher (LB) coded 10% (2) of the
transcripts independently to produce an inter-rater reliability measure. Ongoing discussions of
codes and themes continued through the analyses process, and discrepancies in the codes were
discussed and a decision on the appropriate approach to go forward was determined. A Cohen’s
kappa provides a statistical measure for the coders to use as a standard and limiting subjective
assessment, a kappa of 80% is used to denote agreement (Miles et al., 2013). The Cohen’s kappa
inter-rater reliability for this study was 84% denoting an agreement.
Results
The overarching purpose of this study was to explore the role of pharmacists in
increasing the uptake of influenza vaccines among pregnant women. The results from the study
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indicated that there were several areas discussed by participants, including their knowledge of
influenza vaccines in pregnant women, and the role they had to play. Both of these areas were
substantially impacted by what they know and their day to day interactions with pregnant
patients.
Demographics. A total of 18 participants licensed Florida pharmacists were interviewed
(Table 8), 50% (n=9) of them were female, and 50% (n=9) was male; 39% (n=7) were aged
between 18-30 years, 44% (n=8) were aged between 31-40 years, and 17% (n=3) were aged
between 41-56 years. About 72% (n=13) of them were certified to immunize, while 28% (n=5)
were not certified to immunize. Seventy-two percent (n=13) worked in community pharmacies,
and 28% (n=5) worked in a hospital setting. Twenty-eight percent (n=5) had been practicing for
about five years or less, 33% (n=6) had been practicing for 6-10 years, and 39% (n=7) of them
had practiced for more than 10 years. About 78% (n=14) had the influenza vaccine in stock
where they worked during the past influenza season, and only 6% (n=1) experienced a backorder
for the influenza vaccine during the past influenza season.

Table 8. Licensed Florida Pharmacists Demographics
Characteristics
Certified to Immunize
Yes
No
Age range
18-30
31-40
>51
Sex
Female
Male
Years of practice
0-5
6-10
>10

Number

Percentage (%)

13
5

72
28

7
8
3

39
44
17

9
9

50
50

5
6
7

28
33
39
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Table 8. continued
Location of Pharmacy
Rural
Urban
Sub-urban
Influenza vaccine in stock
Yes
No
Not applicable
Influenza vaccine back order
Yes
No
Not applicable
Ever immunized pregnant woman
Yes
No
Not applicable

1
12
5

06
66
28

14
2
2

78
11
11

1
13
4

06
72
22

7
6
5

39
33
28

Among the pharmacists who worked in the community settings, 77% (n=13) were
certified to immunize, and 23% (n=3) were not certified to immunize, also 2 worked at
independent pharmacies and were both not certified; and among the pharmacists who worked in
the clinical settings 60% (n=3) were certified to immunize, while 40% (n=2) were not certified.
Among the clinical pharmacist, 80% (n=4), had the job title of clinical pharmacist, while 20%
(n=1), was a clinical operations manager; while among the community pharmacists, 31% (n=4)
were pharmacy managers or directors, and 69% (n=9) were staff pharmacists. Among the staff
pharmacist were those who also had positions in other types of pharmacies including managed
care and industry 44% (n=4).
TPB constructs influencing influenza vaccine administration in pregnant women
practices.
Knowledge.
Knowledge about General Influenza Vaccine Administration. Pharmacists’ knowledge
about the influenza vaccine administration and uptake in the general population and in pregnant
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women were assessed using open-ended interview questions. When asked about their general
knowledge on influenza vaccines, all (100%) the participants knew about the influenza vaccine
and its use to prevent the influenza virus illness. One participant stressed the importance of
getting the influenza vaccine regardless of the side effects.

“It is very important that you get it every flu season, it is not going to make you get flu, it
is going to prevent it, it is not going to make you sick. Even if you have an egg allergy,
you are still able to get the flu vaccine, the incidence of people who actually have a true
reaction or true allergy to flu vaccine content is very very minimal, it is rare. And there is
another type of vaccine called the “flublok” that we give or recommend for you that will
be appropriate if you were concerned about that.”

LP16 (Clinical Pharmacist, certified to immunize)
Another participant emphasized how safe the vaccine is based on the recommendation of
governing bodies such as the CDC.

“It’s very safe. There isn’t a whole lot of things that are safer than Flu vaccine. When
patients ask me how safe the flu vaccine is, I explain to them that the CDC, the FDA,
whatever government agencies…, whatever I think they can understand, says that I can
give the Flu vaccine to anybody as young as 6 months of age; if it’s that safe, it’s safe for
everybody. The only contraindication to Flu vaccine is if you are allergic to eggs.”
LP 10 (Retail Pharmacist, certified to immunize)

107

Thirty-nine percent (N = 7) of the participants also mentioned other things they knew about the
influenza vaccines such as the recommended age groups and special populations for the
vaccines.
“If you are over the age of 6 months you are recommended by the CDC and most of other
guidelines to get it. It’s a respiratory virus that can be transmitted. It can cause from mild
to severe disease, especially in our high-risk patients need to be vaccinated.”
LP8 (Retail Pharmacist, certified to immunize)

“Everyone should get a flu shot once you are over the age of 6 months, and it should
be… I would like guesstimate early august before the temperature changes and all of
that.”

LP13 (Retail Pharmacist, certified to immunize)

“The vaccine does not always protect from the virus a 100%, but it provides some sort of
protection, immunity. I think it helps especially in pregnancy and other special
populations it is something people should get. In general people should get the vaccine
even if it is not 100%.”
LP7 (Clinical Pharmacist, certified to immunize)

Other things that were mentioned about the influenza vaccines included: types of
influenza vaccines, time to go get the vaccine, and the side effects. When the efficacy of the
vaccine was mentioned, all participants said vaccine was never 100% effective against the
influenza virus, and it varied from year to year. However, 10% (n=2) felt the vaccines are not
effective against the influenza virus disease based on their personal beliefs.
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“I would say that I believe it doesn’t really stop you from getting the flu, because
sometimes it gives you the symptoms of the flu after you get the flu shot.”
LP17 (Clinical Pharmacist, not certified to immunize)

“I got vaccinated in school and after a day or two I was really sick... It was like I was
going to die. So, it was during finals week. I almost failed school, I couldn’t explain why
the vaccine I got me sick immediately, ever since, I didn’t take the vaccine.”
LP9 (Retail Pharmacist, certified to immunize)

Also, some participants (10%, N=2) encouraged uptake of the vaccine regardless, as it may still
confer some protection.

“In my estimation it is 50-50. It does not hurt to get the vaccine, it does not necessarily
mean if you get the vaccine you won’t get the flu, but it does provide some sort of
protection, it does not hurt to get it, it is something I will recommend and I will get it
myself.”
LP7 (Clinical Pharmacist, certified to immunize)

“I think it can be effective, people have this preconceived notion…, like I hear a lot of
people say that it doesn’t even that they got the vaccine, but it still didn’t prevent them
from getting the flu. But the thing they might not know about it is that the virus is always
creating new genotypes and forms so that it is impossible to have every single type of
virus or whatever in a vaccine to protect you from everything that is out there, but it is
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going to protect you from the most common ones, or the ones that we have already seen
out there.”
LP4 (Clinical Pharmacist, not certified to immunize).

Knowledge about Influenza Vaccine Administration in Pregnant Women. Similar to the
general knowledge theme, all (100%) the participants knew about the influenza vaccine and its
use to prevent the influenza virus illness in pregnant women. Some of the participants (28% n=5)
mentioned the contraindication of live vaccines in pregnant women, and one participant (6%)
mentioned the use of the preservative-free influenza vaccine.

“…In most pregnant women the only contraindication usually is the live vaccine, to not
administer it to pregnant women, but the inactivated vaccine is safe in women who
are pregnant and women who are breastfeeding.”
LP 2 (Retail Pharmacy Director, certified to immunize)

“We are able to immunize pregnant women, but we use the preservative free.”
LP 15 (Retail Director, certified to immunize)

Some of the participants (28%, n=5) mentioned the influenza vaccine can be received at any
trimester by pregnant women, while (17%, n=3) mentioned not being sure what trimester was
safe for pregnant women to obtain the vaccine.

“Pregnant women can receive the vaccine in any trimester, it is safe for pregnant
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women…”
LP 2 (Retail Pharmacy Director, certified to immunize)

“We try to give them flu shot and tetanus shot and I know that they can get it at any time
during their pregnancy, so whatever the trimester they are in, as long as they are within
the flu season, we try to give it to all of them in our pharmacy setting. We do have the
standing order with the doctor so we can administer it. If they are 19 years and older, we
can give it to them.”
LP 12 (Retail Pharmacy Director, certified to immunize)

“Not sure the exact time as far as how many weeks or trimester.”
LP 13 (Retail Pharmacist, certified to immunize)

When asked about the benefits of the influenza vaccine during pregnancy, most (72%, n=13)
respondents mentioned the vaccine provides ‘dual protection’ for the mom and baby from the
influenza illness, keeping them both healthy.

“It is safe in pregnant women. They definitely should receive it, and the vaccine does
not affect the child too, so it provides a double coverage to the mom and baby. It is safe
and recommended.”
LP 11 (Retail Pharmacist, not certified to immunize)

“

…their immune system is weakened when they are pregnant so getting the vaccine would
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help them and the baby stay healthy. Also, the baby can’t get vaccinated until they are 6
months so if the pregnant mum were to get the vaccine, they would be immune over
those first few months after birth.”
LP 8 (Retail Pharmacist Director, certified to immunize)

Two participants mentioned additional benefits including providing protection for the
community (herd immunity) as part of the benefits of the pregnant women receiving the vaccine.

“I think the biggest thing is protecting the mom and the baby. And for…, not only from
each other, but also from the community, that herd immunity.”
LP 8 (Retail Pharmacy Director, certified to immunize)

“The benefits of the vaccine in pregnant women, it definitely protects them, the people around
them, as well as the baby that they are pregnant with. So, yeah getting the vaccine is very
beneficial as the mother whose immune system can be compromised, her organs can be
compromised with having a child, it definitely allows them to be more susceptible to the virus,
them as well as the baby. So, receiving the can give you more immunity and protect you and the
baby and the people you are around.”
LP 2 (Retail Pharmacy Director, certified to immunize)
Attitudes. The theme of attitudes reflects the pharmacist’s belief regarding providing
influenza immunization to pregnant women and the notion that doing so has specific outcomes.
Participants were asked about their thoughts and feelings about providing the influenza vaccine
to both the general public and pregnant women, which was expressed as advantages and
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disadvantages. Across the in-depth interviews’ participants believed it was advantageous to the
community and pregnant women that pharmacist provide immunization services. Pharmacists
described positive attitudes expressed in the following sub-themes: a) accessibility, b) experts, c)
increased scope, and d) ease for practices.

Access. Pharmacist believe they are the most accessible health care providers and this
sentiment was shared by 78% (n=14) of the participants.

“Pharmacists that work in the community settings are very, they are probably the most
accessible healthcare professionals…, I will say they are not the most appropriate, but
the easiest professional to reach to get your flu vaccine. They are the one group of
professionals where you don’t have to make an appointment and things like that.”
LP16 (Clinical Pharmacist, certified to immunize)
“Biggest advantage is accessibility. Can I pick up my medication? sure. Can I get
counseled? sure! oh while I am here can I get my flu shot? Sure! So “One stop shop” for
majority of all their needs.”
LP 6 (Retail Pharmacist, certified to immunize)

Experts. Pharmacists believe they are experts and knowledgeable, hence, that places them
in a great position to provide immunization services to pregnant women. This sentiment was
shared by 33% (n=6) of the participants.

“I think that a lot of people lack the knowledge. I think that they feel that the vaccines are
going to make them sick. We know a lot; we interact with the CDC a lot so we can
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explain to them the importance of it versus the risks of not having it. So, I think that we
are just that one extra level of education for them to feel safe about getting the vaccines.”
LP 8 (Retail Pharmacy Director, certified to immunize)

“We are very knowledgeable, and I think it’s just now that our knowledge is starting to
come into play, we have been doing this forever…”
LP 6 (Retail Pharmacist, certified to immunize)

Increased scope. Pharmacists expressed that providing influenza immunization services
to pregnant women increases the scope of their practice. This sentiment was shared by 39%
(n=7) of the participants.
“…it increases our scope of practice as practitioners.”
LP 2 (Retail Pharmacy Director, certified to immunize)

“I also think that it’s a good way for people to see the advancing role of a Pharmacist;
that they are not just counting pills, but they have a lot more roles.”
LP 8 (Retail Pharmacy Director, certified to immunize)

Ease for practices and patients. Pharmacists expressed that providing influenza
immunization services to pregnant women takes away the burden from physicians and other care
providers. It is also more convenient for pregnant women. This sentiment was shared by 39%
(n=7) of the participants.

“I think it’s a good thing that Pharmacists are involved now because some patients don’t
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have insurance. So, once they think about going to the hospital, getting an appointment,
seeing a Doctor and all that it discourages them from wanting to get the vaccine. But,
knowing they can walk into a Pharmacy and just get it without waiting in line for too
long or setting up an appointment, I think it encourages people at least to want to get
vaccinated.”

LP 18 (Independent Pharmacist, not certified to immunize)

“It saves them time and money. More than likely if you are in the pharmacy, just
speaking of pharmacies now, most pharmacies have convenience stores, so you are doing
shopping there anywhere, to rephrase my earlier statement, it’s a “one stop shop”. No
appointments needed, no doctors, just let us know when you want it, and we will take
care of it for you”
LP 6 (Retail Pharmacist, certified to immunize)

It helps out some of those strained medical facilities that may be inundated with pregnant
women…, I think we, on their end we are a big help to doctors. A lot of doctors’ offices
in particular run out of the vaccine very quickly, whereas a lot of the larger chains keep
it in stock
LP 2 (Retail Pharmacy Director, certified to immunize)

Participants also expressed concerns as to why they may not be in the best position to
provide immunization to pregnant women, under the following subthemes: a) not enough
information (as they do not usually have background information on the pregnant women), b)
115

increased liability and c) lack of education. Others did not share these sentiments and believed
there should not be a reason why they would not give a pregnant woman the influenza vaccine.
Pharmacists expressed that providing influenza immunization services to pregnant women may
not necessarily be disadvantageous to them but would prefer if they had more background
information on or access to pregnant women’s history. This sentiment was shared by 39% (n=7)
of the participants.
“Maybe the pharmacist may not have full comprehensive health history on the patient
because the pharmacy system they are not as connected to the hospital system, I am
speaking more for community pharmacies now, but like health records like EPIC is
becoming more popular, a lot of community pharmacists are starting to use the
ambulatory module for EPIC which connects to other hospital records that use EPIC as
well. So, as long as the patient is at an institution that can use EPIC or any other like
nationwide electronic health record then they should be fine.”
LP16 (Clinical Pharmacist, certified to immunize)

“I think a the main disadvantage that sticks out will be a lack of accessibility to medical
history of patients, so again in the community pharmacy they are not privy to pregnant
females medical history, so maybe they’ve had allergy to a component of the vaccine the
community pharmacists may not be aware of this information because it lives in the
OBGYN or PCPs medical history record. So again, the lack of interphase of medical
records, and the lack of familiarity that you know the community pharmacists would not
have if a pregnant female presents to the community pharmacy”
LP1 (Clinical Pharmacist, not certified to immunize)
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“I don’t think we are at a disadvantage, I mean, because we do not have a continuity of
care, it doesn’t really give them an advantage. We can’t see their records; we don’t
really know anything else with the full picture of their pregnancy to give them good
counselling… Because we do not have a universal healthcare system, we cannot see what
we are doing outside of the office.”
LP 11 (Retail Pharmacist, certified to immunize)

Pharmacists expressed that providing influenza immunization services to pregnant women may
lead to an increase in liability to them. This sentiment was shared by 50% (n=9) of the
participants.
“It probably takes the pharmacist out of his work schedule. There’s room for litigation,
as the pharmacists may not be able to respond to potential complications if they arise,
though rare. Liability as a result of an inability to respond to complications we cannot
anticipate.”
LP 14 (Independent pharmacist, not certified to immunize)

“I think there’s always…, that’s the biggest thing liability, everyone is looking to kind of
like get their angle on, like he didn’t ask me this, he didn’t ask me that, oh you know…, I
developed GBS when I went to CVS. So, liability I think is the biggest thing.”
LP 3 (Retail Pharmacist, certified to immunize)
One (6%) participant expressed that providing influenza immunization services to pregnant
women may be difficult for a pharmacist who is not educated or trained regarding it.
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I think the only disadvantage is just the pharmacist him or herself, maybe not feeling
confident in their skills or maybe education wise, if they haven’t done it in a while, they
are not used to doing it so often or not knowing the type of patient that is in front of them,
whether vaccine live vs attenuated which is okay you know. Or you know maybe
education wise, they might not feel confident, other than that, no.
LP 3 (Retail Pharmacist, certified to immunize)

Others (44%, n=8), believed it would not be disadvantageous to them as pharmacists to provide
immunization services to pregnant women.
“No disadvantage, because we are fully educated on immunization as doctors are, and
most the patients get are side effects or allergic reactions to the vaccine.”
LP17 (Clinical Pharmacist, not certified to immunize)

One participant (6%) however, was not sure pharmacists were allowed to immunize pregnant
women.
“I think they have to go get it (influenza vaccine) at their primary physician. I don’t think
that pharmacists are allowed to do that…, but I am not 100 percent sure.”
LP4 (Clinical Pharmacist, not certified to immunize).

Perceived Control. The theme of perceived control reflects how much the pharmacist
believes that providing immunization or not providing immunization to pregnant women is under
their volitional control. Participants were asked about their thoughts and feelings about the
facilitators and barriers to providing the influenza vaccine to pregnant women, alongside
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education and counseling. Participants described the need for employing other staff such as
pharmacy technicians to assist with workload, so they can focus on immunization services when
the need arises. This sentiment was shared by 50% (n=18) of the participants.
“Another thing again is manpower, because a technician can help while you will be able
to provide these services. They can take away some of the manual aspect of the work,
while you do the clinical aspect of the work.”
LP7 (Clinical Pharmacist, certified to immunize)

“Now if they want to really get the numbers up… take away some of the responsibilities,
staff the Pharmacy efficiently so it can actually feel like a health care instead of a fastfood joint where the next… ‘next flu shot, next they are not coming through a trolley…”
LP9 (Retail Pharmacist, certified to immunize)

Some participants described the need for a physician referral or recommendation immunization
services when the need arises. This sentiment was shared by 50% (n=9) of the participants. One
participant mentioned that the prescription was not necessary but provided a way for physicians
and pharmacists to communicate and helps the patients to follow up. Seen below.
The patients bring their prescriptions for the vaccine, we don’t use the prescription, but
we use it to see what the vaccine is for. I think patients use it as a way to communicate
between the two of us. Because when they tell the patients get this vaccine…, they are not
going to remember the details, so they write it down, that helps a lot, cos we can best
identify that they need that vaccine, because their doctor said get that vaccine. That is
one of the things we have the biggest issue with, when we have to ask, ‘did they tell you to
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get the vaccine? have you had this before?’, we do not really have their details, we have
‘Florida shots’ but not everyone uses that.”
LP 13 (Retail Pharmacist, certified to immunize)

“The physician recommending that you get it from the pharmacist, so you can get it at
any time, since they are easily accessible. And they have already accessed the patient and
they have shown that it is appropriate. It is just like when they say they want a certain
medication for the patient and the patient goes to the pharmacy to get it. It could be the
same for vaccines.”

LP4 (Clinical Pharmacist, not certified to immunize)

Some others (17%, n=3) believed that physicians may also be a barrier to pregnant women
coming to the pharmacy to receive the influenza immunization.

“I think it might present a conflict of financial interest for the physician, it’s like sending
your patient away to somewhere else where you will not be able to recoup funds.”
LP16 (Clinical Pharmacist, certified to immunize)

“They can be a barrier, and also a facilitator, in that sometimes they want their patients
to stay in the practice and get their vaccines there.”
LP 13 (Retail Pharmacist, certified to immunize)

A few participants (33%, n=6), believed outreaches and campaigns tailored to pregnant women
may facilitate pharmacists providing the influenza vaccines to the pregnant women as they will
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create awareness.

“There are some promotions that go on every flu season, we do like a blog entry, just like
promotional items we have with our preferred pharmacies to encourage customers to get
the flu vaccine. It is not targeted to pregnant women specifically but can be.”
LP 5 (Retail Pharmacist, certified to immunize)

I mean when they say “get your flu shot” it’s like a general thing but if they can just put
another caption to let pregnant women know cos when you see “get your flu shot” it is
just like a generalized thing. So, I mean everything starts from that awareness - let
pregnant women know even from the hospitals, commercials though the t.v.,
everywhere… that it is safe. So… even if the sign is there the pregnant woman might not
still take it serious like they are talking to her. So, if there is a lot of awareness, they will
feel more comfortable walking in.
LP 18 (Independent Pharmacist, not certified to immunize)
“It would have to be a campaign, and when I say a campaign I mean a campaign from a
corporate level and not just a campaign that says “it’s Flu season get your shot” If you
really want to be effective with the shots you have to address the fact that these are the
barriers that are influencing the pharmacists from giving the shot, once the company says
‘we are going to remove those barriers’, pharmacists will immunize everyone and
everybody”
LP 6 (Retail Pharmacy Manager, certified to immunize)
One participant (6%), reported that with support and educations, pharmacists will be more likely
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to provide immunization services in pregnant women.

“I think educating them, providing more education around immunizing pregnant women
specifically. I think as long as the pharmacists feel like they are supported, they know it is
recommended by the CDC then they will be more likely to provide the immunization.”
LP 15 (Retail Pharmacy Director, certified to immunize)

Participants mentioned that when an incentive is provided to the pregnant women to obtain the
influenza vaccine, and when it is provided to the pharmacist to provide the vaccine, this can
facilitate the provision of the vaccine. This sentiment was mentioned by 28% (n=5) participants.

“We get incentivized on the back end, so it’s more like our “flu goals”. If you have met
your goals, and your store is up to par for other things, you can ask for a raise…, we
immunized anyone we could find with a pulse, cos we had to meet our goals… But
patients also get the incentives, and that is what helps them come to us. I work at xxx
typically, and they get a $10 coupon at xxx.”
LP 13 (Retail Pharmacist, certified to immunize)

When discussing the barriers, pharmacists expressed various sentiments including lack of
access to pregnant women and the pharmacist, increased workload, workplace environment, and
lack of education of themselves as pharmacists regarding providing vaccines to pregnant women.
Other participants (33%, n=6), expressed that not having access to the pregnant women may be a
barrier.
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“The reality is that a pregnant woman probably…, they are unlikely to come to a
pharmacist for their influenza vaccine. It is usually a package in their antenatal care.”
LP 14 (Independent Pharmacist, not certified to immunize)

“Most pregnant women think the doctor has to do it, or they have to go to the clinic. I
think the lack of knowledge about using pharmacists is the biggest barrier.”
LP 11 (Retail Pharmacist, certified to immunize)

Seventy-two percent (n=13) of the participants believed that providing immunization services
increase their workload.

“Time. That is the biggest thing. Usually, unfortunately when people come to the
pharmacy, they are usually here “let me get my medication and go”. Even as
pharmacists, the amount of things that are determined of us, we do not have time to sit
there and talk to you about your medication, and if we cannot do that about medication,
how can we do that about immunization.”
LP 6 (Retail, certified to immunize)

“It is added work for the pharmacist, it is a lot more work. In my experience when I was
in retail, in fact one of the reasons why I left retail, it was added work, without help, I
don’t get help to cover with other things I am supposed to do. On a given day I have 5-10
immunizations, with people waiting for me, doctors call back, counseling sessions. The
patient load on the pharmacist is a lot, and now some retail store requires the pharmacist
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to give a number of vaccinations in a day or a month, it’s your job. It should not be a
quota thing for pharmacists to provide such services.”
LP7 (Clinical Pharmacist, certified to immunize)

Other participants (11%, n=2) did not feel providing immunization services to pregnant women
interrupted or increased their workload.

No, because I know that there are certain pharmacies…, I don’t know if technicians
actually do that, but you can have your technician set your work flow, set it up. So that
way once they identify a patient who needs to be vaccinated, the pharmacists comes in,
vaccinates the patient, asks questions, answer questions, counsel the patient, do your
‘mtm’, it won’t take you long, you just have to have that built into your workflow.”
LP 3 (Retail Pharmacist, certified to immunize)

A few participants (17%, n=3) shared the sentiment that the pharmacy environment was not in
itself conducive to provide immunizations.

“I think the way it used to be, like in the past when pharmacists started immunizing, they
had immunization rooms in the pharmacy, a certain area for consultation, they had
appointments you would set with the pharmacist for your immunization. Now it has
become if you go to checkers or MacDonald’s and you say, I want a flu shot, and the
technician types it out, it goes through and literally puts it in the basket, it comes to me,
and I am like oh I am doing a vaccine... I do not know your name; I do not know who you
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are. I read the form; I do not see any issues giving the vaccine… So, we are just kind of
moving around like flies…, honestly, I think our workplace environment is a barrier
itself…”

LP 13 (Retail Pharmacist, certified to immunize)

“I think there would be some discomfort, because the pharmacy is not an intimate setting,
and pregnancy is very tough. Because of the setting, pharmacies usually have an open
concept that would probably prevent them from freely going to get retail immunization,
you know, the vaccine. It is not pregnancy friendly”
LP 11 (Retail Pharmacist, certified to immunize)
Other themes regarding factors that may affect pharmacists’ volitional control in
administering the influenza vaccine to pregnant women include the type of insurance or
community settings (rural, urban) of the pregnant woman. When asked about insurance type, all
licensed pharmacists’ expressed sentiments that insurance type may be a barrier or a facilitator
depending on the type.

“If they pay for it, we are going to have an increased influx of women wanting to get it; if
patients have to pay out of pocket then we have to think about costs. HMOs are going to
be the ones that dictate where they go, so those are going to be the ones that probably
won’t pay for at the Pharmacy versus telling them they have to go to their Primary Care
Physician. For like PPOs and so forth, the patients usually get autonomy and get to pick
where they go.”
LP 8 (Retail Pharmacy Director, certified to immunize)
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“I am actually taking a class on how insurances work, but I think the biggest thing is just
the co-pay, that’s the biggest problem. Anytime you walk into a pharmacy and you are
being told that you have to pay forty bucks or sixty bucks or whatever it is, you got your
HMO PPO, you will not want do that when you were just at your doctors yesterday, you
could have gotten it done there.”
LP 3 (Retail Pharmacist, certified to immunize)

“I have mixed feelings on that. Some of them have provided incentives for that to happen
where it is actually cheaper for the Pharmacist to do it than the doctor, so their
reimbursement is greater in the stores. But then again, a lot of them don’t believe in
preventive care… so then why should I have a rejection on an immunization where it
should be automatic preventive care? because they have to think, on the long run,
prevention is better than cure right? So, incentivize patients to get vaccinated, lower the
co-pays or no co-pays… but Medicare does a good job, there’s no co-pay for Medicare
patients.”
LP 9 (Retail Pharmacist, certified to immunize)

“Managed care programs a very good job about it. Pharmacists are given points, saying
give the vaccine it’s that time. You give a vaccine. you get a point. It’s a point system you
can use on whatever, so we see the benefits of it, and they are trying to make sure that it
is promoted to our beneficiaries.”
LP 6 (Retail Pharmacist, certified to immunize)
When asked about patient’s community settings (rural vs. urban), pharmacists’ expressed
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sentiments that insurance type may be a barrier or a facilitator depending on the type. When
asked about the patient’s location or community settings (rural vs. urban), participants shared
varied responses. Some of the participants 50% (n=9) believed there was less access to
healthcare services in rural areas. However, one participant felt individuals in rural areas may
have access to immunization services because of their relationship with their pharmacist.

“Rural is helpful, pharmacists have a relationship with their patients, they are slower
paced, you can actually identify them because you know them. You can say, ‘hey Mrs.
Cooper we think you should get this vaccine today’, and that is a better way compared to
urban where you don’t really have that relationship with your patients who are more in
an urban area.”
LP 13 (Retail Pharmacist, certified to immunize)

One participant expressed that there may be issues with access to the vaccine in both areas
depending on the barriers they encounter. Others (17%, n=3) believed that barriers to
immunization in any region had to do with the patient’s culture or socio-demographic
characteristics.
“When I think about rural areas, I think about places that have less access to healthcare,
less access to providers. I think there are those who might, even if they wanted to get the
flu vaccine might not have access just because there might not be a provider nearby that
can administer the vaccine to them. So, access would be a barrier in that setting. Now in
the urban area I am thinking access to services in addition to a lot of the urban
neighborhoods tend to be in lower socioeconomic status, so affordability becomes
127

something else that we have to think about in that setting. So, where there are free flu
clinics where it is subsidized, and people would be more likely to get the vaccine.”
LP 3 (Retail Pharmacist, certified to immunize)

“I think that depends more on the demographics of the area, the patient’s education
level, their level of awareness, exposure. We already have a propaganda by people who
are against any sort of vaccination, so that’s another thing. It all depends on the
demographics, and social standing, education status all those things. I work in a rural
area of Florida, and I have seen that health care seeking behavior has to do more with
the patients sociodemographic.”
LP7 (Clinical Pharmacist, certified to immunize)

Figure 3. Frequency of facilitators for influenza vaccine administration by type of pharmacy
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Subjective Norms. This refers to pharmacist engagement in providing influenza vaccines
to pregnant women if they feel people close to them think they should. Which then motivates the
pharmacist to administer influenza vaccines based on what these individuals think. For the study,
the pharmacists were asked about the influences of the following individuals on them providing
influenza vaccines to pregnant women: a) the CDC, b) the APhA, c) the Florida state statutes, d)
physicians, e) pregnant women, and f) their peers.

CDC. When asked about the influence of the CDC, licensed pharmacists believe they
serve to play the role of quality control and provide the vaccine guidelines regarding
administration to pregnant women and the general public.

“CDC has a big influence; they have a lot of information on vaccines that is readily
available to everyone. And they make it a little bit easier and more manageable to
understand the different types of vaccines and how they should be administered…”
LP4 (Clinical Pharmacist, not certified to immunize)

“I feel like all those guidelines… the APhA, the ACIP, and the CDC… Those are
where my recommendations come from. We are required to practice under evidencebased medicine so I can’t form my opinion on whether or not they get the shot. I have
to go based of those global guidelines.”
LP 8 (Retail Pharmacy Director, certified to immunize)

“… they do a lot of the monitoring, and quality checks and you know quality control just
to make sure it is the right vaccine for coverage”
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LP 18 (Retail Pharmacist, not certified to immunize)

APhA. When asked about the influence of the APhA, pharmacists (n=4) reported that it is
an important resource through which they obtained their training on immunization and for
continuing education, and license renewal. Others (n=7) expressed that the APhA acted as an
advocate for pharmacists to become immunizers, while a few (n=4), mentioned that the APhA
provides information and guidelines regarding immunization in general, but not specific to
pregnant women.
“I think that they…, APhA at the national level, and also at the affiliate level, have been
very instrumental in getting pharmacists providing care or visibility, so they support
pharmacists providing vaccination and have been lobbying for extended roles for
pharmacists not just relating to flu vaccine but other vaccines that are out there such as
pneumonia and the rest. I know that they really support it from a regulatory standpoint
and a regulatory standpoint too.”
LP16 (Clinical Pharmacist, certified to immunize)
“Generally, APhA doesn’t directly affect vaccines for pregnant women, they more so
affect clinical practice”.
LP1 (Clinical Pharmacist, not certified to immunize)
“I think APhA gives you the continuing education credits. They have the thing every year
where they talk about the flu vaccine, the hits and the misses, all that fun stuff,
information.”
LP 13 (Retail Pharmacist, certified to immunize)
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Standing order. When asked about the influence of the Florida state law regarding
pharmacists providing immunization services under the supervision of a Physician within a
framework of an established protocol (Florida, 2018), pharmacists expressed mixed feelings on
how it affects their vaccine administration practices. Eight of the participants expressed positive
feelings about it. As one participant noted it is a necessary step.
“It has not limited us in any way. My belief is that it was a necessary step in order to
achieve future autonomy, because we had to show how we impact immunization rates and
how we can do it safely. I don’t think we would have gotten autonomy off the back from a
legislative standpoint. we have to earn that.”
LP 15 (Retail Pharmacy Director, certified to immunize)
A few participants (n=3) expressed neutral feelings about the standing order, as it may be
redundant. All three participants who expressed this notion were clinical pharmacists.

“ I think I am neutral about it, I don’t work in community pharmacy now but I have
worked in community pharmacy before and I know that even though the physicians name
is on the standing order as far as the physician in charge for you to give vaccinations. A
lot of us that work in community pharmacies have never even seen the physician whose
name is on the is on the permission slip. It is a moot point, it is there just to satisfy the
regulatory requirement, but the physicians don’t normally do anything, their names are
just on a piece of paper. You can be in the pharmacy 10 years and never see that
physician one time in your life.”
LP16 (Clinical Pharmacist, certified to immunize)
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“I am kind of neutral about it. I mean everything is under the supervision of a doctor,
regardless of if it is the influenza vaccine or prescription for any medication.”
LP17 (Clinical Pharmacist, not certified to immunize)

Other (n=6) participants expressed negative feelings about the standing order, and do not believe
it is needed.
“Personally, I feel we should be able to administer it even without a standing order from
a physician. Maybe in the future it will get to where a pharmacist will be able to
prescribe these vaccinations on their own and provide them without a doctors name
under it.”
LP 12 (Retail Pharmacy Director, certified to immunize)
“I actually think it is pointless, the physician is just on a piece of paper, because if there
was an emergency going on with like you know, vaccine reaction or something like that, I
am not going to call the physician, I am going to call 911 to come get the patient. I don’t
think the physician is necessary.”
LP16 (Clinical Pharmacist, certified to immunize)

The case for independent pharmacists. A few of the participants mentioned why the
standing order requiring the physician to sign off on immunization may not be good for
independent pharmacies, as it is not as feasible for them to afford a doctor to sign off on them
providing immunization services.
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“I mean it’s good on paper, it’s hard, because, number one you have to find a physician
who will let you sign, if you are not working for like a big corporation right. So, if you
are not working for the CVS, the Walgreens, COSTCO or wherever. It’s hard to get a
physician.”
LP 3 (Retail Pharmacist, certified to immunize)

“So, we have one physician who oversees everybody, and that is great. Now what if you
have an independent pharmacy and there is no physician there, now you have maybe ten
people who missed out on vaccinations, you take that and multiply around the country…
So, it is very important to recognize the expertise of these pharmacists and give them
those additional responsibilities, rather to have them jump through loophole from
loophole, because at the end of the day it is the patients that matter”
LP 3 (Retail Pharmacist, certified to immunize)

“Already there is a binding clause, the binding clause is that if I want to provide
immunization, then there must be a concurrence to a physician. If the pay is worth it for
my pharmacy I will go ahead and go through the paperwork and the concurrence with
the physician. If you want to provide immunization services, you need to do that if the
cost is worth it. While this has expanded the opportunity for pharmacists to immunize,
nothing has really changed for us independents.”
LP 14 (Independent Pharmacist, not certified to Immunize)
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Physicians. When asked about the influence of the physician on pharmacists
administering the influenza vaccines to pregnant women, all participants believed that physicians
play a major role with regards to referring the women and creating awareness that they can get
their shots at the pharmacy. One participant mentioned that physicians are key to changing the
number of women getting immunized.

“I think if the doctors encourage them to get vaccinated…, I think if they have a
secondary provider who is trusted, the doctor allows them to or encourage them to seek
their vaccination, that would increase the numbers. Because we know, most essentially
the argument is the pharmacy vs the clinic, it is easier, so I think if the physicians refer
the patients to the pharmacy, you know, go to your local pharmacy and get vaccinated. If
they can encourage that behavior that would be the key to changing the number of
pregnant women getting vaccinated.”
LP 12 (Retail Pharmacy Director, certified to immunize)

Peers. When asked about the influence of their peers or other pharmacists on them
administering the influenza vaccines to pregnant women, participants were neutral about their
colleagues choosing to or not to provide immunization services to these women, one participant,
however, talked about how that impacts vaccine uptake in pregnant women.

“I think if a pharmacist has said no to a pregnant woman to administer the vaccine to
them, they will probably be scared to go to any other pharmacist and that will have a big
influence…”
LP17 (Clinical Pharmacist, not certified to immunize)
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Another participant mentioned that the older pharmacists may not be willing to provide
immunization services to pregnant women.

“The older pharmacists won’t do it, they may be like, ‘why are you immunizing pregnant
women? We don’t do that here’, they think they are a higher risk a patient group for
vaccination.”
LP 13 (Retail Pharmacist, certified to immunize)

Another participant mentioned the importance of a retail pharmacist being capable of providing
such services.

“It depends on what industry the pharmacist is working in, if you are a retail pharmacist,
you really have no choice, you cannot ignore immunization or that pharmacists won’t
have the job, if you cannot. If you are in a hospital you are not required to immunize, in a
managed care setting you are also not required to that, so it depends on the pharmacy
industry where you work”
LP 7 (Clinical Pharmacist, certified to immunize)

One participant mentioned if more pharmacists were getting certified to immunize, it might spur
others up to want to get theirs.

“I mean that will influence me to get my certification and learn more about it. I mean if
everyone is doing it, if everyone is providing a service, then I am going to have to try to
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transition to that just like when it comes to…,you know, things are advancing so you
have to advance with it.”
LP 4 (Clinical Pharmacist, not certified to Immunize)

Pregnant Women. When asked about the influence of the pregnant women on
pharmacists administering the influenza vaccines to them, pharmacists expressed that providing
influenza immunization services to pregnant women would not be difficult due to the fact that
patients trust pharmacists with their health questions. This sentiment was shared by 11% (n=2) of
the participants. However, two other participants shared the sentiment that pregnant women may
trust a doctor over a pharmacist.
I’ve always considered us as the first line because, with the patient we… they come to us
first and they have that trust-factor with regards to their health questions
LP 9 (Retail Pharmacist, certified to immunize)

“Pregnant women should be comfortable going to the pharmacist for their vaccine,
because a lot of people trust the pharmacist’s knowledge of the drug, they trust the
pharmacists of drug interactions, there’s a lot of trust in pharmacists in what they
provide. As long as they are certified, I don’t think pregnant women will have any
reservations getting the vaccine from the pharmacist”
LP7 (Clinical Pharmacist, certified to immunize)

“I think that me just not having an “MD” title. Just not having the faith that I have
enough education to Uhm, give it and then if there were a risk to happen that maybe… I
just don’t think that Pharmacists are at that level with MDs in most patients’ eyes.”
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LP 9 (Retail Pharmacist, certified to immunize)

“Even though the pregnant woman would trust her pharmacist, for the most parts, a lot
of pregnant women put a lot of trust in their gynecologist, their doctors such that even if
the pharmacists says, they still ask if they can ask their doctors first if it is safe for them.
So, a lot of convincing, a lot of convincing…”
LP18 (Independent Pharmacist, not certified to immunize)

Current practices. Among the 11 pharmacists who are currently not providing
immunization or have never immunized a pregnant woman before, a few (n=8) reported that they
will be willing to provide immunization in the future, while (n=3) reported it was not something
they were willing to do.

“I feel like I may be comfortable doing it but then, just like with anything, the fact that
you are putting something in somebody’s body… I mean, it comes with the risk itself that
you just have to be careful about.”
LP18 (Independent Pharmacist, not certified to immunize)

“No, it is not something I am interested in”
LP14 (Independent Pharmacist, not certified to immunize)
Among those who provide or have provided the vaccine to pregnant women before, one
participant mentioned providing the vaccine is a basic skill, while another mentioned the benefit
of providing the service, and another participant mentioned it was not their favorite activity.
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“I mean, it isn’t brain surgery, or trying to run a catheter through someone’s femoral
artery, it is just an IM procedure, it is really not a big deal. Eventually it felt like riding a
bike, I just get up, stick the needle and it is done… but you may want to assess the
general state of the pregnant woman.”
LP7 (Clinical Pharmacist, certified to immunize)

“I will feel like I am getting two people at once, other than that it is pretty normal.”
LP 12 (Retail Pharmacy Director, certified to immunize)

“Absolutely not! When I first started immunizing pregnant women gave me the most
anxiety because they ask you all the questions about like mercury, autism all the things…
the lot number, the manufacturer of the vaccine, then it makes you kind of question what
you are giving them. And then you are nervous they are going to have a side effect, what
they are going to call back and say. So, it gives you pause… Now that I have done so
many, it’s like okay, it’s alright. They are not my favorite population to vaccinate.”
LP 3 (Retail Pharmacist, certified to immunize)

Pharmacists in clinical settings regardless of immunization certification status, do not provide
immunization in clinics. Clinical pharmacists reported nurses as the individuals responsible for
administering immunization in hospitals.
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Table 9. Pharmacy Setting Impact on Immunization by Sampling Group
Clinical
Pharmacist

Community
Pharmacist

Certified
N=2
“I don’t provide vaccines in the hospital, the nurses are the
ones that make the assessment, and they call on me the
pharmacist to say we need to provide a vaccine, and then I pull
in the patients profile so that the technician will run it to them
and they give the vaccine. I really don’t have much contact
with patients in that regard” (LP7)

Not Certified
N=3
“I don’t give the
vaccines, but I read
the policies for
vaccine administration
for the hospital.”
(LP1)

N=10

N=3
cost standpoint
(independent)

“So long as it is indicated, as long as it is something that is part
of their vaccine schedule or recommended by the CDC and
there have been studies for them.” (LP15)
“I feel like I am getting two people at once, other than that it is
pretty normal.” (LP12)

“No, it is not
something I am
interested in” (LP 14)

“if the data says its’ good…., no qualms whatsoever.” (LP6)

Discussion
The primary purpose of conducting these in-depth interviews was to explore the
perceptions of licensed Florida pharmacists and their role in administering influenza vaccines to
pregnant women. The in-depth interviews provided information about the knowledge, attitudes,
perceived behavioral control and subjective norms of pharmacists. It also explored the current
and future practices of the pharmacists as regards to administering the influenza vaccines to
pregnant women.
In discussing pharmacist’s knowledge about the influenza vaccine generally and it’s
benefit to pregnant women, they were conversant with influenza general knowledge including
the types, recommendations, efficacy and side effects; and also knowledge specific to pregnant
women, such as safety, the type of the vaccine used, and the benefits. However, only about 25%
of them mentioned that the influenza vaccines can be received by pregnant women at any
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trimester. This is in line with the American College of Obstetricians and Gynecologist (ACOG)
recommendation (ACOG, 2018; Fiore et al., 2010; Thompson et al., 2011) that influenza
vaccines can be administered at any trimester. About 72% of the pharmacist also reported
knowledge of the dual benefit of protection of the mother and infant for the first six months of
life (ACOG, 2018; Simondsen & Hayney, 2011).
In understanding pharmacists’ attitudes about administering inactivated influenza
vaccines to pregnant women, there was an expressed overall sentiment among the participants. In
terms of accessibility, 78% expressed that they were the most accessible health care providers,
this is consistent in what has been reported in previous studies (Murphy et al., 2012). About a
third (33%) of the pharmacists viewed themselves as knowledgeable and therefore experts to
provide influenza immunization to pregnant women. Pharmacists also reported that providing
such services increased their scope of practice, as seen in the study by Dolan et al (2012), also
reported that providing immunization services was seen by pharmacists to expand their scope of
practice. In terms of providing ease for patients, research has proven that pharmacists providing
immunization services is cost-effective (Grabenstein et al., 1998; Prosser et al., 2008). However,
participants expressed negative feelings such as liability and not having enough information on
the pregnant women was expressed by participants (Dolan et al., 2012).
In understanding perceived control, pharmacists reported facilitating conditions to
provide influenza immunization to pregnant women to include provider recommendation or
referral, employing more staff (pharmacy technicians), educating pharmacists and marketing
campaigns. Higher influenza vaccine rates are seen among pregnant women who received a
recommendation from their provider when compared to those who did not, also pharmacy
technicians are known to aid pharmacists to engage in a more effective workflow. Campaigns
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and outreaches are also associated with increased immunization rates (Ding et al., 2017;
Albanese, Rouse, Schlaifer, & CCP, 2010; Grabenstein et al., 1998). Several barriers were
mentioned which include increased workload, no access to pregnant women, pharmacists not
perceived as a conducive environment, lack or type of insurance and poor sociodemographic
factors of patients. Studies have shown these to be true (Dolan et al., 2012; Murphy et al., 2012;
Ballas et al., 2015; SteelFisher et al., 2011). However, not all participants agree that providing
immunization to pregnant women will increase workload.
Regarding subjective norms, pharmacists expressed that CDC serves as a quality control
resource, and where to get updated vaccine information, the APhA was viewed as a training,
certification and continuing education resource. Pharmacists also reported that the APhA served
as an advocate, pushing for pharmacists to be immunizers. Studies have shown that pharmacists
are fine with providing immunization services if they get information from the required
organization (Dolan et al., 2012). In discussing the influence of the Florida standing order
statutes, participants reported varied views, some felt it was needed, some felt it was redundant,
as they have no physical interactions with the physician signing off on immunization they
provide and felt it was not necessary. Since the inception of the standing orders for
immunization, vaccine uptake rates have increased (Goode et al., 2007; Steyer et al., 2004;
Weitzel, 2000). Participants perceived physicians to play a key role in educating and referring
women to pharmacies for immunization (Ding et al., 2017). Additionally, pharmacists expressed
that pregnant women would rather go to their OBGYNs than come to them. A study by Wang et
al (2014), reported that pharmacists are the most trustworthy health care providers next to
physicians (Wang et al., 2014).
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Overall, pharmacist expressed sentiments that they are equipped to provide immunization
services to pregnant women, 17% however, reported that they were not willing to provide
immunization services to these women. Participants also called on the need for the standing
order to be reviewed to allow for independent pharmacists to provide immunization services. A
study by Burson et al (2016), showed that independent pharmacists were less likely to be
certified to provide immunization services (Burson, Buttenheim, Armstrong & Feemster, 2016).
This was also demonstrated in the study, as the two independent pharmacists interviewed were
not certified to immunize.
There were several study limitations. Firstly, it was a qualitative study, therefore, it
cannot be generalized. Another limitation is there may be social desirability bias from the
pharmacists. The pregnant women themselves would not be interviewed on their perceptions on
going to the pharmacists to receive the influenza vaccine, also, the study does not include
providers such as the OB/GYN, Midwives or family medicine doctors who usually attend to
pregnant women, so as to explore their perceptions on pharmacists administering the influenza
vaccine to pregnant women.
This study also has several strengths. The qualitative nature of this study is important in
explore how licensed pharmacists perceive as their role in providing immunization to pregnant
women. In addition, the study was guided by the Theory of Planned Behavior. Furthermore, this
study included the perception of pharmacists, who are usually overlooked when it comes to
providing care for pregnant women.
Conclusion
Pharmacists play an important role to increase inactivated influenza vaccine
immunization rates among pregnant women, inadvertently providing coverage for moms and
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infants. Pharmacists have been providing immunization to adults for almost 20 years now and
are capable of providing immunization to pregnant women. Systematically implementing
pregnant women specific strategies in pharmacists continuing education and training would be an
effective intervention.
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Manuscript 3: Community-pharmacist-led Inactivated Influenza Vaccine (IIV)
administration in pregnant women in the US
Abstract
Influenza illness continues to cause increased morbidity and sometimes death in pregnant women
and their babies. The infection is also associated with a drain on the nation economically.
Although the CDC has placed pregnant women as an at-risk group recommending them for the
influenza vaccine, the uptake rate is still lower than the targeted health people 2020 goals.
Traditional prenatal care providers include OBs, family physicians, advance-practice nurses, and
certified nurse-midwives; however, pharmacists led influenza immunization services have been
documented to increase immunization in adults and other at-risk groups. Pharmacists,
specifically community pharmacists are trusted among patients, are an accessible and costeffective resource and can reach medically underserved individuals. Allowing a task shift in the
provision of influenza immunization services from traditional providers of prenatal care to
pharmacists will help to increase inactivated influenza vaccine uptake rates among pregnant
women. This review aims to suggest the task shifting framework that can equip pharmacists to
effectively play the role to administer inactivated influenza vaccines in pregnant women.
Introduction
Seasonal influenza infection in the United States continues to be responsible for hospital
visits, hospitalization and mortality due to its related complications such as pneumonia (Nowak,
Sheedy, Bursey, Smith, & Basket, 2015). Influenza illness also exacerbates chronic diseases and
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cardiopulmonary illnesses which lead to increased mortality (Biggerstaff, Cauchemez, Reed,
Gambhir, & Finelli, 2014; Nowak et al., 2015). In its epidemic form, the influenza virus can
cause mortality and morbidity in as much as twenty percent of the population in the United
States every year, and it results in about three thousand to forty-nine thousand influenza-related
deaths (Biggerstaff et al., 2014). The economic cost of seasonal influenza in the United States is
estimated to be about $87 billion annually including direct medical costs of about 10 billion.
Missed workdays and loss in productivity account for a bulk of the burden, these emphasize how
much influenza illness is a drain on the U.S. economy (Molinari et al., 2007; Nowak et al.,
2015).
The Influenza viruses change regularly either through "antigenic drifts," which are minor
point mutations or through major "antigenic shifts" (Biggerstaff et al., 2014; Cox & Subbarao,
2000). These antigenic drifts and shifts can cause a new version or strain of the influenza virus to
be introduced into the human population of which individuals are not yet immunized against
hence, causing epidemics and pandemics (Biggerstaff et al., 2014; Cox & Subbarao, 2000;
Treanor, 2004). As a result of these changes, the pattern of new pandemics will be hard to predict
(Biggerstaff et al., 2014).
Several groups of individuals are considered as high risk for major influenza illness and
mortality, and they include pregnant women, children, adults aged 65 years or older, and
individuals who have chronic conditions such as diabetes, obesity, asthma, and
immunosuppression, as well as cardiovascular (except hypertension), renal, hepatic, neurologic,
and hematologic disease. (Nowak et al., 2015) (CDCs “Pink Book”). During the 2009/2010 flu
pandemic, pregnancy was identified to be a risk factor for extreme cases influenza; among
women aged 18-29, influenza-pregnancy related deaths occurred in about 16% and
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hospitalizations in 29% (Biggerstaff et al., 2014; Memoli, Harvey, Morens, & Taubenberger,
2013).
The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease
Control (CDC) in 1997 added recommending the influenza vaccine for pregnant and
breastfeeding women (Arden, Izurieta, Fukuda, Cox, & Schonberger, 1998; CDC, 2003; Fiore et
al., 2010). This was added to the influenza vaccine recommendation guideline following a study
of the effect of influenza virus infection in pregnant women during seventeen interpandemic
influenza infection seasons (Arden et al., 1998). It was documented that there is an associated
increase in morbidity in pregnant women in their second and third trimesters; it was also
concluded that one out of two hospitalizations or admissions in pregnant women could be
avoided per 1000 women who get the influenza vaccine (Arden et al., 1998). The influenza
vaccine remains the best way to prevent influenza illness among this population (Naleway,
Smith, & Mullooly, 2006). The American College of Obstetricians and Gynecologists (ACOG)
in 2004 sent out a directive to all its members to use the ACIP recommendation that all pregnant
women should receive the inactivated influenza vaccine (ACOG, 2004; Fiore et al., 2010;
Thompson et al., 2011). However, inactivated influenza vaccine uptake rates pregnant women
have remained lower (figure 4) than the targeted 90% coverage proposed by the healthy people
2020 goals (Lu, Bridges, Euler, & Singleton, 2008; Plans-Rubió, 2012; Whitley & Monto, 2006;
Xakellis, 2005).
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Figure 4: Trends of Influenza vaccine uptake among pregnant women

Several studies have reported barriers and reasons for low inactivated influenza vaccine
uptake in pregnant women, such as women being in their first or second trimester of pregnancy,
concerns with safety for themselves and their unborn child, and lack of awareness of the “twofold” benefit of the vaccine (Chamberlain et al., 2015; Meharry, Colson, Grizas, Stiller, &
Vázquez, 2013; Wheelock et al., 2013). Other barriers include issues with access, lack of
transportation to the health care center, lack of time, distance to care centers, and lack of
availability of influenza vaccine at providers’ office (Arao, Rosenberg, McWeeney, & Hedberg,
2015; Healy, Rench, Montesinos, Ng, & Swaim, 2015; Meharry et al., 2013). A study by Healy
et al, (2015) reported other reasons from the providers standpoint such as; too little time during
hospital visits, women’s allergic reaction to the vaccine, and their own personal lack of
knowledge about the vaccines (Healy et al., 2015).
Physicians also reported other barriers including: the pregnant women’s prior beliefs,
non-belief in the safety and effectiveness of the inactivated influenza vaccine in pregnant
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women, physicians lack of enthusiasm when recommending the vaccine and insufficient time to
explain the benefits of the vaccine (Broughton et al., 2009; Arao et al., 2015; O’Leary., et al,
2018). A study by Wallis et al, (2006) reported that obstetric practices had lower inactivated
influenza vaccination rates when compared to family physicians (Wallis et al., 2006). Also,
larger health (group practices compared to private/solo practices) care centers had lower vaccine
recommendation rates (Wallis et al., 2006; O’Leary et al., 2018). Providers also reported not
having the vaccine in stock or a shortage in supply and other issues surrounding ordering,
tracking, and storing of vaccines (Frew et al., 2018; O’Leary et al., 2018; Clark, Cowan, &
Wortley, 2013).
Community Pharmacists as Providers for Influenza Vaccination Services
Since the inception of the Standing Order for Immunization by the ACIP in the year
2000, which authorized pharmacists and nurses to administer vaccines to adults (McKibben,
Stange, Sneller, Strikas, & Rodewald, 2000), immunization rates in the general population has
improved, and it has helped to take the pressure off physicians (McKibben et al., 2000). Studies
have shown the effectiveness of pharmacists providing influenza immunization adults. This has
been demonstrated by an increase in influenza immunization rates in adults and high-risk
patients (Hagemann et al., 2014; Loughlin et al., 2007; Murphy et al., 2012; Prosser et al., 2008;
Singhal & Zhang, 2014; Steyer et al., 2004; Wang et al., 2014; Papastergiou, Folkins, Li, &
Zervas, 2014), economical or cost-effective (Grabenstein et al., 1992; Prosser et al., 2008), and
effective in providing services to medically underserved areas (Murphy et al., 2012).
In studies that evaluated patients’ experiences and perspectives regarding pharmacy-led
immunizations, it was noted that patients reported high levels of acceptance with receiving
immunization from pharmacists, this was mostly due to pharmacists being accessible and
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convenient (Ernst et al., 1997; Goode & Stanley, 2007; Murphy et al., 2012; Papastergiou, et al.,
2014). Patients reported that second to physicians, pharmacists are the second most trustworthy
vaccine administrators among health care workers, and they would be comfortable receiving
their influenza shot from pharmacists (Wang et al., 2014). The patients also reported that if the
pharmacy-led immunization services were not available, they would not have received
immunization (Papastergiou, et al., 2014). These findings demonstrate that community
pharmacists are able to offer complimentary immunization services to that provided by
physicians (Papastergiou, et al., 2014).
Alternative Solution-Task Shifting Framework
The Task Shifting framework was developed to tackle discrepancies and shortages of
primary healthcare especially in developing countries (WHO 2018; Aithal & Aithal, 2017). It is
defined as a process “that involves extending the scope of practice of existing cadres of health
workers to allow for the rational redistribution of tasks among the health workforce in order to
make better use of human resources and ease bottlenecks in the service delivery system”
(Francesca et al., 2010; Aithal & Aithal, 2017). Task shifting is often used in developing nations
to manage the shortage of healthcare professionals, but it has also been used in developed nations
(Aithal & Aithal, 2017). Task shifting as demonstrated in the shift from doctors to nurses has
been recognized to improve overall health care efficiency and delivery, as nurses who were
educated properly were noted to be able to provide about the same level of care as compared to
doctors (Maier & Aiken, 2016). Several countries such as the U.S. have adopted task shifting
from physicians to other healthcare professionals, especially in patients who are not critically ill
and have good health outcomes (Maier & Aiken, 2016).
According to ACOG, during pregnancy, a woman can receive basic level prenatal care
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from healthcare providers such as OBs, family physicians, advance-practice nurses, and certified
nurse-midwives (American Academy of Pediatrics, & American College of Obstetricians and
Gynecologists, 2002). Studies have demonstrated that these providers sometimes experience
influenza vaccine shortage, issues with ordering, tracking and storing of the influenza vaccines,
experience billing and reimbursement issues and providers not having the time during pregnant
women visits (Frew et al., 2018; O’Leary et al., 2018; Clark, Cowan, & Wortley, 2013).
Pharmacists have been shown to be educated and trained to provide immunization in adults, they
have also been reported to be the first healthcare provider that is questioned on medication
advice (Globe, Johnson, Conant, & Frausto, 2004; Turner et al., 2007; Samuel & Einarson,
2011). In order to improve inactivated influenza vaccine rates among pregnant women, task
shifting from pregnant women’s prenatal care providers to pharmacists can be applied as an
alternative strategy to increase inactivated influenza vaccine uptake rates in pregnant women
(figure 5).

Problem
(Low Influenza
vaccine uptake in
pregnant women)

Solution Plan &
Strategy

Implementation
Constraints

(Past interventions
– electronic
reminders)

(Cost, vaccine not
available, no
transport)

Optimum
Solution
(Increase in
vaccine uptake)

Alternative Strategy
(Provider referral to Pharmacist and
Pharmacists administering)

Figure 5. Task Shifting Alternative Strategy to Increase Influenza Vaccine Uptake
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Studies have demonstrated some increase in vaccine uptake in pregnant women.
Examples are provider-centered interventions providing electronic reminders for providers to
(Klatt & Hopp, 2012), and the use of standing orders to provide immunization without a
physician’s consult (Sherman, Raker, & Phipps, 2012; Wong et al., 2016). Despite over ten years
of research on inactivated influenza vaccine uptake among pregnant women, uptake rates remain
low. Influenza vaccine uptake rates among pregnant women have remained low over last few
years with the highest coverage rate being 53.6% in the 2016/2017 influenza season (Ding et al.,
2017), and as of November 2017, influenza vaccine uptake among pregnant women was 35.6%
(CDC, 2017). The study by Ding et al (2017), also reported that among the 1893 women
surveyed, only 67.3% of women received both influenza vaccine recommendation and offered by
their physicians, the uptake or coverage rate among those women was 70.5%. About 12% of the
women received influenza vaccine recommendation but no offer, and the vaccine uptake or
coverage rate among them was 43.7% (Ding et al., 2017). Among the group of women who
receive vaccine recommendation, with the use of standing orders and the implementation of task
shift completely to pharmacists may increase influenza vaccination rates in these women
(figure1). When traditional prenatal care providers refer pregnant women to pharmacists, this
may increase inactivated influenza vaccine uptake in this population.
Conclusion
At-risk patients such as pregnant women, fare alongside the worst hit during influenza
epidemics and pandemics, and eventually, become a burden on the health care system and the
economy; dictating the need for changes to be made on how influenza immunization is being
delivered. In addition, campaigns should target pregnant women to make them aware that they
can receive immunization from their pharmacists and that IIV is safe to be administered during
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any trimester of pregnancy. Pharmacists are highly skilled healthcare professionals who have
also been demonstrated to provide cost-effective care, therefore policies need to be targeted
towards equipping them more than they already are to enable them to provide these services as
stand-alone providers.
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Conclusions and Recommendations
Introduction
Significance of topic. Exposure to influenza illness can result in dire consequences for
the health of the pregnant woman and the development of the fetus, including as pneumonia,
spontaneous abortions, preterm births, birth defects and fetal loss (Mak et al., 2008; Rasmussen,
Jamieson, & Bresee, 2008). During influenza pandemics and epidemics pregnant women are at a
great risk compared to the general population (Rasmussen et al., 2008). This increase in
mortality during influenza pandemics is a significant cause for concern, thereby placing pregnant
women as a priority group for recommending the influenza vaccine (Callaghan et al., 2010;
Thompson et al., 2011). The influenza vaccine is not recommended in infants under 6 months,
placing them at a risk for influenza morbidity and mortality. These infants, however, receive
immunity from the mother for the first 6 months of life, hence it is important for mothers to
receive the vaccines as it provides a two-fold benefit, as it protects the mother and the baby
(Simondsen & Hayney, 2011).
Despite over ten years of research on influenza vaccine uptake among pregnant women,
uptake rates remain low. Influenza vaccine uptake rates among pregnant women have remained
low over last few years with the highest coverage rate being 53.6% in the 2016/2017 influenza
season (Ding et al., 2017). The study by Ding et al (2017), also reported that among the 1893
women surveyed, only 67.3% of women received both influenza vaccine recommendation and
offer by their physicians, the uptake or coverage rate among those women was 70.5%. About
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12% of the women received influenza vaccine recommendation but no offer, and the vaccine
uptake or coverage rate among them was 43.7% (Ding et al., 2017). Among the group of women
who receive vaccine recommendation, the use of standing orders (which recommends that other
health care providers such as pharmacists and nurses be able to assess vaccine status and also
administer the vaccine) can help to close the gap of low vaccine uptake (Ding et al., 2017).
Situations where pharmacists have provided immunization services have proven to be beneficial,
as there was an increase in vaccine uptake rates, as they provide services that are cost-effective,
convenient and accessible to individuals, and serve at-risk populations and can reach individuals
that reside in medically underserved communities (Grabenstein et al., 1992; Prosser et al., 2008).
These statistics and trends highlighted the need to explore other avenues through which
pregnant women can receive the inactivated influenza vaccine outside their providers’ offices.
This study sought to fill these gaps in the research. The overall purpose of this study was to
explore, in-depth, the perceptions of pharmacists on their role in administering inactivated
influenza immunization to pregnant women. Using the Theory of Planned Behavior, this study
sought to identify the knowledge, attitudes, perceived control and subjective norms of
pharmacists when it comes to administering the influenza vaccines to pregnant women.
In addition, this study examined the pharmacy school curricula, to determine the content
on administration of influenza vaccine to pregnant women as taught to pharmacy students. The
study also explored the perceptions of pharmacy students on course content, and the projected
future practices of pharmacy students as it relates to administration of influenza vaccines to
pregnant women. The goal of this study was to create a set of recommendations to pharmacy
schools and the department of health regarding a pregnancy immunization content in pharmacy
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curriculum and advocate for additional avenues through which pregnant women can obtain the
inactivated influenza vaccine though the task shifting strategy.
Overview of Research Design
The study utilized a qualitative research method design which composed of in-depth
interviews with licensed pharmacists in the state of Florida, and Academic Deans of the 6
accredited schools of pharmacy in Florida. Focus group sessions were carried out with 3 rd and 4th
year pharmacy students at the accredited schools of pharmacy in Florida. Participants were
recruited through emails (academic deans), and flyers for licensed pharmacists and pharmacy
students. All 6 academic deans and 18 licensed pharmacists participated in in-depth interviews,
and 3 focus groups with pharmacy students were conducted. Interviews were digitally recorded
and transcribed verbatim, and a second coder independently coded the majority of interviews.
Triangulation of findings. Triangulation can be defined as the combination or blending
two or greater than two types of data from different sources in the same study. The sources may
differ based on theoretical perspectives, the investigators, type of methodological approach used
and (Flick, 2004; Patton, 1990; Thurmond, 2001). Triangulation helps to validate a study by
testing the consistency of findings to minimize bias, and also gives the researcher a deeper and
wider understanding of the research. Triangulation is used to explain, confirm, refute and enrich
the data to be combined (Denzin, 2012; Patton, 1990). There are several types of triangulation
namely (i) investigator triangulation, (ii) data sources triangulation, (iii) theoretical triangulation,
and (iv) methodologic triangulation (Patton, 1990; Thurmond, 2001).
For this study, the data sources triangulation was applied. Data sources triangulation
helps to compare different perspectives of different individuals from their different points of
view, which leads to an increase in the confidence of the data collected (Patton, 1990). The
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findings from the data collected from academic deans of pharmacy schools, pharmacy students
and licensed pharmacists in the state of Florida, informed the interpretation of the overall results
meaningfully. The findings from the Academic Deans interview and the pharmacy students focus
groups elicited that pharmacy students receive training on immunization and are equipped to
provide immunization services. It also elicited a lack of pregnancy specific content on
immunization in some schools. The interviews with licensed pharmacists also elicited that
pharmacists were equipped to and considered themselves experts on providing immunization
services, a few of them reported apprehension towards providing immunization to pregnant
women.
Conceptual Implications
This study utilized the Theory of Planned Behavior (TPB) framework to understand the
influenza vaccine administration practices to pregnant women among pharmacists and pharmacy
students. The philosophy of this framework as applied to pharmacists providing influenza
vaccines to pregnant women, is that a pharmacists' ability for influenza vaccine administration to
pregnant women may vary based on the volitional control, normative beliefs, preconceived
notions, perceived difficulty or ease of offering and administering the vaccine to pregnant
women. Based on this philosophy, the constructs of the TPB framework include pharmacists
having the knowledge about the influenza vaccine in pregnant women; pharmacists having the
right attitudes about providing the vaccine to pregnant women; pharmacist understanding and
being able to navigate the barriers to providing these services; and the subjective norms that
support their role to provide these services are the best predictors of pharmacists providing
immunization to pregnant women (Ajzen, 1991).
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This study suggests that these constructs are applicable to studying pharmacists and other
providers and their intentions to provide a healthcare service, and also have important
implications for both interventions and prevention efforts with at risk pregnant women. This is a
positive finding in the light of the knowledge that pharmacy schools cover immunization in their
curriculum, and some more than others provide content specific to pregnant women, also most
pharmacists believe they can play a role in providing influenza vaccines to pregnant women.
However, in this study, few schools do not provide immunization content specific to pregnant
women, and a few pharmacists had knowledge gaps, and do not believe they have a role to play
in administering vaccines to pregnant women, which suggest there is still more work to be done.
Implications for Public Health
This research followed the natural progression of pharmacists from education to
subsequent practice. This research offers a distinctive perspective of three different but related
datasets. All put together findings show that what students are taught may be associated with
what they learn, which inadvertently may be associated with vaccine administration practices in
pregnant women which inevitably may be associated with pregnant women access to care. This
can be further explained using the vaccine uptake definition as applied to this study; vaccine
uptake was defined as a situation where vaccines are available, healthcare providers recommend
the vaccine and individuals accept the vaccine (figure 6).
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Figure 6: Diagram of modified definition of vaccine uptake as applied to the study.

However, this depiction is significant, in that if all of the elements are not in place, the
vaccine uptake may not happen, thereby limiting access to vaccines to those who need it. While
this study did not directly assess “acceptance” by the pregnant women, or recommendation by
providers, it assessed the ability of the pharmacist to provide counseling and education to
pregnant women. Hence, the study model for vaccine uptake demonstrates how there are
elements are associated with each other and potentially impact vaccine uptake. Although a multipronged approach addressing the pharmacy school curricula, student learning, and pharmacist
practice is ideal, an intervention at any point would be beneficial.
Policy implications. Federal implication. In 2012, the National Vaccine Advisory
Committee (NVAC) published a report to improve immunization rates in adults. Some of the
recommended changes included expanding immunization services offered by pharmacists,
increasing immunization by providers that give care to pregnant women, and the inclusion of the
Affordable Care Act (ACA) which requires first-dollar provision. Under the ACA nongrandfathered plans will cover some recommended preventive services such as vaccines
recommended by the ACA with no cost sharing (Committee, 2014). This allowed for increase in
immunization coverage generally. While it is unclear what the American Health Care Act
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(AHCA) plans for immunization are, it will be beneficial if the ACA remains implemented to
provide coverage for more people.
State implication (Florida). In the year 2000, the ACIP recommended standing order
programs (SOPs) which authorize pharmacists and nurses to administer vaccination to adults
(McKibben et al., 2000). In the title XXXII of the Florida Statutes, chapter 465, section 189,
licensed pharmacists may administer vaccines to adults within the framework of an established
protocol (Florida, 2018). To be able to administer vaccines, a pharmacist must have a Florida
license and be in good standing, they must complete an immunization certification program, they
have to maintain a professional liability insurance of $200,000 or more, they must obtain a
written permission from the owner of the pharmacy, they must report administered vaccines into
the immunization information state registry, and lastly, they have to enter into a protocol under a
supervising licensed physician (Florida, 2018). The protocol between the licensed physician and
pharmacist should include patient specific categories and conditions for which the supervising
physician will authorize a pharmacist to administer immunization (Florida, 2018). Authorization
of SOPs in states have been seen to increase overall immunization rates (Stewart, Lindley, &
Cox, 2016). The SOPs, however, do not specify pregnant women, specification of this group
may help increase influenza vaccination. Also, there should be considerations for autonomy for
pharmacists to be able to be considered as practitioners, this sentiment was shared by both the
licensed pharmacists and pharmacy students.
Implications for research. The proposed study findings do not only add to literature in
this field, but it can also spur on future research. Future studies can apply this study to
understand pharmacy roles in administering vaccines to other high-risk groups such as people
older than 65 and children. The findings can also bring about potential research questions
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regarding school curricular review and linking it to practice. Based on the qualitative results of
this study, future research could be developed using quantitative methods to reach a wider and
more generalizable audience. Future studies can also examine pregnant women’s perceptions on
seeking health care from pharmacists or going to the pharmacy to receive vaccines during
pregnancy, and maybe track vaccine refusals or uptake from pregnant women, to understand if
pregnancy women go to the pharmacist and agree to accept the vaccine. Furthermore, future
studies can examine physicians/OBGYNs views on pharmacists providing immunization to
pregnant women. Another area that can be explored would be to assess the role pharmacists can
play in providing other pregnancy required vaccines, to see if there are similarities or differences.
Implications for practice. Although this study was concerned with increasing
inactivated influenza vaccine among a specific population, with the utilization of pharmacy
services, it has broader implications for public health and for healthcare professionals. For
instance, training or education and its translation to clinical practice for healthcare professionals
such as doctors, nurses, geneticists, and so on is very important. Successful teaching and its
translation to effectual learning and proficient practice and effective policy is essential to better
health outcomes in communities. Clinical practice should be driven by research and not personal
beliefs or views, also, pharmacists providing influenza immunization should not be diminished
due to lack of knowledge. From the pharmacy school curricula review and focus groups, there
was an expressed need for pregnant women focused content during immunization classes, there
were also shared sentiments by 33% of the students not remembering being taught about vaccine
administration in pregnant women. 11% of the licensed pharmacists believed the influenza
vaccine caused the influenza illness, and about 40% had ever provided influenza vaccines to
pregnant women.
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Conclusion
The proposed research has the potential to increase inactivated influenza vaccine uptake
in pregnant women. Inactivated influenza vaccine coverage rate continues to remain low in
pregnant women, despite ACIP recommendations, interventions on provider recommendation
and interventions for pregnant women (Ding et al., 2017). It is important women receive the
vaccine during pregnancy as it provides a two-fold benefit of protecting the mother and the
unborn infant up until the first few months of life (Naleway et al., 2006). The state of Florida had
a 21.6% influenza vaccine coverage among pregnant women during the 2009-2010 influenza
season, and it also ranked the lowest among the states studied (Kennedy et al., 2012). The state
of Florida would benefit from this research as it hopes to create more opportunities and avenues
for pregnant women to receive the inactivated influenza vaccine, by emphasizing the role of
pharmacists can play may help increase vaccine uptake. The study explored what is being taught
in pharmacy schools, regarding administering influenza vaccine to pregnant women and also
how licensed pharmacists are implementing inactivated influenza vaccine administration in
pregnant women. Overall, study showed that despite barriers and concerns, pharmacists believe
they have a role to play in administering inactivated influenza vaccines to pregnant women.
Strengths and limitations
The proposed study used qualitative methods to explore how the immunization course
content is being taught in pharmacy schools in Florida and the experiences of pharmacists in
administering specifically influenza vaccines to pregnant women. The qualitative interview and
focus group questions were guided by the theory of planned behavior theoretical framework. The
study is innovative, and to the best of the researcher’s knowledge it has not been conducted
elsewhere.
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One limitation of this study is that it is a qualitative study, and therefore cannot be
generalized to other populations, also, the sample size was small. Another limitation lies with the
fact that the pregnant women themselves would not be interviewed on their perceptions on going
to the pharmacists to receive the influenza vaccine. Also, the study does not include providers
such as the OB/GYN. Midwives or family medicine doctors who usually attend to pregnant
women, so as to explore their perceptions on pharmacists administering the influenza vaccine to
pregnant women.
Trustworthiness
In qualitative studies the terms that have been used to assess the general validity of
qualitative research include rigor, trustworthiness, reliability and specific validity. These
terminologies are used to differentiate good quality research from a poor quality one (Elo et al.,
2014; Golafshani, 2003). In terms of the criteria for validity and reliability, there is no distinct
line dividing quantitative and qualitative content analysis (Elo et al., 2014), rather the qualitative
data can be assesed for trustworthiness by applying the following criteria: dependability,
credibility, transferability, and confirmability (Elo et al., 2014). Dependability refers to the
researcher being cognizant of the changes made by the researchers during the qualitative data
analysis process and the degree to which the data changes during that period so as to ensure
consistency (Graneheim & Lundman, 2004). For the proposed study an audit trail was used to
ensure dependability due to the subjective nature of qualitative data analysis. A detailed
notebook was maintained where all the observations of the data collection and analysis process
were recorded. During the interview and focus group processes, notes were recorded capturing
what participants were more communicative about, and events that may influence the
information collected. The notes were uploaded as a memo into the MAXQDA software for the
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other coder to also review. Credibility refers to researchers ensuring their study measures the
intended focus during the analytic process (Graneheim & Lundman, 2004; Shenton, 2004). For
the proposed study, credibility was ensured in the various stages of the data collection process.
The interview guides were developed using a theoretical framework and was piloted and
pretested with pharmacists for readability. Data was monitored as they were collected, and
feedback was elicited from participants after interviews to improve and clarify any issues that
came up. Also, during the data collection process, iterative questioning was applied through the
use of probes and returning to previous answers raised by participants. Transferability refers to
how possible it is to demonstrate that the conclusions and findings of a study can be applied or
transferred to other settings or populations (Graneheim & Lundman, 2004; Shenton, 2004). For
the study, transferability was ensured by clearly defining the study population and their
characteristics and providing in detail the process of the data collection and analysis. Using a
theoretical framework, TPB as a guide, to make it more adaptable for other populations. Also,
transferability was achieved by providing a rich and robust presentation of the results using the
appropriate quotations. Lastly, confirmability which refers to ensuring objectivity in a study
(Shenton, 2004). Subjectivity is an issue that arises with qualitative data, especially when
creating and apply codes to the transcript text (Guest et al., 2011). For this study, the intercoder
agreement was used to increase reliability, and was calculated using the Cohen’s Kappa (84%).
Also, the audit trail was used to increase transparency and document the processes that were
carried out throughout the data collection and analysis period.
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Appendix A: Review of the Literature
Review of Literature 1- Reasons for Low Influenza Vaccine Uptake (Pregnant Women and
Provider Perspectives)
Influenza virus overview. The influenza virus is an RNA virus which depending on the
annual genetic change and severity of the illness can be grouped as seasonal or pandemic. The
influenza virus is transmitted through inhaling aerosols contaminated with the virus (Iwasaki &
Pillai, 2014). There are three types namely, A, B and C, of which A and B are known to cause
major seasonal outbreaks with associated illnesses and deaths, and A may also cause pandemics
(WHO, 2012; Cox & Subbarao, 2000). Influenza epidemics occur yearly all over the world. In
the U.S. they cause significant comorbidities and deaths in about 20% of the U.S. population
annually (Biggerstaff et al, 2014).
The Influenza viruses change regularly either through "antigenic drifts," which are minor
point mutations or through major "antigenic shifts" (Biggerstaff et al., 2014; Cox & Subbarao,
2000). The pandemic strains of the virus which occur every ten to twenty years, are as a result of
the “antigenic shift”, while the “antigenic drift is responsible for the seasonal strain of the
influenza virus (Iwasaki & Pillai, 2014). These antigenic drifts and shifts can cause a new
version or strain of the influenza virus to be introduced into the human population of which
individuals are not yet immunized against hence, causing epidemics and pandemics (Biggerstaff
et al., 2014; Cox & Subbarao, 2000; Treanor, 2004). As a result of these changes, the pattern of
new pandemics will be hard to predict (Biggerstaff et al., 2014). The economic cost of seasonal
influenza in the United States is estimated to be about $87 billion annually including direct
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medical costs of about $10 billion. Missed workdays and loss in productivity account for a bulk
of the burden; these consequences emphasize how much influenza illness is a drain on the U.S.
economy (Molinari et al., 2007; Nowak et al., 2015).
Influenza vaccination guidelines. The Advisory Committee on Immunization Practices
(ACIP) recommends that all individuals 6 months or older receive the influenza vaccine, as it
remains the most effective way to prevent influenza illness and its comorbidities (Lu et al.,
2018). The CDC prioritizes influenza vaccination in several groups of individuals considered
high risk or priority, and especially if vaccine shortage occurs. These individuals such as include
children aged six months to fifty-nine months, people 50 years and older, pregnant women or
women who plan get pregnant during the influenza season, health care personnel, residents of
chronic care centers and nursing homes, people aged six months to 18years on long term aspirin
treatment who with the influenza illness can develop Reye syndrome, individuals who are
Alaskan natives or American Indians, and contacts and caregivers of adults 50 and older and
children younger than 5 years, with an important focus on children aged younger than 6 months
(CDC, 2016a, 2016b). Other groups of individuals who are also considered as priority or high
risk for major influenza illness and mortality, such as individuals who have chronic conditions
such as diabetes, obesity and, asthma (Nowak et al., 2015).
Overview of influenza infection in pregnant women. Pregnancy is a unique
immunological state, in which the immune system is modulated as a result of placental response
and its tropism for specific pathogens and viruses. These affect the pregnant woman's
susceptibility to certain infections (Mor & Cardenas, 2010). Research has shown an increase of
about a four-fold in influenza antibody titers during pregnancy. (Mak, Mangtani, Leese, Watson,
& Pfeifer, 2008). In between influenza epidemics, and during influenza pandemics, pregnant
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women are usually more susceptible to contracting influenza and its subsequent complications
such as pneumonia, spontaneous abortions, preterm births, birth defects and fetal loss (Mak et
al., 2008; Rasmussen, Jamieson, & Bresee, 2008).
Usually the morbidity from influenza in this population is low, however during the
influenza pandemics such as 1918, 1957, 2009 and other influenza outbreaks, there were high
death rates in pregnant women (Callaghan, Chu, & Jamieson, 2010; Mak et al., 2008; Thompson
et al., 2011). During the 1918 influenza pandemic in the U.S., 27% of pregnant women died, also
in the 1957 pandemic influenza, 20% of influenza-associated deaths occurred in pregnant women
(Rasmussen et al., 2008). This increase in mortality during influenza pandemics is a significant
cause for concern, thereby placing pregnant women as a priority group for recommending the
influenza vaccine (Callaghan et al., 2010; Thompson et al., 2011). Also, uptake of influenza
vaccine during pregnancy has a two-fold benefit, as it protects the mother and the baby for its
first few months of life (Simondsen & Hayney, 2011). This protection for the baby is essential,
as there is no licensed influenza vaccine for infants under six months of age, and also because,
during influenza outbreaks, children experience the highest infection rates (Simondsen &
Hayney, 2011).
Reasons for influenza non-vaccination in pregnant women. In order to assess the
current reason for influenza non-vaccination in pregnant women in the United States, a
systematic literature review was conducted. Articles were systematically selected from a search
of PubMed, Web of Science and CINAHL during a date range of January 1st, 1998 to February
8th, 2019. The Search terms were ordered into broad categories of influenza vaccine (e.g.,
influenza vaccines, [Mesh]) OR influenzavirus vaccines OR flu vaccines OR flu vaccine),
prenatal care (e.g., perinatal care"[Mesh] OR perinatal OR pregnancy OR pregnan* [Mesh] OR
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preNatal OR antenatal OR antenatal), vaccination refusal (e.g., refuse OR refusal OR uptake OR
accept*), and physician (e.g., physicians"[Mesh] OR doctor OR nurse OR midwife). The search
strategy for each database used the Boolean term of ‘OR’ for inclusion of each search term
within the broad category, and the Boolean term of ‘AND’ for inclusion of each broad category.
The inclusion criteria for the search were: (1) qualitative and quantitative studies; (2) conducted
in English; (3) peer reviewed; (4) Examined the reasons for influenza vaccine refusal or low
uptake in pregnant women; (5) conducted post-vaccine recommendation for pregnant women
(1998); and (6) conducted in the United States. Studies were excluded if only a published
abstract was the full paper was not found.
The initial search of the literature identified 181 studies, and 8 additional studies for gray
literature. After removing 28 duplicates, 161 studies remained. Study abstracts were then
screened based on the relevance to the topic; this removed 94 studies, and 67 studies were left.
Next, the full texts were assessed to determine eligibility based on the inclusion and exclusion
criteria. The following articles were removed: 25 for being not related to the study, 5 as they
were commentaries, 3 as full texts were not found, 2 for being systematic reviews or metaanalysis, and 1 for being outside of the United States. As a result, 31 articles remained; 26 were
quantitative studies and 5 were qualitative.
Description of studies. The study with the earliest date was conducted in 2006, while the
most recent were conducted in 2018 (Wallis et al., 2006; Frew et al., 2018; Wootton et al., 2018;
O’Leary et al., 2018). The included studies had the following types of samples: 24 studies
including pregnant women postpartum women and women of reproductive age (Chamberlain et
al., 2015; Eppes et al., 2013; Kharbanda et al., 2011; Gorman et al., 2012; Healy et al., 2015;
Ahluwalia et al., 2014; Kharbanda et al., 2013; Meharry et al., 2013; Beel et al., 2013; CDC,
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2009; Wootton et al., 2018; Frew et al., 2018; Marsh et al., 2014; Goodman et al., 2015;
Chamberlain et al., 2016; Groom et al., 2016; Ballas et al., 2015; Meharry et al., 2014; Drees et
al., 2012; Drees et al., 2013; Goldfarb et al., 2011; Ahluwalia et al., 2011; SteelFisher et al.,
2011; Howland et al., 2013; Moniz et al., 2013), 7 studies with health care providers (Broughton
et al., 2009; O’Leary et al., 2018; Wallis et al., 2006; Frew et al., 2018; Arao et al., 2015; Clark
et al., 2013; Moniz et al., 2013) 1 study included both women and providers (Healy et al., 2015),
1 study involved a minority population (African American women), and 11 studies involved
national health surveys (SteelFisher et al., 2011; Ahluwalia et al., 2011; Howland et al., 2013;
O’Leary et al., 2018; Groom et al., 2016; Wootton et al., 2018; CDC, 2009; Kharbanda et al.,
2013; Ahluwalia et al., 2014; Clark et al., 2013; Gorman et al., 2012). Four studies used a
theoretical framework (Health Belief Model) (Drees, et al., 2012; Meharry et al., 2014; Gorman
et al., 2012; Goodman et al., 2015;), and 2 studies were interventions (Moniz et al., 2013;
Meharry et al., 2014). One study assessed both pandemic and seasonal influenza vaccine
coverage (Ahluwalia et al, 2014), while the other studies assessed seasonal influenza vaccine
coverage. Reasons for influenza non-vaccination, as well as, barriers to influenza vaccination
among pregnant women or women of reproductive age were abstracted from each article. These
determinants were then explained by levels of the Socioecological framework which is used to
understand the different interactive effects of the personal and environmental factors that
determine health behavior (McLeroy, Bibeau, Steckler, & Glanz, 1988). It has five levels;
namely the intrapersonal, the interpersonal, organizational, community and political (McLeroy et
al., 1988). This review summarizes the current state of the reason’s influenza non-vaccination
among pregnant women in the United States. From this review of literature, it is evident that the
bulk of existing research and interventions has focused on the intrapersonal level and on the
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pregnant women. The reasons for low vaccine uptake were similar across all sample locations
and sizes.
Reasons for low vaccine uptake. The Social Ecological Model (SEM): This framework
is used to understand the different interactive effects of the personal and environmental factors
that determine health behavior. It has five levels; namely the intrapersonal, the interpersonal,
organizational, community and political (Coreil, 2010). For this literature review, it was used to
identify the individual, intrapersonal, organizational and community factors that affect vaccine
uptake in pregnant women. Intrapersonal reasons for influenza non-vaccination among pregnant
women can be described as demographic characteristics which include; lower vaccine uptake
was reported in minority groups such as African Americans (Ahluwalia et al., 2014; Kharbanda
et al., 2013; Ballas et al., 2015; Drees et al., 2012; Steelfisher et al., 2011). However, the study
by Ballas et al noted higher vaccination uptake in Hispanic women (Ballas et al, 2015). Other
groups reported to have low vaccine uptake were women of younger age less than 35 (Groom et
al, 2016; Drees et al 2012; Steelfisher et al,2011), women with low income making less than
$35,000 a year (Ballas et al, 2015) less education (Steelfisher et al, 2011) and those reported to
live at a distance further away from the clinics (Ballas et al, 2015). A study by Wallis et al
(2006), noted lower influenza recommendation in larger obstetric practices when compared to
family physicians; while another study by Ballas et al (2015) noted lower vaccine uptake in
women seen by family physicians. There were no observed differences between study population
recruited from the clinic or community, and also between the smaller samples sizes verses the
larger ones.
Barriers such as costs, time, safety concerns, needle phobia, lack of knowledge about
vaccines, habits such as not receiving vaccines in the past and women in their first and second
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trimester (Beel et al., 2013; Chamberlain et al., 2016; Healy et al., 2015) as reasons for low
vaccine uptake which were classified as intrapersonal. Living at a distance further away from the
clinics (Ballas et al., 2015), perceived low risk to the influenza infection, feeling that the vaccine
is not important and the women not habitually receiving the vaccine were also classified as
intrapersonal (Ahluwalia et al., 2014; Drees et al., 2012; Groom et al., 2015; Malik et al., 2016).
Pregnant women also reported not perceiving influenza virus infection as a serious illness,
doubted the efficacy of the vaccine and reported a lack of awareness of the benefit of the vaccine
(Kharbanda et al., 2013; Meharry et al., 2013).
The interpersonal level reasons for low vaccine uptake included patient provider
interaction (Ahluwalia et al., 2014; Chamberlain et al., 2015; Drees et al., 2012; Eppes et al.,
2013; Gorman, Brewer, Wang, & Chambers, 2012; Healy et al., 2015; Kharbanda et al., 2013),
and other reasons such as influence from pregnant women family and friends, pregnant women
work commitment and insufficient time during hospital visits (Arao, Rosenberg, McWeeney, &
Hedberg, 2015; Meharry et al., 2013). The organizational level reasons for low vaccine uptake
had to do with non-availability of vaccine at health care centers (Ahluwalia et al., 2014; Meharry
et al., 2013). Community-level determinants of vaccine uptake in this population include
transportation issues (Beel et al., 2013; Healy et al., 2015), distance from the clinic and the
media (Ballas et al., 2015; Beel et al., 2013).
A reason such as cost can be classified as both intrapersonal and system level; nonavailability of vaccine could be viewed as organizational or system level. Studies usually identify
reasons situated in intrapersonal, interpersonal, or organizational levels for low influenza vaccine
uptake, and do not examine these reasons from a policy or system level (Hershey & Velez,
2009).
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Figure 7. Showing the Differences in the Reasons for Low Influenza Vaccine Uptake

Application of theoretical models. Of the studies included in this review, only one theory
was used, which is the Health Belief Model (HBM). HBM suggests that an individual's
perceptions or beliefs influence the likelihood that they will take action (e.g., receive the
influenza vaccine) (Glanz, Rimer, & Viswanath, 2008). Although five of the studies in the
literature review used this model in their studies (Drees et al., 2012; Goodman et al., 2015;
Gorman et al., 2012; Meharry et al., 2014; Puchalski, Hollema, & Marshall, 2015), the constructs
of the HBM are reflected in many of the other studies and are discussed as follows:
(i) Perceived susceptibility to the influenza virus infection. Women reported that they
were not at risk of influenza virus infection, they felt vaccination against influenza is not
important, and that they usually do not receive the influenza vaccine (Chamberlain et al., 2011;
Kharbanda et al., 2011; Malik et al., 2016; Goodman et al., 2015; Ahluwalia et al., 2011; Drees
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et al., 2012; Groom et al., 2016; Eppes et al., 2013). (ii)Perceived severity of the influenza virus
infection. Studies included in this review also reported that women felt the influenza virus
infection was not a severe illness (Ahluwalia et al., 2011; Drees et al., 2012; Groom et al., 2016;
Malik et al., 2016). (iii) Perceived benefits of the influenza vaccine. Women in some of the
studies reviewed reported the lack of efficacy of the vaccine (Eppes et al., 2013; Kharbanda et
al., 2011; Puchalski et al., 2015). One study also reported a lack of awareness of the benefits if
the vaccine for them and the baby (Meharry et al., 2013). (iv) Perceived barriers to influenza
vaccine. The review noted various barriers women perceive which stops them from getting the
influenza vaccine such as safety concerns for both the mother and the fetus, and fearing they may
have a miscarriage or a malformation in the fetus (Chamberlain et al., 2011; Gorman et al., 2012;
Kharbanda et al., 2011; Malik et al., 2016; Healy et al., 2015; Alhuwaila et al., 2014; CDC,
2009; Goodman et al., 2015; Meharry et al., 2013; Meharry et al., 201; Drees et al., 2012;
Goldfarb et al., 2011; Ahluwalia et al., 2011; Puchalski et al., 2015). Cost, needle phobia, lack of
transportation, work commitments, no vaccine available and adverse reaction to the vaccine were
also perceived as barriers to vaccine uptake (Healy et al., 2015; Beel et al., 2013; Meharry et al.,
2013; Ahluwalia et al., 2011). (iv)Cues to action. In a few of the studies included in this review,
it was reported that lack of provider recommendation was a reason for low uptake of influenza
vaccine (Chamberlain et al., 2012; Kharbanda et al., 2011; Healy et al., 2015; Kettunen et al.,
2010; Drees et al., 2012; Ahluwalia et al., 2011). Health care provider indifference and lack of
knowledge about the vaccine were also reported to cause low vaccine uptake (Healy et al., 2015;
Meharry et al., 2013).
Pregnant women perspective. Low vaccine uptake was associated with women’s
concerns regarding safety of influenza vaccine during pregnancy, as they fear it may cause harm
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to them and the baby (Chamberlain et al., 2011; Gorman et al., 2012; Kharbanda et al., 2011;
Malik et al., 2016; Healy et al., 2015; Alhuwaila et al., 2014; CDC, 2009; Goodman et al., 2015;
Meharry et al., 2014; Meharry et al., 2013; Drees et al., 2012; Goldfarb et al., 2011; Ahluwalia et
al., 2011; Puchalski et al., 2015). Harm to themselves was expressed in one study as they may
come down with influenza after uptake of vaccine (Puchalski et al., 2015). The influenza vaccine
not being efficacious and hence not protective was another reason for low vaccine uptake (Eppes
et al., 2013; Kharbanda et al., 2011; Puchalski et al., 2015). History of not receiving influenza
vaccine ever or normally in the past was also a reason for not accepting the vaccine by the
pregnant women (Ahluwalia et al., 2011; Drees et al., 2012; Groom et al., 2016; Malik et al.,
2016). Most women also believed that they were not at risk to influenza infection and they
usually do not come down with influenza infection, hence did not receive the vaccine (Eppes et
al., 2013; Kharbanda et al., 2011; Malik et al., 2016; Goodman et al., 2015). Women were also
reported to have noted vaccine cost, insufficient knowledge of vaccine benefit, no transportation,
work commitments and needle phobia as other reasons for low vaccine uptake (Healy et al.,
2015; Beel et al., 2013).
Some studies reported that lack of provider recommendation was a primary reason for
low influenza vaccine uptake (Chamberlain et al., 2012; Kharbanda et al., 2011; Healy et al.,
2015; Kettunen et al., 2010; Drees et al., 2012; Ahluwalia et al., 2011), one study reported
provider indifference Meharry et al., 2013), and another study reported lack of health care
provider reminder (Gorman et al., 2012). Other reasons such as being in the first or second
trimester of pregnancy, not being pregnant during influenza season, and influence of family and
friends were also reported (Chamberlain et al., 2016; CDC, 2009; Meharry et al., 2013). Nonavailability of the vaccine was also published as a reason for low uptake of the influenza vaccine
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(Meharry et al., 2013; Ahluwalia et al., 2011). Women reported lack of knowledge, lack of
insufficient information and complete lack of information regarding influenza vaccines also as
reasons for not considering taking the vaccine (Eppes et al., 2013; Beel et al., 2013; Kettunen et
al., 2010; Meharry et al., 2014; Ahluwalia et al., 2011).
Provider perspective. The study by Healy et al. noted physicians reported that reasons
such as too little time during hospital visits, allergic reaction to the vaccine, and their lack of
knowledge about the vaccines were the cause of low vaccine uptake in pregnant women (Healy
et al., 2015). Physicians also reported that the prior beliefs held by the women, their lack of
enthusiasm when recommending the vaccine and insufficient time to explain the benefits of the
vaccine during visits are responsible for low influenza vaccine uptake (Arao et al., 2015;
O’Leary., et al, 2018). A study by Wallis et al. reported that obstetric practices had lower
influenza vaccination rates versus family physicians, and larger health (group practices vs.
private/solo practices) care centers had lower vaccine recommendation rates (Wallis et al., 2006;
O’Leary et al., 2018). Health care workers also reported a non-belief in the safety and
effectiveness of IIV in pregnant women (Broughton et al., 2009). Providers also reported not
having the vaccine in stock or a shortage in supply, and other issues surrounding ordering,
tracking, and storing of vaccines. (Frew et al., 2018; O’Leary et al., 2018; Clark, Cowan, &
Wortley, 2013).
Discussion
Since the ACIP recommendation, influenza vaccine coverage among pregnant women
has remained suboptimal. This systemic literature review identified reasons for low uptake of
influenza vaccine in this population both from health care provider and pregnant women
perspectives. Most pregnant women believe there are harmful outcomes for them and their
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babies when they receive the vaccine, or that the vaccine is not effective or efficacious.
Additionally, some pregnant women do not perceive influenza virus infection as severe illness or
do not believe they are at risk of the disease. Other concerns reported by women, such as cost,
transportation, and non-availability of vaccines were also reasons for low vaccine uptake. The
importance of vaccine recommendation by health care providers resonated across most of the
studies; thus, continued efforts will be required to ensure health care providers follow the CDC
and ACOG recommendation and guidelines. Targeted efforts are also needed for minority
populations such as African American population, as they have been reported to have lower
influenza vaccine uptake rate (Kharbanda et al., 2013).
Given the results of the review, future research directions may consider formative
research with pregnant women-specific intervention. Educating these pregnant women during
prenatal visits and addressing logistic concerns such as costs and supply may assist in increasing
vaccine uptake. Interventions that targeted pregnant women have been carried out through text
message reminders, flyers, workshops, classes and media (Wong, Lok, & Tarrant, 2016). Studies
show that education using pamphlets and a "vaccine benefit statement" increases influenza
vaccine uptake (Meharry et al., 2014; Wong et al., 2016). However, a study carried out by Moniz
et al. (2013) showed no significant increase uptake in influenza vaccines by pregnant women
using weekly text messages (Moniz, Hasley, Meyn, & Beigi, 2013).
Provider-centered interventions to increase influenza vaccine uptake among pregnant
women usually target reduction of missed opportunities, and they involve the use electronic
reminders (Klatt & Hopp, 2012), education, provider feedback and standing orders to administer
vaccines without doctors consult. These strategies have been shown to increase influenza vaccine
uptake (Sherman, Raker, & Phipps, 2012; Wong et al., 2016). Studies regarding interventions
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targeted towards barriers the pregnant women face such as no vaccine available, cost and
accessibility have not been described in the literature and should be included in future
interventions (Wong et al., 2016).
Conclusion
This review identifies the various reasons for low uptake of IIV in pregnant women from
provider and women perspectives in the U.S. Interventions for pregnant women should be
targeted to individuals in the lower SES and the African American population with sensitivity to
cultural differences. Interventions that address the HBM determinants such as benefits, and
barriers should be developed and tested. Interventions for healthcare professionals should target
education which may involve courses and seminars; also, implementation of the ACIP and
ACOG recommendations at care centers, which may include incentives and packages to
encourage providers to recommend, provide and administer influenza vaccines. Other
interventions should target organizational and system level determinants of influenza vaccine
uptake, such as insurance coverage, availability at care centers and cost reduction.
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Literature Review 2- Pharmacists Administration of Influenza Vaccines in Adults
Introduction
The overall purpose of this literature review is to identify the state of influenza vaccine
administration in adults among pharmacists in the U.S. and its impact. Specifically, to examine
the studies that have been conducted to date that show the impact on the community of
pharmacists administering the influenza vaccines in adults. Additionally, this review will attempt
to examine participant characteristics such as urban vs. rural areas, high-risk individuals,
race/ethnicity among existing literature reporting on the impact of pharmacist's administration of
influenza vaccine in adults.
Results
Description of studies. The study with the earliest date was conducted in 1992, while the
most recent was carried out in 2014. Fourteen of the articles reviewed were quantitative studies,
and two were qualitative studies. Six of the studies were cross-sectional studies (Bearden & Holt,
2005; Ernst, Chalstrom, Currie, & Sorofman, 1997; Murphy et al., 2012; Singhal & Zhang, 2014;
Wang, Munshi, & Hong, 2014; Weitzel, 2000), two of the studies were quasi-experimental
(Bourdet, Kelley, Rublein, & Williams, 2003; Steyer et al., 2004), two studies were
retrospective, the study by Grabenstein et al, 2009 was a retrospective cohort study (Grabenstein,
2009) and the other a retrospective controlled study (Loughlin, Mortazavi, Garey, Rice, &
Birtcher, 2007). Two studies evaluated costs, the study by Prosser et al., 2008 conducted a cost
decision model qualitative study (Prosser et al., 2008), and the other conducted a cost analysis
model (Grabenstein, Hartzema, Guess, Johnston, & Rittenhouse, 1992). One study was a
randomized control trial (Hagemann, Johnson, & Conway, 2014), one was a case report study
(Doucette et al., 2012), another a case series study (Goode, Mott, & Stanley, 2007).
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Sampling methods for participant recruitment were from community pharmacists, clinics,
hospitals, and university campuses. Two of the articles analyzed pooled data from various
databases, the study by Singhal et al. 2014 used the health insurance database of patients
(Singhal & Zhang, 2014), the study by Grabenstein et al, 2009 used automated pharmacy records
and the study by Wang et al, used the Medicare expenditure survey (Wang et al., 2014). All
fifteen studies assessed seasonal influenza vaccine coverage. The study with the largest sample
size was 71,135,249 million (Wang et al., 2014), and the study with smallest sample size was
had 72 people and was a qualitative study (Penfold et al., 2011).
Demographics. Significantly increased influenza vaccine uptake observed among highrisk patients with conditions such as cardiovascular diseases and adults 65 years and older (Ernst
et al., 1997; Loughlin et al., 2007; Steyer et al., 2004). Also, influenza vaccine administration by
pharmacists was seen to increase coverage among medically underserved individuals (Murphy et
al., 2012). In the study by Grabstein et al, 2009, which compared the vaccine administration rates
in pharmacies that use nurses to administer vaccine in a single day and pharmacies that allow for
daily vaccine administration daily by pharmacists over an influenza season, found the
vaccination uptake rates to be significantly higher with pharmacist’s administration
(Grabenstein, 2009).
Feasibility of pharmacists administering influenza vaccine. Of the studies that assessed
the scope of pharmacists practice in administering vaccines to adults, it was noted be facilitated
by policy such as the standing order which increased influenza vaccine administration and hence
uptake in states (Goode et al., 2007; Steyer et al., 2004; Weitzel, 2000). Several barriers to
feasibility were identified such as vaccine purchase which was affected by lack of predictability
of vaccine supply, lack of certainty of the demands of the community, and a limit in purchasing
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power (Penfold et al., 2011). Another barrier was vaccine delivery which was affected by the
complications of managing off-site centers such as schools, the differences in requirements
across states for credentialing (Penfold et al., 2011). The last barrier identified involved
reimbursement issues (Penfold et al., 2011).
Effectiveness of pharmacists administering influenza vaccine. Fifteen of the studies
noted how effective the pharmacist's administration practices of influenza vaccine to adults was,
as influenza vaccine uptake rates were increased (Bearden & Holt, 2005; Bourdet et al., 2003;
Doucette et al., 2012; Ernst et al., 1997; Goode et al., 2007; Grabenstein, 2009; Hagemann et al.,
2014; Loughlin et al., 2007; Murphy et al., 2012; Prosser et al., 2008; Singhal & Zhang, 2014;
Steyer et al., 2004; Wang et al., 2014; Weitzel, 2000). Some studies measured the costeffectiveness of pharmacists administering the vaccine to adults (Grabenstein et al., 1992;
Prosser et al., 2008). The study by Grabenstein et al., (1992) reported that pharmacists
advocating campaigns inadvertently prevent hospitalizations and save costs (Grabenstein et al.,
1992). The study by Prosser et al., (2008), reported the cost of vaccination was lower with
pharmacists administered vaccines compared to clinics (Prosser et al., 2008). The study by
Murphy et al., 2012, noted the accessibility of pharmacists administered influenza vaccines to
individuals residing in medically underserved areas emphasizing the unique positions pharmacies
might play reducing geographic barriers (Murphy et al., 2012).
Acceptability of pharmacists administering influenza vaccine. Three studies noted that
several factors were associated with individuals accepting pharmacies and pharmacists as
vaccine administrators, and they include long hours of operation, convenience and easy
accessibility (Ernst et al., 1997; Goode et al., 2007; Murphy et al., 2012). The study by Wang et
al. (2014), noted that individuals placed pharmacists as the second most trustworthy vaccine
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administrators among health professionals following doctors. The study also noted that
individuals reported that they would be comfortable receiving their influenza shot from
pharmacists (Wang et al., 2014).
Discussion. Since the inception of the standing order by ACIP for pharmacists to
administer vaccines to adults (McKibben et al., 2000), pharmacists have been responsible for
administering vaccines to about 30 percent of the population (Kirkdale, Nebout, Megerlin, &
Thornley, 2017). The review shows that pharmacists have a unique role in increasing influenza
vaccine uptake in the community, as they provide services that are cost-effective, convenient and
accessible to individuals, serve at-risk populations and can reach individuals that reside in
medically underserved communities. A study by Goad et al, (2013), noted that about 20-30
percent of physicians stocked CDC recommended vaccine (Goad, Taitel, Fensterheim, &
Cannon, 2013), nontraditional places where vaccines can be received, such as pharmacies can
offer an advantage and provide more vaccine coverage (Goad et al., 2013).To explain factors
influencing the state of pharmacists as influenza vaccine administrators the result of the literature
review will be further illustrated by dividing the findings to patient factors, provider factors and
system factors (figure 8).
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Figure 8. Showing factors influencing the pharmacist’s delivery of influenza vaccine
The review noted systemic factors that affect the delivery of influenza vaccines by
pharmacists to individuals to include facilitators such as lower costs and access (Grabenstein et
al., 1992; Prosser et al., 2008), and barriers that involve vaccine purchase and delivery (Penfold
et al., 2011). The patient-centered factors include accessibility, lower costs, and trust in ability of
pharmacists to administer the vaccines (Ernst et al., 1997; Goode et al., 2007; Grabenstein et al.,
1992; Murphy et al., 2012; Prosser et al., 2008; Wang et al., 2014). The provider centered factors
include the provision of standing orders, the hours of operation of a pharmacy, which could also
be system centered, and the advocacy campaigns carried out by pharmacists (Ernst et al., 1997;
Goode et al., 2007; McKibben et al., 2000; Murphy et al., 2012; Steyer et al., 2004).
Conclusion
This review identifies the impact of pharmacists administering the influenza vaccine.
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Interventions could be targeted towards advocating for at-risk groups such as pregnant women to
utilize these services. Interventions can target the vaccine supply and delivery, and the
private/public vaccine distribution system. Interventions can also target mandating the standing
order for every licensed pharmacist in every state.
Limitations of current research. Several methodological issues have been identified
regarding research surrounding the role of pharmacists in administering vaccines. Most of the
research involving pharmacists administering vaccines are carried out using nationally
representative data such as BFRSS, which has limitations as it uses a general health risk
surveillance not specific to pregnant women (Steyer et al., 2004). Furthermore, the BFRSS data
did not specify the type of health care provider administering the vaccine (Steyer et al., 2004).
Other studies carried out to research the role of pharmacists in administering vaccines, used
samples that included high risk group individuals with co-morbidities, children, and the general
population (Goad et al., 2013; Kamal, Madhavan, & Maine, 2003; Papastergiou, Folkins, Li, &
Zervas, 2014; Steyer et al., 2004; Taitel, Cohen, Duncan, & Pegus, 2011). For the predictor
variables, most studies used age, demography and comorbid conditions in relation to the role of
pharmacists administering vaccines (Kamal et al., 2003; Steyer et al., 2004; Taitel et al., 2011).
Studying the role of pharmacists in administering influenza vaccine to the general population and
other high-risk groups, cannot be extrapolated and made generalizable to pregnant women, as
they area a unique priority group (Ding et al., 2017).
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Appendix B: Academic Deans Informed Consent Form

Script for Obtaining Verbal Informed Consent for Academic Deans
Information to Consider Before Taking Part in this Research Study
Title: An exploration of the role of pharmacists in increasing influenza vaccine uptake in
pregnant women in Florida
Pro # 00038934

Overview: You are being asked to take part in a research study. The information in this
document should help you to decide if you would like to participate. The sections in this
Overview provide the basic information about the study. More detailed information is provided
in the remainder of the document.
Study Staff: This study is being led by Oluyemisi Falope who is a PH.D. Candidate at
the University of South Florida This person is called the Principal Investigator. She is
being guided in this research by Dr. Russel Kirby. Other approved research staff may act
on behalf of the Principal Investigator.
Study Details: This study is being conducted at the University of South Florida. The
purpose of the study is to explore the role pharmacists can play in increasing influenza
vaccine uptake among pregnant women. This would be carried out by exploring
pharmacy school curriculum regarding what is taught regarding influenza vaccine
administration to pregnant women.
Participants: You are being asked to take part because you are an academic dean at an
accredited school of pharmacy in Florida. We want to ask you about how the course
content regarding vaccine administration in pregnant women, with a focus on influenza
vaccine is taught at your college. This interview session is expected to last for about 30
minutes. The interview will take place at a location convenient for you (e.g. public place,
parks, participant homes), where you will be comfortable. The interview will be audio
recorded. This is done so that what you say will be properly captured and not misrepresented.
Voluntary Participation: Your participation is voluntary. You do not have to participate
and may stop your participation at any time. There will be no penalties or loss of benefits
or opportunities if you do not participate or decide to stop once you start. Your decision
to participate or not to participate will not affect your job status, employment record,
employee evaluations, or advancement opportunities.
Benefits, Compensation, and Risk: We do not know if you will receive any benefit from
your participation. There is no cost to participate. You will not be compensated for your
participation. This research is considered minimal risk. Minimal risk means that study
risks are the same as the risks you face in daily life.
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Confidentiality: Even if we publish the findings from this study, we will keep your study
information private and confidential. Anyone with the authority to look at your records
must keep them confidential. We will do our best to keep your records private and
confidential. We cannot guarantee absolute confidentiality. Your personal information
may be disclosed if required by law. Certain people may need to see your study records.
The only people who will be allowed to see these records are: The Principal Investigator,
the advising professor, the research team and the University of South Florida Institutional
Review Board (IRB).
If you have any questions, concerns or complaints about this study, call Oluyemisi Falope at
XXXXXXXXXX .If you have questions about your rights, complaints, or issues as a person
taking part in this study, call the USF IRB at (813) 974-5638 or contact by email at RSCHIRB@usf.edu.
Would you like to participate in this study?
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Appendix C: Pharmacy Students Informed Consent Form

Script for Obtaining Verbal Informed Consent for Pharmacy Students
Information to Consider Before Taking Part in this Research Study
Title: An exploration of the role of pharmacists in increasing influenza vaccine uptake in
pregnant women in Florida
Pro # 00038934
Overview: You are being asked to take part in a research study. The information in this
document should help you to decide if you would like to participate. The sections in this
Overview provide the basic information about the study. More detailed information is provided
in the remainder of the document.
Study Staff: This study is being led by Oluyemisi Falope who is a PH.D. Candidate at the
University of South Florida This person is called the Principal Investigator. She is being
guided in this research by Dr. Russel Kirby. Other approved research staff may act on
behalf of the Principal Investigator.
Study Details: This study is being conducted at the University of South Florida. The
purpose of the study is to explore the role pharmacists can play in increasing influenza
vaccine uptake among pregnant women. This would be carried out by exploring
pharmacy school curriculum regarding what is taught regarding influenza vaccine
administration to pregnant women.
Participants: You are being asked to take part because you are a 3rd or 4th year pharmacy
student at an accredited school of pharmacy in Florida. We want to ask you about how
the course content regarding vaccine administration in pregnant women, with a focus on
influenza vaccine is taught at your college. Also, we want to understand your perceptions
about administering influenza vaccines in pregnant women. This focus group session is
expected to last for about 80 minutes. The focus groups will take place at a location
convenient for you (e.g. public place, parks, participant homes), where you will be
comfortable. The focus group sessions will be audio recorded. This is done so that what
you say will be properly captured and not mis-represented.
Voluntary Participation: Your participation is voluntary. You do not have to participate
and may stop your participation at any time. There will be no penalties or loss of benefits
or opportunities if you do not participate or decide to stop once you start. Your decision
to participate or not to participate will not affect your student status, course grade,
recommendations, or access to future courses or training opportunities.
Benefits, Compensation, and Risk: We do not know if you will receive any benefit from
your participation. There is no cost to participate. You will be compensated with a $10
Starbucks gift card for your participation. This research is considered minimal risk.
Minimal risk means that study risks are the same as the risks you face in daily life.
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Confidentiality: Even if we publish the findings from this study, we will keep your study
information private and confidential. Anyone with the authority to look at your records
must keep them confidential. We will do our best to keep your records private and
confidential. We cannot guarantee absolute confidentiality. Your personal information
may be disclosed if required by law. Certain people may need to see your study records.
The only people who will be allowed to see these records are: The Principal Investigator,
the advising professor, the research team and the University of South Florida Institutional
Review Board (IRB).
You will be compensated $10 if you complete the focus group session. If you withdraw
for any reason from the study before completion you will be compensated with a $5 for
participating in the study at all.
Please be advised that although the researchers will take every precaution to maintain
confidentiality of the data, the nature of focus groups prevents the researchers from guaranteeing
confidentiality. The researchers would like to remind you to respect the privacy of your fellow
participants and not repeat what is said in the focus group to others.
If you have any questions, concerns or complaints about this study, call Oluyemisi Falope at
XXXXXXXXXX. If you have questions about your rights, complaints, or issues as a person
taking part in this study, call the USF IRB at (813) 974-5638 or contact by email at RSCHIRB@usf.edu.
Would you like to participate in this study?
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Appendix D: Licensed Pharmacists Informed Consent Form

Script for Obtaining Verbal Informed Consent for Pharmacists
Information to Consider Before Taking Part in this Research Study
Title: An exploration of the role of pharmacists in increasing influenza vaccine uptake in
pregnant women in Florida
Pro # 00038934
Overview: You are being asked to take part in a research study. The information in this
document should help you to decide if you would like to participate. The sections in this
Overview provide the basic information about the study. More detailed information is provided
in the remainder of the document.
Study Staff: This study is being led by Oluyemisi Falope who is a PH.D. Candidate at the
University of South Florida This person is called the Principal Investigator. She is being
guided in this research by Dr. Russel Kirby. Other approved research staff may act on
behalf of the Principal Investigator.
Study Details: This study is being conducted at the University of South Florida. The
purpose of the study is to explore the role pharmacists can play in increasing influenza
vaccine uptake among pregnant women. This would be carried out through exploring the
perceptions on pharmacists as regards to administering influenza vaccines to pregnant
women.
Participants: You are being asked to take part because you are an academic dean at an
accredited school of pharmacy in Florida. We want to ask you about how the course
content regarding vaccine administration in pregnant women, with a focus on influenza
vaccine is taught at your college. This interview session is expected to last for about 60
minutes. The interview will take place at a location convenient for you (e.g. public place,
parks, participant homes), where you will be comfortable. The interview will be audio
recorded. This is done so that what you say will be properly captured and not misrepresented.
Voluntary Participation: Your participation is voluntary. You do not have to participate
and may stop your participation at any time. There will be no penalties or loss of benefits
or opportunities if you do not participate or decide to stop once you start. Your decision
to participate or not to participate will not affect your job status, employment record,
employee evaluations, or advancement opportunities.
Benefits, Compensation, and Risk: We do not know if you will receive any benefit from
your participation. There is no cost to participate. You will not be compensated for your
participation. This research is considered minimal risk. Minimal risk means that study
risks are the same as the risks you face in daily life.
Confidentiality: Even if we publish the findings from this study, we will keep your study
information private and confidential. Anyone with the authority to look at your records
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must keep them confidential. We will do our best to keep your records private and
confidential. We cannot guarantee absolute confidentiality. Your personal information
may be disclosed if required by law. Certain people may need to see your study records.
The only people who will be allowed to see these records are: The Principal Investigator,
the advising professor, the research team and the University of South Florida Institutional
Review Board (IRB).
If you have any questions, concerns or complaints about this study, call Oluyemisi Falope at
XXXXXXXXXX .If you have questions about your rights, complaints, or issues as a person
taking part in this study, call the USF IRB at (813) 974-5638 or contact by email at RSCHIRB@usf.edu.
Would you like to participate in this study?
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Appendix E: IRB Approval

2/6/2019
Oluyemisi Falope
Community and Family Health
RE: Exempt Certification
IRB#: Pro00038934
Title: An exploration of the role of pharmacists in increasing influenza vaccine uptake in
pregnant women in Florida
Dear Ms. Falope:
On 2/5/2019, the Institutional Review Board (IRB) determined that your research meets criteria
for exemption from the federal regulations as outlined by 45 CFR 46.104(d):
(2) Research that only includes interactions involving educational tests(cognitive, diagnostic,
aptitude, achievement), survey procedures, interview procedures, or observation of public
behavior (including visual or auditory recording) if at least one of the following criteria is met:(i)
The information obtained is recorded by the investigator in such a manner that the identity of the
human subjects cannot readily be ascertained, directly or through identifiers linked to the
subjects; (ii) Any disclosure of the human subjects’ responses outside the research would not
reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects’
financial standing, employability, educational advancement, or reputation; or (iii) The
information obtained is recorded by the investigator in such a manner that the identity of the
human subjects can readily be ascertained, directly or through identifiers linked to the subjects,
and an IRB conducts a limited IRB review to make the determination required by 45 CFR
46.111(a)(7).
As the principal investigator for this study, it is your responsibility to ensure that this research is
conducted as outlined in your application and consistent with the ethical principles outlined in
the Belmont Report and with USF HRPP policies and procedures.
Please note, as per USF HRPP Policy, once the exempt determination is made, the application is
closed in ARC. This does not limit your ability to conduct the research. Any proposed or
anticipated changes to the study design that was previously declared exempt from IRB oversight
must be submitted to the IRB as a new study prior to initiation of the change. However,
administrative changes, including changes in research personnel, do not warrant an Amendment
or new application.
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We appreciate your dedication to the ethical conduct of human subjects research at the
University of South Florida and your continued commitment to human research protections. If
you have any questions regarding this matter, please call 813-974-5638.
Sincerely,
Kristen Salomon, Ph.D., Chairperson USF Institutional Review Board
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Appendix F: Sample Student Recruitment Flyer

Are you a 3rd or 4th year Pharm D. student in Pharmacy School?
Then we need YOU to be part of a research study focus group on influenza
vaccine administration in pregnant women with 3rd and 4th year Pharm D.
students at the University of Florida.
Who is eligible?
o 3rd and 4th year Pharm D. students
What will I have to do?
o Participate in a focus group discussion with 7 other students.
o Discuss your disciplines influenza immunization course instruction
o Discuss your perception of administering influenza vaccines to pregnant women
How much time will this take?
o Participation will take approximately 30 minutes
Do I get anything for my time?
o Receive a $10 Starbucks gift certificate and add to scientific knowledge.
When will the group meet?
o Flexible online via zoom or at an agreed location and time
o Dates: 3rd or 4th of June 2019
To participate: Contact Oluyemisi Falope (813) 407-1504 Or email: ofalope@health.usf.edu

IRB number: Pro00038934
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